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SUMMARY 
 
 The ability of generating ions directly from solid samples, in their native state without 
the need for sample preparation is rapidly changing the field of mass spectrometry (MS). 
The key technological innovations enabling these advancements include the development 
of atmospheric pressure ionization MS interfaces and the introduction of ambient 
ionization technologies. Pioneered by desorption electrospray ionization (DESI) 
introduced by Cooks and coworkers in 2004, and followed closely by direct analysis in 
real time (DART) introduced by Cody et al. in 2005, ambient MS methods allow removal 
of sample size and shape constrains, thereby making many objects amenable to direct MS 
analysis. The elimination of sample preparation requirements allows rapid analysis times, 
making such mass spectrometric methodologies more amicable over other techniques 
where throughput is sought, especially when dealing with the analysis of a large sample 
set.  
The work presented in this thesis is aimed at studying some of the fundamental 
processes prevailing in ambient mass spectrometry, and the application of these 
techniques to the detection of molecules of pharmaceutical importance.  A review of the 
state-of-the art in ambient mass spectrometry is presented in Chapter 1. Chapter 2 
presents the first implementation of DESI MS to the chemical fingerprinting of 
counterfeit drug tablets that mimic the vital anti-malarial artesunate. Chapter 3 presents 
an investigation of the effect of performing various ion-molecule reactions in the charged 
liquid droplet/solid sample boundary in DESI and its effect on the selectivity, gas phase 
stability and the associated analyte ion yields for the determination of artesunate in drug 
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tablets. Chapter 4 presents the direct quantitation of artesunate in solid antimalarial 
tablets by DESI MS. Chapter 5 presents the development of a selective and sensitive 
DESI MS protocol for screening of Tamiflu® quality. Chapter 6 presents an 
implementation of DESI MS in imaging mode. In Chapter 7, an investigation of the 
complementarity between DESI and DART is presented, enabling the development of a 
robust multimode ambient ion source.
  1 
CHAPTER 1. AMBIENT MASS SPECTROMETRY  
 
1.1. Abstract 
Ambient ionization mass spectrometry provides the ability to record mass spectra 
on a variety of samples in their native environment, without the need for sample 
preparation or preseparation, by generating ions directly from the sample placed outside 
the instrument. In these methods, analyte desorption/ionization occurs in concert or 
decoupled resulting in several different permutations culminating in a proliferation of 
techniques and acronyms. This chapter presents some of the earlier ionization techniques 
still commonly in use today, underscoring the capabilities provided by ambient MS 
methods. It also portrays some of the technological advancements leading to the 
introduction of this new field, and highlights the different ionization approaches and 
some of their applications since the description of DESI in 2004.1 The multitude of 
techniques that have been reported since then are also sorted into various categories 
based on the physicochemical processes involved in surface sampling and ionization. 
 
1.2. Vacuum Ionization Techniques 
In the past, the range of sample types and chemical species amenable to mass 
spectrometric investigations was greatly limited by the vacuum requirement of the 
spectrometer’s modular components including the ion source, mass analyzer and detector. 
Common ionization sources, for example for coupling gas chromatography (GC) with 
MS, include electron ionization (EI)2 and chemical ionization (CI)3. In EI, ions are 
generated from vaporized neutral analytes by interactions with 70 eV electrons resulting 
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in extensive fragmentation, frequently exploited to obtain structural information. CI 
usually deposits a lower amount of internal energy than EI, with less fragmentation and 
simpler spectra where the intact analyte is easily recognized. In CI, the large ratio of 
reagent gases (e.g methane, ammonia, isobutene) to analyte molecules that interact with 
the electrons entering the ionization volume, results in dampening of the electron’s 
kinetic energy by preferential ionization of the reagent gas. Reactive species produced by 
this process interact with gaseous analyte neutral species resulting in protonated analyte 
ions. The 70 eV energy commonly used to accelerate electrons in EI and CI, results in 
their de Broglie wavelengths matching the typical bond lengths in organic molecules, 
maximizing energy transfer to them and allowing efficient ionization/fragmentation.4 
These techniques have commonly been used in the analysis of low molecular weight 
volatile organic molecules, but fail terribly when applied to molecules larger than 
~700 Da due to the higher number of degrees of freedom.  
Vacuum ionization techniques such as secondary ion mass spectrometry (SIMS), 
vacuum matrix-assisted laser desorption ionization (MALDI), and fast atom 
bombardment (FAB) have also played a pivotal role for chemical interrogation and for 
biomolecule characterization. These techniques provide an extension of the range of 
molecular weights and sample types that can be investigated in vacuum by MS, enabling 
applications in a wide range of fields including biology, material sciences and 
geochemistry.5-7 SIMS is probably the most sensitive surface analysis technique and 
historically has been developed to measure the elemental, isotopic, or molecular 
composition of surfaces. SIMS is able to detect elements present in parts per billion 
ranges by sputtering the sample surface with a primary ion beam, and analyzing the 
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secondary ions generated. MALDI, on the other hand, is a soft ionization technique and 
has extensively been used for analyzing biomolecules such as peptides, proteins sugars 
etc. In MALDI, analyte desorption and ionization is triggered by a laser beam that is fired 
onto the sample, co-crystallized in a matrix. This matrix serves to absorb the laser energy, 
mitigating fragmentation and facilitating vaporization/ionization of the analyte.6 In FAB, 
the analyte mixed with a non-volatile matrix (e.g glycerol, thioglycerol, 
3-nitrobenzylalcohol etc.) is bombarded with a high energy beam of atoms such as argon 
or xenon, resulting in intact gas phase protonated or deprotonated analyte species in the 
positive and negative ion modes, respectively.8 The generation of intact gas phase ions by 
FAB makes it a relatively soft ionization technique, however, not as soft when compared 
to MALDI. One of the main advantages enjoyed by surface chemical interrogation 
techniques such as SIMS and MALDI is their ability to provide spatially-resolved 
chemical information, a feature advantageously exploited for chemical imaging 
applications.7   
 
1.3. Atmospheric Pressure Ionization Techniques 
Driven by the need to investigate high molecular weight species, and for coupling 
liquid-phase separation techniques such as liquid chromatography and capillary 
electrophoresis to mass spectrometry; the introduction of atmospheric pressure ionization 
(API) techniques was a critical milestones in the progressive implementation of the 
present-day mass spectrometer. API sources are characterized by operation at 
atmospheric pressure outside the vacuum system of the mass spectrometer. Technical 
challenges arise from the fact that interfacing of an API source with a mass analyzer 
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requires a 107-108 fold pressure reduction for preserving the mean free path of the ions.9 
In addition, the marriage of liquid chromatography with mass spectrometry (LC-MS) is 
particularly challenging because of the need to vaporize the LC mobile phase prior to MS 
analysis in order to prevent overloading of the vacuum system. In order to meet these 
challenges, two major approaches have been used to couple API ion sources to MS. The 
first approach includes the sampling of ions from the AP region directly into high 
vacuum using either a relatively small orifice (10-25 µm) or a very high pumping 
capacity (> 100,000 L/s) section.10 The second approach, which turns out to be the most 
preferred and probably the only employed today, uses a multi-stage differential pumping 
system. In this approach, ions are first drawn into the sampling orifice from AP 
(760 Torr) into a first chamber where they are pumped down to approximately 1-4 Torr 
by a rotary pump. Secondly, part of the expanding beam of gas and ions is sampled into a 
second chamber pumped down to 10-3 Torr or less, at which point most of the gases and 
solvent molecules have been pumped away. Finally, a suitable arrangement of ion optics 
elements guides the ions to the mass analyzer region.  
Historically important approaches for the generation of ions at atmospheric 
pressure comprise the use of a radioactive metal foil (63Ni) or a plasma initiated by an 
electrical discharge at the tip of a needle held at high voltage, both of which provide a 
source of ionizing electrons.11-13 These ionizing electrons initiate the generation of ions 
by interactions with nearby gases. Because of the short mean free path between 
molecules at atmospheric pressure, the initial species quickly undergo ion-molecule 
reactions with air and other gaseous molecules producing various reactive intermediate 
ions that readily interact with analyte molecules resulting in atmospheric pressure 
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chemical ionization (APCI). Application of these approaches for the analysis of 
condensed phase analytes generally requires heating using a heated gas passing over the 
sample and/or resistive heating. As such, these techniques are limited to the analysis of 
relatively low molecular weight species that can be vaporized intact, thereby precluding 
their application for the analysis of thermally labile, highly polar and high molecular 
weight compounds. In APCI-MS, vaporized analytes with high gas phase basicities or 
acidities are preferentially ionized in positive and negative ion modes respectively. Early 
APCI-MS systems were highly publicized for their ability to rapidly analyze various 
target analytes in complex matrices without the need for chromatography or sample 
clean-up. In these systems, selectivity was afforded by tandem MS with typical 
applications being drugs of abuse and explosives detection.14, 15  
Prior sample separation via chromatography is generally beneficial (perhaps 
necessary) to allow detection of components with lower volatility and/or concentration. 
The most difficult challenge for generating ions of biomolecules from a liquid inlet 
system has been the ability to transition these molecules from the liquid to the gas phase 
without depositing too much internal energy in them to cause degradation. This transition 
normally occurs at the ion source interface and begins with the generation of 
uniform-sized droplets from the liquid effluent stream. Solvent molecules can be 
removed gradually from these droplets to eventually produce gas phase analyte 
molecules/ions. 
The first reported coupling of LC to MS for the analysis of biomolecules was 
reported by Horning in 1974 through an APCI interface. The effluent stream emanating 
from the LC column, generally a mixture of a volatile solvent and analyte, is vaporized 
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using heated nebulizer gas. The vaporized sample then undergoes ionization through 
ion/molecule reactions with reagent ions present in the area surrounding the APCI 
needle.16, 17  
In 1979, Thomson et al. introduced AP Ion Evaporation (APIE), using a 
pneumatic nebulizer to create a spray of droplets from a nebulizer approximately 1 cm 
away from an induction electrode held at 3.5 kV to induce droplet charging.18 Spectra 
obtained using this technique showed solvent clusters in high abundance, resulting in 
poor sensitivity and interferences. The same authors later modified this approach by 
introducing a heated nebulizer probe coupled to a corona discharge needle, such as in 
APCI. This technique gave similar spectra and showed similar limitations to APCI.19  
In 1980, Vestal and coworker introduced Thermospray (TS)20, 21, a technique in 
which an aqueous mobile phase was vaporized as it passed through a heated stainless 
steel capillary located in a heated ion source with no external field charging to induce 
ionization. The composition of the spray after exiting the heated capillary was believed to 
be at least 90 % vapor, the remainder being composed of small droplets containing a 
statistical imbalance of charges originating from pre-charged solutes in solution. Ions 
were generated from these droplets after they gradually decreased in size following 
evaporation of neutral solvent molecules. Because no external field charging was used, 
this technique suffered from poor sensitivity. Later integration of a discharge needle into 
the apparatus allowed for the generation of APCI-type spectra. However, it also suffered 
from poor interday reproducibility with analyte signal intensity exhibiting a strong 
dependence on solvent composition and flow rate. 
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Notwithstanding the partial successes of these techniques, the final breakthrough 
that enabled the facile coupling of LC to MS for widespread routine application for the 
analysis of biomolecules occurred with the introduction of electrospray ionization (ESI) 
by Fenn and coworkers22-24 and Aleksandrov and coworkers.25, 26 In conventional ESI, the 
first essential step involves the dispersion of a sample solution into a charged aerosol, 
which undergoes desolvation as droplets migrate into the high vacuum regions of the 
mass spectrometer. The charged aerosol is generated by application of a potential to the 
exterior of a capillary, which induces charge separation in the through-flow solution. 
Charge builds up at the capillary tip, forming a Taylor cone and causing the forcible 
ejection of a charged droplet. In early experiments, Dole and coworkers in 1968 made use 
of a concurrent flow of inert gas to facilitate droplet desolvation in the analysis of 
negative ions of relatively high molecular weight polystyrene.27  
With John Fenn’s report at a 1988 symposium in San Francisco showing the 
interfacing of ESI with MS for the analysis of peptides and proteins of molecular weight 
up to 40 kDa28 (later extended to 180 kDa the following year22), the golden era of modern 
mass spectrometry begun. Fenn built on his knowledge of free-jet expansions29 to 
improve Dole`s ESI method. Fenn’s approach required a countercurrent flow of N2 for 
efficient droplet desolvation, thus eliminating re-solvation of the formed macromolecule 
ions.  Because the electrospray process requires efficient solvent evaporation, typical ESI 
solutions are prepared by mixing a volatile organic solvent e.g (methanol, acetonitrile) 
with water and small amounts of a weak organic acid (e.g formic, acetic acid etc). The 
charged aerosol emanating from the Taylor cone is sampled into the first vacuum stage of 
a mass spectrometer through a capillary, which is generally heated to facilitate further 
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solvent evaporation. As the droplets/ions transit through the AP and first evacuated 
region, they reach the Rayleigh limit where they become unstable undergoing Columbic 
explosion to give progeny droplets. This cycle continues until the droplets reach such a 
size from which desolvated ions are generated following two proposed mechanisms: (1) 
the ion evaporation model, which suggests that as the droplets reach a certain size, they 
start emitting ions directly into the gas phase after the repulsion forces on the droplet 
surface become high enough to break the surface tension18, or (2) the charge residue 
model, which proposes that charged droplets undergo evaporation and explosion cycles, 
resulting in progeny droplets, which finally contain one analyte molecule per droplet on 
average. Complete evaporation of solvent liberates the analyte carrying the charge 
initially present in the droplet.27 A large proportion of indirect evidence suggests that 
smaller ions are liberated into the gas phase by the ion evaporation mechanism while 
larger ions are formed by the charge residue model.  
Operation of the electrospray ion source at low flow rates such as in micro- and 
nano-ESI to generate much smaller initial droplets results in improved ionization 
efficiency due to the smaller initial droplet population. Because of spray instabilities 
observed in conventional ESI experiments, Henion and coworkers introduced 
pneumatically assisted ESI30 where they used a coaxial flow of an inert gas around the 
spray capillary to facilitate droplet formation.  This has now become the most widely 
used approach for implementing ESI. A variant of pneumatically-assisted ESI is 
electrosonic nebulization, which operates a traditional microESI source with a much 
higher velocity, supersonic nebulizer gas resulting in the preservation of even the weakest 
non-covalent interactions during the transition to the gas-phase.31 The elimination of the 
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spray voltage used in pneumatically assisted ESI has given rise to a relatively new 
technique known as sonic spray ionization (SSI),32, 33 where gas phase ions can be 
generated due to the statistical imbalance in the droplet charge distribution. 
Other AP ion sources which are also gaining a significant amount of popularity 
include: atmospheric pressure photoionization (APPI), the atmospheric pressure version 
of MALDI (AP-MALDI), and atmospheric pressure solid analysis probe (ASAP). In 
APPI, analytes aerosolized from a nebulizer, are selectively ionized by 10 eV photons 
emitted by a krypton discharge lamp. The ionization mechanism in APPI depends on the 
analyte and solvent system used.34-36 High ionization efficiencies are usually achieved in 
the presence of a dopant (e.g toluene) which is directly photoionized generating reactant 
ions. In positive ion mode, and in the presence of an aprotic solvent (e.g hexane, 
chloroform), ionization by charge exchange predominates, while in protic solvents (e.g 
methanol) ionization by proton transfer is the most important pathway. In negative ion 
mode, compounds with high electron affinity ionize by electron capture or by charge 
exchange, while compounds with high gas phase acidities ionize by proton transfer.35, 36  
APPI shows superior performance over ESI and APCI for the analysis of low polarity 
compounds, thus broadening the range of analytes that can be investigated by MS based 
techniques. AP-MALDI is similar to vacuum MALDI with the exception that ions are 
created at atmospheric pressure, resulting in limited sensitivity and mass range. ASAP is 
a commercial corona discharge-based atmospheric pressure ionization technique that was 
introduced in 2005 by McEwen el al.37 In ASAP a solid sample probe is introduced 
directly into the corona discharge region of a commercial APCI ion source via a custom 
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built sample port. Heated N2 nebulizer gas is used to facilitate vaporization of the sample 
from which ions are generated by standard APCI processes.38 
1.4. Ambient Ionization Techniques 
The technological advancements that enabled the establishment of AP ionization 
techniques eliminated the requirement for samples to be ionized in vacuum, greatly 
increasing the scope of compounds amenable to MS analysis and increasing the analytical 
toolbox for the fields of proteomics and metabolomics. However, the need to dissolve, 
extract and/or filter the sample prior to analysis still remains, limiting throughput and 
setting limitations on the type, sizes and shape of samples susceptible to MS analysis. 
Recently introduced ionization techniques operated under ambient conditions aim to 
address these limitations. 
Ambient ionization mass spectrometry allows for the direct analysis of the surface 
of samples of any size, shape texture/morphology by creating ions in the open air. 
Whereas in conventional mass spectrometric experiments the sample is generally 
dissolved prior to analysis, in ambient MS the sample is interrogated in its native state. 
The importance of this new field is reflected by the explosive appearance of a multitude 
of new ionization approaches catalyzed by the introduction of DESI1 in the fall of 2004 
and closely followed by DART.39 Ambient ionization techniques can be separated into 
three major categories based on their associated desorption and/or ionization mechanisms 
including spray or jet based desorption/ionization techniques; ambient gas-, heat-, laser- 
and radiofrequency-based desorption/electrospray-assisted ionization techniques, and 
electric discharge-, beta electron-, photon-based ambient chemical ionization techniques. 
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Spray- or jet-based desorption/ionization techniques include DESI, desorption 
sonic spray ionization (DeSSI40, also referred to as easy ambient sonic-spray ionization, 
EASI41, 42) and probe electrospray ionization (PESI).43-45 Techniques that rely on ambient 
gas-, heat-, laser- and radiofrequency-based desorption/electrospray-assisted ionization 
include fused droplet ESI (FD-ESI),46 extractive electrospray ionization (EESI),47-51 nano 
EESI (nano-EESI),52 neutral desorption sampling extractive electrospray ionization (ND-
EESI),53-55 ultrasonically-assisted EESI (UA-EESI),56 radio frequency acoustic 
desorption/ionization (RADIO),57 electrospray-assisted laser desorption/ionization 
(ELDI),58-63 matrix-assisted laser desorption electrospray ionization (MALDESI),64-67 
laser ablation-electrospray ionization (LAESI),68-70 infrared laser-assisted desorption ESI 
(IR-LADESI),71 and laser-induced acoustic desorption/ESI (LIAD/ESI).72 Techniques 
that rely on electric discharge-, beta electron-, photon-based ambient chemical ionization 
include DART, desorption atmospheric pressure chemical ionization (DAPCI),73, 74 laser 
desorption-atmospheric pressure chemical ionization (LD-APCI),75-77 dielectric barrier 
discharge ionization (DBDI),78, 79 low temperature plasma (LTP),80 plasma-assisted 
desorption/ionization (PADI),81 flowing atmospheric pressure afterglow (FAPA),82, 83 
beta electron-assisted direct chemical ionization (BADCI),84 atmospheric pressure 
thermal desorption/ionization (APTDI),85 and desorption atmospheric pressure 
photoionization (DAPPI).86-89 
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1.4.1. Spray- or Jet-based Desorption/Ionization Techniques: DESI, DeSSI and PESI 
These are open-air ionization techniques where a solvent spray is used to effect 
surface sampling and ionization. A schematic of a typical DESI MS set-up is shown in 
Figure 1, together with all the experimental set-up variables. 
In DESI, a pneumatically assisted ESI source equipped with XYZ translation 
capabilities (for spray positioning) is placed over the sample to be analyzed. An extended 
AP ion transfer capillary is used to lead ions from the surface desorption point to the 
mass spectrometer. The sample is often mounted on a movable stage to facilitate 
positioning, improving reproducibly and providing imaging capabilities. Similar to ESI, a 
voltage between 2-8 kV is applied to the emitter. A combination of the high voltage, 
solvent flow (1.5-10 µL/min), and coaxial flow of high velocity nebulizer gas (100-200 
psi) helps to create charged solvent micro-droplets, which are directed to the sample 
surface creating an elliptical90, 91 impact region from which surface chemicals are 
desorbed. 
 















To MS ion 
optics
 
Figure 1.1. Schematic of a typical DESI MS set-up showing various experimental set-up 
variables. 
 
 The most critical variables in DESI are the tip-to-surface distance (d1), the 
incident angle (α), the spray solvent composition and the gas flow rate. For analytes 
present in a compact solid matrix, sensitivity also depends on sample hardness. For dried 
analytes spots deposited onto hard surfaces, sensitivity also depends on the choice of 
surface material, which determines the degree of analyte-to-surface interactions and the 
crystal size. For the same material, sensitivity and signal stability are a function of the 
surface roughness, with rough surfaces showing better sensitivity than smooth surfaces. 
The DESI emitter is typically positioned 1–3 mm above the surface to be analyzed, and at 
an angle of 45–60 degrees relative to it. The spray-to-capillary distance is typically in the 
2–3 mm range. The mass spectrometer inlet capillary is usually positioned in close 
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proximity of the surface (~1 mm), however, Kertesz and coworkers have shown that up 
to a 5-fold sensitivity improvement can be obtained by positioning the bottom of the 
sampling capillary beneath the surface plane in what they termed “edge sampling”.92 
Other DESI MS configurations have also been reported including geometry independent 
DESI,93 which eliminates sample to sample parameter adjustments, and transmission 
mode DESI,94, 95 implemented for analyzing samples spotted on a mesh. 
 In DESI, the continuous liquid jet directed onto the sample surface results in a 
thin solvent film where surface molecules are dynamically extracted. The solvent flow 
from the spray continuously dislodges the surface film resulting in the generation of 
analyte-containing secondary droplets, sampled downstream by the mass spectrometer 
inlet capillary. Ionization occurs following ESI mechanisms.24, 96 Further evidence of the 
similarity of ESI and DESI ionization mechanisms was provided  by recent internal 
energy deposition studies with thermometer molecules.97 Several mechanisms were 
initially proposed for DESI, including droplet pick-up, momentum transfer, and chemical 
sputtering.1, 98 However, recent investigations utilizing Doppler particle sizing analysis 
provided new insight, supporting the droplet pick-up or ‘splashing’ mechanism, and 
dismissing momentum transfer effects.99 Computational fluid dynamics simulations have 
also confirmed the prevalence of this mechanism.100, 101 
 DESI has been implemented in combination with various types of mass 
spectrometers including linear (LiT), quadrupole (QiT) ion traps,1, 102 triple quadrupoles 
(QqQ),103 orbitraps,104 quadrupole time-of-flights (Q-TOFs),105 Fourier transform ion 
cyclotron resonance (FT-ICR),106 QqQ/LiT,107, 108 miniature handheld rectilinear ion traps 
(RIT),109 ion mobility spectrometry (IMS)/TOFs,110 and ion mobility/QTOF111-113 hybrid 
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instruments. The numerous literature reports on DESI MS demonstrate its potential as a 
powerful tool for a wide range of surface-sampling applications including detection of 
non-volatile pyrolysis products,114 polymers,115 inks,116 various organic compounds,117-119 
carbohydrates,120, 121 peptides,112 semi-volatile organic compounds,122 chemical warfare 
agents,122, 123 intact bacteria,124-126 proteins,127 tissues,128-130 aerosols,131 lipids,132 amino 
acids,133 metabolites,51, 134-136 pharmaceuticals,105, 107, 137-140 drugs of abuse,134 
explosives,141-143 agrochemicals,142, 144 genuine and counterfeit drugs.102, 145-150 
Particularly appealing are those experiments taking advantage of the ‘reactive’ and 
imaging capabilities of DESI as outlined below. 
 In reactive DESI MS the spray solvent is doped with an additive, enabling 
heterogeous chemical reactions between the reagents in the charged micro-droplets and 
condensed phase analytes exposed on the sample surface. These reactions are believed to 
take place in the thin solvent film present on the sample surface or in the secondary 
droplets as they are transported through the atmospheric sampling capillary of the mass 
spectrometer. Reactive DESI MS methods enjoy the same high throughput capabilities of 
conventional DESI, with the added benefits of increased selectivity and/or sensitivity102, 
136, 146, 147, 151-154. The high sensitivity afforded by reactive DESI has also been exploited 
for chemical imaging applications.155 Recently, direct quantitation by reactive DESI of 
active ingredients in pharmaceutical formulations, in the presence of an isotopically 
labeled internal standard has been shown. This approach showed a 6 % precision and 94 
% accuracy.148 Porous tetrafluoroethylene (PTFE) substrates, which show good signal 
stability, have also been used to demonstrate the quantitative capability of DESI MS for 
  16 
the analysis of various analytes spotted together with an internal standard, showing good 
inter-day precision (13 % RSD) and accuracy (±7 % relative error).156, 157  
 Chemical imaging with DESI MS is emerging as a powerful tool for determining 
the two dimensional distribution of various chemical species. It has already been 
employed in applications such as profiling phospholipids in tissue sections,158-162 the 
forensic examination of ink on paper,90, 116, 163 investigation of analyte bands on thin-layer 
chromatography plates,164 analysis of propanolol in whole mice body sections,165 active 
ingredient in pharmaceutical tablets,145 bromophycolides on alga tissue etc.166 In DESI 
imaging the sprayer is kept in a fixed position and a specimen is mounted on an 
automated sample stage that is programmed to move in a predetermined raster pattern, 
allowing the DESI spray to probe specific points of the sample surface. Fundamental 
investigation of the surface scanning and alignment conditions conducted by Van Berkel 
and colleagues have shown that fixing the DESI source positioning and distances relative 
to the sample is critical, and that chemical image resolution is enhanced by utilizing 
unidirectional scanning instead of raster scanning.90, 91 The lateral resolution for routine 
applications is estimated to be less than 500 µm, however for samples with a uniform 
texture and appropriately strong analyte-to-surface interaction, lateral resolutions 
approaching 40 µm are achievable by exerting very careful control of operational 
parameter such as the spray tip-to-surface distance, solvent flow rate and spacing of lane 
scans.167 
 Very similar to DESI is a technique termed desorption sonic spray ionization 
(DeSSI),40 also referred to as EASI,41, 42, 168-170 the only difference in terms of 
implementation being that no voltage is applied to the spray solution, which leads to 
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inferior sensitivity. It is believed that droplet charging in DeSSI occurs as a result of 
statistical fluctuations of the charge spatial distributions within the sprayed droplets such 
as in the SSI mechanism.32, 33, 171, 172 The capabilities of DeSSI have been showcased in 
various applications including the analysis of TLC plates,41 biodiesel,168 perfumes,169 
fabric softeners,170 and has been coupled to membrane introduction MS for the analysis 
of drug molecules.42 
 In PESI, a solid needle is used to probe the surface of a wet sample resulting in 
the pick-up of a small amount of biological fluid (0.35 ± 0.09 pl) by adhesion to the 
needle tip.45 The needle is then actuated to the sampling inlet of the mass spectrometer 
where an electrospray is initiated by turning on the potential on the needle probe. In the 
case where the biological fluid dries out before the needle gets to the MS inlet, the 
sample can be re-dissolved (prior to electrospray initiation) by solvent vapors generated 
from an auxiliary heated solvent sprayer. PESI has been used in the analysis of biological 
samples such as mouse brain, urine, mouse liver, salmon eggs, and fruits44 and in the 
ambient molecular imaging of rat brain tissues with 60 µm lateral resolution.173 
 
1.4.2. Ambient Gas-, Heat-, Laser-, or Radiofrequency-based Desorption/Electrospray-
assisted Ionization Techniques: FD-ESI, EESI, nanoEESI, ND-EESI, UA-EESI, 
RADIO, ELDI, MALDESI, LAESI, IR-LADESI and LIAD/ESI 
These techniques decouple the processes involving analyte desorption and/or 
transport from the subsequent electrospray-assisted ionization event for the generation of 
gas phase ions. FD-ESI46, 174 introduced by Shiea and coworkers, and essentially the same 
as EESI49, introduced by Cooks et al. have both been shown to be very useful for the 
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analysis of solution phase analytes in the presence of relatively high salt contents. In 
these techniques, an analyte solution is nebulized into a fine aerosol and directed towards 
highly charged micro-droplets emanating from an ESI emitter. This gives progeny 
analyte-containing droplets following fusion, with subsequent ionization by electrospray 
processes.  Both techniques rely on liquid-liquid extraction for the uptake of analytes into 
progeny droplets resulting in selectivity being largely dependent on the relative solubility 
of sample components in the electrospray solvent. Using methanol as ESI solvent, Shiea 
and coworker were able to obtain good quality spectra of various peptides and protein 
including cytochrome C in solutions containing up to 10 % w/w NaCl.46 The high salt 
tolerance of the technique has also been showcased in the direct analysis of undiluted 
urine, milk, serum and polluted waters without sample clean-up by Cooks and 
coworkers.49 Chen and coworkers introduced a variant of EESI termed nanoEESI where a 
conventional nanoESI emitter is used for the generations of charged solvent droplets, 
which are then fused with an analyte-containing aerosol.52 Zenobi and coworkers have 
also described a clever variant of EESI, which they termed ND-EESI.54, 175 In ND-EESI, 
analytes are desorbed or aerosolized from a sample using a gentle stream of nitrogen or 
air to give an analyte-containing gas stream, which is then merged with the normal 
desolvation gas stream of a pneumatically assisted ESI emitter. Coupling ND-EESI to a 
hybrid Q-TOF mass spectrometer allowed rapid metabolic fingerprinting of a wide 
variety of biological samples with detection limits as low as 10 femtograms/cm2.53 Other 
applications of ND-EESI include the rapid analysis of fruits for maturation47 
manipulation of the charge state of biopolymers,48 in-vivo fingerprinting of nonvolatile 
compounds in breath,50 sampling on living tissues including human skin, plant tissues,53 
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analysis of perfumes,176-178 and coupling to a hybrid Q/IMS/TOF instrument for the rapid 
analysis of drugs.55 
UA-EESI and RADIO use ultrasonic volatilization for decoupling analyte 
desorption from subsequent electrospray-assisted ionization. In UA-EESI a small sample 
droplet (~3 µL) is deposited on an ultrasonic transducer and nebulized into an aerosol. In 
RADIO, an analyte solution (1 µL) is deposited onto a quartz crystal microbalance 
(QCM) and immediately aerosolized by radiofrequency actuation. The sample aerosol 
generated is entrained by charged droplets from an ESI emitter resulting in the extraction 
and ionization of sample constituents. UA-EESI has been coupled to a hybrid QTOF 
mass spectrometer and has been successfully applied to the detection of melamine in 
various food matrices including raw milk, wheat gluten, and milk powder.56  RADIO has 
been coupled to a hybrid LiT/FTICR mass spectrometer for the analysis of some model 
peptides, including melittin and ubiquitin.57  
A few different laser-based techniques have been reported. These decouple 
surface sampling by laser desorption/ablation from the subsequent electrospray-assisted 
ionization for the generation of ions from various samples in the open air including 
ELDI, LAESI, MALDESI, and IRLADESI. In ELDI, first reported by Shiea and 
coworkers,62 a 337 nm N2 laser operating at 20 µJ per shot is used to ablate samples 
placed underneath an electrospray plume. The ablated material is then captured by the 
charged micro-droplets with subsequent ionization by ESI processes, leading to the 
observation of multiply charged species such as peptides and proteins. ELDI has been 
employed for the characterization of various chemicals on the surface of different solids 
including paintings, compact discs, drug tablets, tissue samples,60, 62 identification of 
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organic compounds separated on TLC plates,61 characterization of the polar components 
of crude oil, analysis of amber and humic substances,59 continuously monitoring the state 
of ongoing chemical reactions,58 detection of intact multiply-charged proteins (up to 66 
kDa) and tryptic digests.62, 63, 179 In-situ chemical reactions between reagents that are 
incorporated into the electrospray solvent and laser ablated analyte species have also been 
implemented within this technique and referred to as reactive ELDI.180  
MALDESI is a hybrid ionization technique very similar to ELDI (both use UV 
lasers) with the only difference being the use of an organic acid matrix in the former, 
which affords increased sensitivity and is believed to extend the limit of detection and 
molecular weight range of ELDI.64, 66 Analysis of peptides and proteins by MALDESI 
results in the generation of multiply charged species suggesting ESI to be the 
predominant mechanism for ion generation.64, 65 An infrared laser has also been used for 
MALDESI for the direct top-down characterization of carbohydrates, proteins and 
lipids.181  A variant of this technique referred to as liquid MALDESI (Liq-MALDESI) 
has also been reported where ions are generated by laser ablation of a liquid sample that 
is deposited onto a stainless steel target and biased up to 3 kV. In this case multiply 
charged ions of peptides and proteins are generated from the liquid sample directly 
without any secondary ionization.67 The liquid sample is reported to act as a macroscopic 
charged droplet similar to those generated by electrospray ionization, resulting in the 
generation of multiply charged ions.  
LAESI and IR-LADESI employ electrospray-like ionization of entrapped material 
ablated and/or desorbed from a surface by an IR laser source. The penetration of the IR 
lasers used in these techniques is several orders of magnitude larger than the UV lasers 
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used in ELDI or MALDESI, resulting in the removal of larger amounts of material from 
the sample surface. Nemes and Vertes developed LAESI by sampling the ablation plume 
formed by an Er:YAG laser with the spray from an ESI emitter.69 The implementation of 
the laser source at a 90o angle respect to the sample surface is believed to preferentially 
contribute to sample ablation.69 Femtomolar-level detection limits for proteins, lipids, and 
metabolites were attained.69 LAESI has been used for two dimensional imaging and 
depth profiling applications68, 70 and is the only ambient MS techniques with 
demonstrated capabilities for 3D chemical imaging.182 The Murray group developed a 
similar technique termed IR-LADESI for the direct analysis of biological fluids and 
pharmaceuticals.71 In this case, the laser was positioned at 45o with respect to the sample 
surface, and lower pulse energies were used, resulting in both ablation and desorption of 
surface neutrals.71 The mechanisms of both LADESI and IR-LADESI are probably 
similar, where the material ablated from the surface interacts with ESI droplets, in a 
dynamic solid–liquid extraction-like process. It has been postulated that in IR-LADESI, 
small, more volatile materials are directly desorbed as free molecules, and incorporated 
directly into ESI droplets. 
In LIAD/ESI, a sample solution deposited on a metal foil is irradiated in 
transmission mode with a Nd:YAG IR laser that creates acoustic waves, which propagate 
through the foil, enabling thermally-assisted sample desorption. The analytes then 
interact with the charged droplets from as ESI emitter to give single and multiply charged 
ions following ESI processes. LIAD/ESI has been used for the analysis of small organic 
and large biological compounds including amino acids, peptides, and proteins.72 
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1.4.3. Electric Discharge-, Beta Electron-, or Photon-based Ambient Chemical 
Ionization Techniques: DART, DAPCI, LD-APCI, DBDI, LTP, PADI, FAPA, BADCI, 
APTDI, DAPPI 
This group of techniques takes advantage of ion-molecule reactions to effect 
ionization of desorbed analyte from various samples. DART is a commercial ambient 
ionization technique that was introduced by Cody et al in 2005.39, 183 In DART, a glow 
discharge sustained by the continuous flow of He gas results in the generation of 
electronically excited (metastable) He atoms (23S1, 19.82 eV) with lifetimes of up to 
8000 s.184 The gas stream carrying these metastables is heated (to facilitate thermal 
desorption of analytes) before exiting the ionization source where Penning ionization 
occurs to eventually generate protonated water clusters. In positive ion mode, the 
protonated water clusters serve as proton transfer reagents for chemical ionization of 
analytes desorbed from samples placed directly within the ionization region. Under 
appropriate conditions, oxygen radical (O2
+•) and nitric oxide (NO+) cations can also be 
generated by Penning ionization both of which are dependent on the source-to-mass 
spectrometer distance, the grid potential and/or addition of various charge exchange 
reagent in the sampling region. These modify the chemistry of the reactive ionization 
region resulting in analyte ionization by charge exchange, hydride abstraction, or/and 
oxidation reactions.39, 183, 185 In negative ionization mode ionization occurs predominantly 
by electron capture (EC), dissociative EC, proton transfer, and anion attachment.38, 186 Ion 
transmission efficiency within the DART ionization region has been shown to dependent 
on complex coupled fluid dynamic, heat transfer and electrostatic phenomena, which are 
determined by sample placement considerations.187 Ion transmission has also been shown 
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to improve by about two orders of magnitude when the DART ion source is coupled to 
the mass spectrometer through a commercial VAPUR® interface, which acts as an 
gas/ion separator.188 Because of its commercial nature, DART has enjoyed a significant 
amount of popularity and its potential has been demonstrated for several applications 
including the analysis of whole bacterial cells,189 planar chromatography plates,190 flavors 
and fragrances,191, 192 reaction product monitoring,193 self-assembled monolayers,185 
contaminated pet food,194 drinking water,195 writing ink,196 in-vivo hydrocarbon 
analysis,197 counterfeit drugs,145, 150, 198-200 authentication of olive oils,201 urine samples 
for drugs of abuse202 and for quantitative analysis of drugs in biological matrices.188 Very 
similar to DART is the technique referred to as FAPA,82, 83 introduced by Hieftje and 
coworkers. The major difference reported between DART and FAPA is the fact that 
DART operates within a corona-to-glow transition (C-G) discharge regime, whereas 
FAPA operates via a glow-to-arc transition (G-A) discharge.203 Some applications of 
FAPA include the direct detection of volatile organic compounds,82 tea leaves, coffee 
beans, pharmaceutical tablets83 and for elemental analysis.204 Laser ablation had also 
been used to decouple analyte desorption from FAPA ionization for the ambient chemical 
imaging of pharmaceutical tablets.205 
DAPCI, originally introduced by Cooks and coworkers in 2005, uses toluene as 
the reagent gas in a modified DESI sprayer where the spray capillary is replaced with a 
sharp stainless steel needle to generate a corona discharge.206 DAPCI has been observed 
to show superior performance for ionizing compounds of moderate to low polarity than 
DESI139, and is preferred in cases where the sample surfaces may be damaged by the 
application of DESI solvent spray.74 In DAPCI, the plasma generated by the electrical 
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discharge interacts directly with the sample enabling direct surface sampling/ionization 
by APCI processes, unlike in DART, which employs a non-contact plasma physically 
separated from the ionization region. DAPCI has also been implemented without the use 
of carrier gases. Instead, ambient air, with about 60 % relative humidity, was used as a 
reagent to generate primary ions.207, 208 Applications of DAPCI include the trace detection 
of pharmaceuticals, molecular markers of meat spoilage, impurities, explosives, 
herbicides, chemical warfare agent simulants, illicit drugs, peptides and tea products.73, 74, 
139, 207, 208 Doping the carrier gas with chemical reagents such as ammonia can also enable 
gas phase ion/molecule reactions improving the sensitivity of the technique.73  
In an earlier technique referred to as LD-APCI, laser desorption has been coupled 
to APCI using a corona discharge in ambient air. LD-APCI was initially implemented to 
probe the gas-phase neutral molecule population generated by the AP-MALDI. The 
source utilizes a laser pulse to desorb molecules from a stainless steel target followed by 
chemical ionization via reagent ions produced by a corona discharge. The technique has 
been shown to provide up to three orders of magnitude improvement in the AP-MALDI 
signal.75, 209 LD-APCI has been used for various applications including the analysis of 
compounds separated by TLC,210 peptides from aqueous solution,75 and proteins 
separated on polyacrylamide gels.76, 77  
DBDI, LTP and PADI are electric discharge-based ionization techniques which 
differ from DAPCI, DART and FAPA in that they use an alternating voltage to drive the 
electrical discharge. In DBDI a low temperature, dielectric barrier discharge is created 
between a hollow stainless steel needle (discharge electrode) and a dielectric barrier 
material (glass). The AC voltage that initiates the discharge is applied between the 
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discharge electrode and a copper sheath electrode holding the dielectric barrier material. 
In DBDI, the dielectric barrier material also serves as the sample plate. The discharge is 
sustained by the flow of He gas through the hollow discharge electrode to generate 
metastable helium atoms and fast electrons, which serve to induce desorption and 
ionization of analytes. DBDI has been used for the analysis of amino acids79 and 
explosives.78 LTP is very similar to DBDI, the only difference being that in LTP the 
dielectric barrier discharge is created between a grounded stainless steel electrode and a 
glass tube surrounding it. The discharge gas (He, Ar, N2 or air) flows through a small gap 
between these two electrodes. The counter electrode consists of a copper tape 
surrounding the outside of the glass tube. This design allows the low temperature plasma 
to be projected away from the probe, enabling the direct analysis of a broader range of 
sample types than DBDI. LTP has been used for the analysis of explosives on PTFE 
substrates, cocaine on human skin, active ingredients in pharmaceutical tablets, toxic and 
therapeutic compounds in complex biological samples,80  and recently for to the detection 
and quantitation of melamine in milk.211 PADI employs a radiofrequency driven non-
thermal atmospheric glow discharge in helium, to probe the surface of various samples.81 
The plasma normally extends up to 10 mm away from the probe tip and can be brought 
into direct contact with the sample to effect desorption/ionization of various surface 
chemicals. PADI has been used for applications in the analysis of pharmaceuticals 
tablets, tobacco and garlic.81 
BADCI is a technique recently introduced by Fernández and coworkers where 
thermally assisted analyte desorption is followed by chemical ionization under 
atmospheric pressure. The unique feature in BADCI is that the reactions leading to the 
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formation of CI reagent ions are initiated by beta electrons emitted from a low activity 
(~10 µCi) 63Ni probe eliminating the need for high voltages within the ionization region. 
BADCI has been used for the direct analysis of pharmaceutical tablets.84 
Direct thermal ionization of condensed phase species in the ambient environment 
was first reported by Cooks and coworkers in a technique referred to as APTDI. This 
technique has been shown to be very useful for the analysis of inorganic and organic salts 
including ionic liquids.85 In APTDI, a sample is placed in a tube and heated, resulting in 
the breakdown of the strong ionic interactions, followed by sublimation of one or both of 
its counter ions. The flow of N2 carrier gas through the tube helps to transfer the 
sublimated counter ions to the mass spectrometer for detection. Doping the carrier with 
various protic solvents such as methanol has been shown to enable chemical ionization of 
vaporized neutrals by gas phase protonation.85 
In DAPPI a heated nebulizer microchip is used to deliver a hot jet of vaporized 
solvent (e.g toluene) to facilitate the thermally-assisted desorption of analytes from 
various surfaces. A krypton discharge UV lamp emitting 10 eV photons and positioned 
~10 mm above the sample spot then effects the ionization of vaporized neutrals following 
similar mechanisms such as in APPI.86-89 One of the major advantages of DAPPI is its 
superior performance for the analysis of low polarity compounds compared to DESI.86 
Together with applications in the analysis of low polarity compounds,86 DAPPI has also 
been employed in the analysis of illicit drugs.88, 89 
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1.5. Conclusions 
The introduction of ambient MS methods has triggered a renewed interest in the 
field of analytical mass spectrometry due to the removal of some of the bottlenecks 
present in AP ionization techniques. Ambient mass spectrometry preserves spatial 
chemical information, avoids dilution and maximizes sensitivity. The breadth of this new 
field is reflected by the explosive appearance of a multitude of new ionization 
approaches, which continue to provide unprecedented capabilities such as rapid 
quantitative screening, high throughput imaging, and direct in vivo analysis. 
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CHAPTER 2. CONSTRUCTION OF A PROTOTYPE DESI MS ION 




This chapter presents the implementation of DESI MS for the rapid 
characterization of counterfeit artesunate antimalarial tablets. Proof-of-concept results on 
coupling a custom-built DESI ion source interfaced to a linear ion trap (LiT) mass 
spectrometer for the routine characterization of counterfeit artesunate tablets collected in 
South East Asia are presented. The results are complemented and validated using 
attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopic 
imaging analysis enabling the facile typing of samples based on their chemical 
fingerprints.   
 
2.2. Introduction 
Malaria is a life threatening parasitic disease transmitted by Anopheles 
mosquitoes. It is a risk for some 40 % of the world’s population, and claims over one 
million lives each year.212, 213 To date, there are no effective vaccines to prevent malaria 
in humans and, as such, prevention and treatment has depended on potent antimalarial 
drugs including chloroquine, sulfadoxine-pyrimethamine etc. Unfortunately, in many 
areas all of these have become ineffective, due to development of drug resistance.214 The 
current increase in drug resistance to malaria treatments not only threatens the life of any 
individual who travels to malaria-endemic areas, but also damages the economies of 
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tropical countries, which are a major market for goods and services.215 The most effective 
treatment therapies, especially for the multidrug resistant Plasmodium falciparum malaria 
parasite strain, are based on semi-synthetic artemisinin derivatives (depicted in Figure 
2.1); the most common one being artesunic acid (artesunate). Artemisinin is a 
sesquiterpene lactone isolated from the Chinese herbal plant Artemisia annua, which is 
then converted into various semi-synthetic derivatives to improve solubility and  
 
Artemisinin R1, R2 = O                 
Dihydroartemisinin R1 = H, R2 = OH                   
Artemether R1 = H, R2 = OMe
Arteether R1 = H, R2 = OEt
Artelinic acid R1 = H, R2 = OCH2C6H4CO2H                
Artesunic acid R1 = H, R2 = O2CCH2CH2CO2H
 
Figure 2.1. Structure of artemisinin and its derivatives. 
 
bioavailability. Artemisinins contain an endoperoxide linkage in their structure believed 
to be responsible for their antiparasitic activity by causing free radical damage to the 
parasitic membrane systems.216 With malaria being one of the principal health problems 
in developing countries, and antimalarial drugs representing a large sector of the 
pharmaceutical market, these drugs have been increasingly targeted by counterfeiters. 
 Counterfeit drugs are pharmaceutical products, which are deliberately and 
fraudulently mislabeled with respect to their identity and/or source. This includes 
products, which contain wrong active pharmaceutical ingredient(s) (APIs), insufficient 
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quantities of the API(s), no API(s), and/or false packaging. Basically, a counterfeit drug 
is produced with the intent of deceiving the customer and should be differentiated from a 
substandard drug, which is simply a drug produced by the genuine manufacturer, but that 
does not meet the quality standards set for it. Counterfeit antimalarials have been 
particularly detected in SE Asia and Africa, as malaria is one of the principal health 
problems in those areas.198, 200, 217-220 Since 1998 an “epidemic” of multiple types of 
counterfeit artesunate tablets has occurred in mainland SE Asia. Ad hoc surveys 
conducted since 2000 in Myanmar, Lao People’s Democratic Republic (Lao PDR, Laos), 
Cambodia, Vietnam, and along the Thai-Myanmar border suggested that 33-53% of 
bought artesunate was counterfeit, containing either no or subtherapeutic quantities of 
artesunate.200, 217, 218, 220-223 In SE and East Asia there are at least 16 manufacturers of 
artemisinin and its derivatives and millions of tablets are produced each year both for 
consumption in Asia and export to Africa. Of these manufacturers, one major producer of 
artesunate, Guilin Pharmaceutical Co. Ltd. (Guilin, Guangxi autonomous region, China), 
has been particularly targeted by counterfeiters resulting in 16 different types of fakes so 
far.200 
 The consumption of fake antimalarial medicines is believed to have resulted in 
more deaths than have been documented220, 224 as various evidence suggests that the 
production of counterfeit antimalarials is on an industrial scale.200  One example is a case 
where one health care organization in SE Asia purchased 100,000 artesunate tablets, all 
of which were later shown to be counterfeit.218 In another related example, an alliance 
between Belgian and Chinese authorities resulted in the interception of 57,000 packs of 
counterfeit halofantrine capsules (another antimalarial) en route from China to Nigeria.225 
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 Conventional antimalarial tablet analysis is generally carried out via liquid 
chromatography with optical or mass spectrometric detection.222, 226, 227 Although these 
methods offer comprehensive information on sample composition, they suffer from 
throughputs of a few samples per hour. Since artesunate tablets are manufactured in the 
millions in Asia and Europe, exploring new approaches for antimalarial tablet screening 
is central to rapidly ensuring the quality of the genuine product and for the early detection 
of fakes.  
 In this study, a prototype DESI ion source was constructed and tested for the 
routine rapid chemical fingerprinting of various types of counterfeit artesunate 
antimalarial tablets. The DESI MS results were complemented and validated using 
attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopic 
imaging. FTIR spectroscopic imaging has been shown to be a versatile tool in 
pharmaceutical analysis with a broad range of applications, ranging from the 
characterization of drug formulations to the elucidation of kinetic processes in drug 
delivery.149, 228-235 ATR-FTIR is also advantageous for the analysis of pharmaceutical 
tablets because the analysis is non-destructive, therefore requiring no sample preparation. 
In FT-IR imaging, infrared spectra are acquired at different areas on a sample in a 
grid pattern, and the variation of the intensity of a specific absorption band that represents 
a particular component can be plotted as a map to obtain an image that corresponds to the 
2 dimensional distribution of that component in the sample. Conventionally, this is 
achieved by performing a point-by-point mapping with an aperture and a computer-
controlled motorized stage, making it a very time-consuming process. With the 
introduction of the focal plane array (FPA) detector, images based on the distribution of 
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IR absorption bands can be collected within a matter of a few minutes or even seconds 
with up to 4 µm lateral resolution.230 
In this study, the combined potential of DESI MS and ATR-FTIR as orthogonal 
and complementary tools for rapidly screening and characterizing counterfeit antimalarial 
tablets is evaluated. 
 
2.3. Experimental Details 
2.3.1. Sample Collection 
Sample collection for the present study and for the routine chemical 
characterization of artesunate samples by DESI MS in various studies was coordinated by 
Dr. Paul N. Newton. Since 1998, sixteen different types of fake artesunate samples have 
been cataloged as shown in the next section. Counterfeit and genuine artesunate tablets 
were collected in a wide area of SE Asia encompassing Laos, Myanmar, Vietnam, 
Cambodia, and along the Thai-Myanmar border. Figure 2.2 shows a map of the 
distribution of fake artesunate in relation to the fake packaging type. As a 
proof-of-concept, a total of six samples constituting six different packaging types were 
evaluated in this study. These included a genuine sample and five counterfeit samples 
with the following collection codes: 11 KHA P 7/1 #2 (Type 4), 12 PAS P 64/1 (Type 8), 
S 12/2005 (Type 9), Lao 05/03 (Type 11) and S 40-1 (Type 13).  
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Figure 2.2. Map of the distribution of fake artesunate as of 2008, compiled by the 
Wellcome Trust-University of Oxford SE Asian Tropical Medicine Research Program 
and collaborators. Map taken from Newton, et al.200 
 
2.3.2. Analysis of Physical Appearance and Tablet Packaging 
 The manufacturer of the most commonly counterfeited artesunate antimalarials; 
Guilin Pharmaceutical Co. Ltd. first developed a hologram as a security measure in 
response to the first type (‘Type 1’) of counterfeit artesunate circulated, which had no 
hologram attached. As a result, any ‘Guilin Pharmaceutical Co. Ltd’ artesunate 
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circulating without a blister pack hologram is almost certainly counterfeit or expired. 
Thereafter, a total of sixteen different hologram types, which mimic the genuine 
packaging used by Guilin (Figure 2.3.a) have been found in Southeast Asia with 
counterfeit stickers or holograms, and there are probably more types circulating. 
The physical appearance, text on packets, leaflet inserts and blisterpacks were 
examined by Paul Laurin of the Royal Canadian Mounted Police Forensic Laboratory 
Services, National Anti-Counterfeiting Bureau in Ottawa, Ontario, Canada. 
For these analyses, tablets are compared with known genuine Guilin 
Pharmaceutical Co. Ltd artesunate obtained directly from the company. Packets, leaflets 
and blisterpacks are examined with an x6 hand lens, x100 stereo microscope and a 
handheld UV (375nm) light source and then electronically scanned. Batch numbers, 
expiration and manufacture dates, the color, clarity and text of printing on the blisterpack, 
packet and leaflet (when present) are documented. Guilin Pharmaceuticals Co. Ltd. then 
provides information about the validity of batch numbers. 
Figure 2.3 shows blister pack holograms for the samples analyzed in this study 
with the counterfeit holograms showing a range in sophistication with the most common 
feature being the misalignment of the blocks forming the circular border of the Guilin 
logo. The different counterfeit holograms show various specific features including: Type 
4, which is a good hologram copy but lacks microscopic ‘Guilin Pharma’ legend and has 
‘Tablte’ printed on blisterpack (Figure 2.3.b), Type 8, which has a poor sticker with 
shoulder plateau on mountain with abbreviations of ‘MFG’, ‘EXP’ in capital letters 
(Figure 2.3.c), Type 9, which is a good hologram with ‘Guilin Pharma’ legend in correct 
font (Figure 2.3.d), Type 11, which has a sticker similar to Types 8 but mountain outline 
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differs and also has abbreviations of ‘MFG’, ‘EXP’ in capital letters (Figure 2.3.e) and 
Type 13, which has a hologram, with similar mountain outline to Types 4 but with 
different pictograms and outer circle with no ‘Gulin Pharma’ legend (Figure 2.3.f). For a 
full description of all fake packaging identified, see Figure S-1 from Newton, et al.200 
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Figure 2.3.  Hologram type of samples evaluated in this study, (a) genuine Guilin 
Pharmaceutical artesunate blister pack hologram, (b) Type 4, (c) Type 8, (d) Type 9, 
(e) Type 11, (f) Type 13.236 
 
2.3.3. DESI Ion Source 
The custom-built DESI ion source consisted of a movable sample stage and a high 
performance sprayer based on the oscillating capillary nebulizer (OCN) concept 
(Figure 2.4). The OCN produces primary droplets with a small mean diameter and 
narrow size distribution compared to conventional pneumatic nebulizers, thus potentially  


















Figure 2.4. Schematic of a custom-built DESI ion source coupled to a commercial linear 
ion trap (LiT) mass spectrometer. 
 
maximizing surface doesorption/ionization.237 
The spray emitter consisted of a 18.2 cm long inner spray capillary (147 µm o.d., 
50 µm i.d.) surrounded by an outer nebulizer gas capillary (358 µm o.d., 250 µm i.d.), 
both made from polyimide-coated, fused silica tubing (Polymicro Technologies, Phoenix 
AZ). The inner capillary was offset from the outer capillary by 0.2 mm, which gave the 
most stable spray conditions. This distance can be manually adjusted by screwing the two 
pieces that conform the sprayer body, thus changing their position with respect to each 
other. The inner capillary is fixed to the proximal piece of the sprayer, and the outer 
capillary is fixed to the distal piece. Samples are held in a cylindrical brass hollow tablet 
holder (9.3 mm i.d., 3.5 cm deep), which is mounted at the distal end of a 10.2 cm-long 
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laminated carbon fiber piece, which is affixed to a manual x-y translational stage. The 
sprayer tip, from where charged microdroplets are emitted, is positioned at 5-6 mm from 
the mass spectrometer capillary inlet, and 1-2 mm away from the surface of the mounted 
tablet, at an angle of 55o. The collection angle was approximately 0o. The sample holder 
is mounted on a system of rods and clamps affixed to the bench where the mass 
spectrometer is placed. The nebulizer gas consists of nitrogen. The spray solution is 
normally biased via an external high voltage power supply (SRS PS350, Sunnyvale CA), 
which is placed in electrical contact with the spray solution through one of the ports of a 
T union. The DESI spray mixture is usually delivered to a second port of this T union by 
a 500 µL glass syringe (Hamilton Company, Reno, NV). The third port of the T union is 
connected to the DESI sprayer by a short piece of 127 µm i.d. PTFE tubing.  
 
2.3.4. DESI MS 
All reagents were used as purchased, without additional purification. HPLC grade 
acetonitrile (Fisher, Hampton NH), dodecylamine (DDA) (Sigma-Aldrich, St. Louis MO) 
was used for “reactive” DESI (See details in Chapter 3) experiments. Ultrapure water 
(18.2 MΩ cm-1) was obtained from a Nanopore purification unit (Barnstead, San Jose 
CA).  
DESI MS experiments were performed by coupling the DESI ion source to an 
LTQ linear ion trap mass spectrometer (Thermo Finnigan, San Jose, CA). Dr. Charlene 
Bayer and Dr. Victor de Jesus in the Georgia Tech Research Institute provided access and 
training on the use of this instrument. “Reagentless” DESI MS was performed by 
spraying samples using a solution of 75:25 CH3CN:H2O unless stated otherwise, at a flow 
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rate of 5 µL min-1. The spray was pneumatically assisted by a coaxial spray of N2 gas at a 
flow rate of 0.3 L min-1. The spray solution was electrically charged to ±3 kV, depending 
on the ionization mode used. For all experiments, the mass spectrometer was auto-tuned 
for optimum detection of analytes of interest. Data was acquired via the Xcalibur 
software interface set to collect spectra in automatic gain mode for a maximum ion trap 
injection time of 200 ms, and 2 micro-scans per spectrum. The capillary temperature was 
set to 300oC. Tablets were mounted on an x-y stage and exposed to the DESI jet for 6 s, 
resulting in a maximum sample throughput of approximately 6 samples min-1, if the time 
taken to place a tablet in the sample holder is taken into account. Artesunate analysis by 
LC-MS requires approximately one hour per sample, if the time required by the sample 
preparation steps are included in the calculation.222 For this study, several points on the 
tablet surface were sampled in order to obtain an accurate picture of the components 
present. In addition to reagentless DESI, one of the samples (S 12/2005, Type 9) was also 
analyzed by “reactive” DESI MS by spraying the sample with a solution containing 
100 µM dodecylamine in 75:25 CH3CN:H2O, to further verify the identity of its 
constituent(s).  
 
2.3.5. FTIR Spectroscopic Imaging 
FTIR imaging experiments were performed by Dr. Camilla Ricci, a postdoctoral 
associate with Dr. Sergei Kazarian in the Department of Chemical Engineering in 
Imperial College, London. For these experiments, an FPA detector (Santa Barbara, USA) 
comprising 16384 pixels arranged in a 128x128-grid format was used to measure FTIR 
spectra with a spectrometer operating in continuous scan mode. Spectra were collected 
with 8 cm-1 spectral resolution in the 4000-900 cm-1 range using 32 scans. The chemical 
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images were obtained by attributing a color to each pixel according to the absorbance of a 
spectral band characteristic of a given compound. In the micro ATR configuration, the 
spectrometer and the FPA detector were coupled to an infrared microscope with a 20x 
cassegrainian objective and a Ge ATR crystal. The total area imaged was 64x64 µm2. 
 
2.4. Results and Discussion 
The short sampling time requirement for high-throughput analysis of 
pharmaceutical tablets by DESI MS allows only the first layer of the sample to be probed 
by the DESI spray. For the analysis of counterfeit pharmaceutical, which in most cases 
are highly inhomogeneous (due to poor manufacturing practices) the spray impact area is 
a very important parameter as it determines the surface chemical information content that 
can be captured as the DESI spray plume bounces off the sample surface. The surface 
information content is expected to increase with the size of the impact area. Figure 2.5 
shows the effect of the two most important variables that affect the impact area including 
the spray duration and the solvent flow rate. The impact area is observed to increase with 
time at a fixed solvent flow rate (Figures 2.5.a). It also increases with the solvent flow 
rate for any given spray duration (Figure 2.5.b). Flow rates below 5 µL min-1 produced a 
very small spray impact area. This could lead to a DESI spectrum that is less 
representative of the whole sample. As such a solvent flow rate of 5 µL min-1 was chosen 
for all experiments which resulted in the best sensitivity with an appreciably large spray 
impact area to give a good representative spectrum for single spot rapid throughput 
analysis. However, for this study several different spots were probed for each sample in 
order to get a detailed representation of the surface chemical information content.  
   40 
(a)
Solution flow rate (uL/min)



















Solution flow rate (uL/min):
1      2     3      4      5      6      7      8       9 
(b)
Duration of spray (s)





















                      time (s)
5s        10s        20s        30s        40s 
(a) (b)
 
Figure 2.5. Area impacted by the custom-built DESI sprayer jet for various ion source 
settings. The spots were obtained by spraying 1 mM Reactive Blue 4 dye onto a white 
sheet of paper. (a) Impacted area vs. spray duration at a dye solution flow rate of 
5 µL min-1, (b) impacted area vs. dye solution flow rate (10 s spray duration). 
 
Analysis of each of the representative samples in this proof-of-concept study by 
packaging analysis, DESI MS and ATR-FTIR imaging resulted in the classification of the 
samples in each of the categories of genuine and counterfeit drugs definition. This 
included (A) Genuine, (B) products with wrong active ingredient(s), (C) insufficient 
quantities of the AI(s) and (D) no AI(s), as discussed below.  
 
2.4.6. Genuine Artesunate 
DESI MS experiments for all samples were performed by spraying a 75:25 
CH3CN:H2O solution onto the tablets. This solvent composition was chosen based on 
preliminary experiments, which indicated that solvent mixtures with higher aqueous 
content resulted in significant wetting of the tablets with time and higher background in 
the low m/z region. The positive ion mode DESI spectrum of a genuine Guilin 
Pharmaceutical Co. Ltd artesunate tablet (50 mg artesunate per tablet) is shown in Figure 
2.6.a. The spectrum shows peaks corresponding to monomeric and dimeric artesunic acid 
adducts and their fragment ions. The formation of Na+ and K+ adducts was favored over 
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the protonated precursor, with peaks at m/z 407.2 and 423.3 respectively. A peak at m/z 
790.8 corresponding to the sodiated artesunic acid dimer ([2 artesunic acid + Na]+) was 
also observed. The peak at m/z 261.2 corresponds to a sodiated fragment of artesunic acid 
([artesunic acid - C4H6O4 - CO + Na]
+), which originates from in-source fragmentation. 
Figure 2.6.b shows the negative ion mode DESI spectrum of a genuine artesunate 
antimalarial tablet. Peaks corresponding to the deprotonated analyte monomer and dimer 
were observed at m/z 383.2 ([artesunic acid - H]-) and m/z 767.7 ([2 artesunic acid - H]-), 
respectively. Various artesunic acid fragment ions were also observed in negative ion 
mode, including peaks at m/z 283.5 and m/z 255.5 due to C4H4O3 and C4H4O3 + CO 
losses from the deprotonated monomer respectively. The peak at m/z 725.2 corresponding 
to a loss of C2H2O from [2 artesunic acid - H]
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Figure 2.6. Analysis of a genuine Guilin Pharmaceutical Co. Ltd. artesunate tablet by: 
(a) reagentless DESI MS in positive ion mode, (b) reagentless DESI MS in negative ion 
mode, (c) Micro-ATR-FTIR imaging showing the distribution of (i) artesunic acid, 
(ii) avicel and (iii) talc. The size of each image is approximately 64x64 µm2. The 
representative spectra at the location indicated by the arrow are also shown and compared 
with the reference spectra of (ii) pure avicel and (iii) pure talc. 
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 Analysis of a genuine artesunate tablet by ART-FTIR imaging is shown in Figure 
2.6.c. Artesunate shows a strong ν(C=O) band at ca. 1750 cm-1, which was used to 
generate the chemical image representative of the distribution of this drug in the imaged 
area (Figure 2.6.c.i). For this sample, the presence of a total of four bands within spectral 
region investigated, at 1030, 1055, 1100, and 1160 cm-1, suggests the presence of avicel, 
a common excipient used to enhance or control tablet dissolution.238 The integrated 
absorbance of the band at 1055 cm-1 was used to plot the distribution of this excipient 
(avicel Figure 2.6.c.ii).  The genuine sample also shows a characteristic band at 
1003 cm-1, corresponding to the main vibrational mode of talc (Si-O stretching), which 
was used to create the distribution of this excipient in the imaged area (Figure 2.6.iii). 
The collected images show that the active ingredient (artesunate) domains in avicel and 
talc can easily be identified by use of FTIR imaging, unlike in ordinary optical 
microscopy. In addition to verifying the presence of the correct active ingredient, 
ATR-FTIR imaging also detected the presence of various excipients including avicel and 
talc in the genuine Guilin Pharmaceutical Co. Ltd artesunate tablet thereby 
complementing the DESI MS results. 
 
2.4.7. Counterfeit Artesunate Containing Wrong Active Ingredient(s) 
Three of the samples evaluated in this study contained various wrong active 
ingredient(s) with a range in sophistication including samples containing an analgesic 
(11 KHA P 7/1 #2, Type 4),  no longer efficacious antimalarials (12 PAS P 64/1, Type 8) 
and the correct active ingredient precursor (detected in S 40-1, Type 13) as presented 
below.  
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 Results from the analysis of the counterfeit sample 11 KHA P 7/1 #2 (Type 4) are 
shown in Figure 2.7. Analysis of this sample by DESI MS in positive ion mode shows a 
peak at m/z 218.2 corresponding to the methylaminoantipyrine proton adduct, a dypirone 
fragment with the elemental formula (C12H16N3O, Figure 2.7.a). This assignment was 
verified by DESI MS analysis in negative ion mode, which showed a peak at m/z 310.3 
corresponding to deprotonated dipyrone (Figure 2.7.b). No artesunate was detected in this 


























































Figure 2.7. Analysis of a fake artesunate Type 4 (11 KHA 7 7/1 #2) by (a) reagentless 
DESI MS in positive ion mode, (b) reagentless DESI MS in negative ion mode, 
(c) Micro-ATR-FTIR imaging showing the distribution of the bands at (i) 1008 cm-1 and 
(ii) 1655 cm-1. The size of each image is approximately 64x64 µm2. The representative 
spectra at the locations indicated by the letters are also shown and compared with the 
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Analysis of the sample 11 KHA P 7/1 #2 by ATR FTIR imaging is shown in 
Figure 2.7.c. The analysis shows a strong band at 1008 cm-1 corresponding to the 
presence of talc, with the integrated abundance of this band over the imaged area used to 
obtain its distribution in the sample (Figure 2.7.c.i). The sample also showed a strong 
band at 1655 cm-1 corresponding to the presence of dipyrone and its distribution obtained 
by plotting the integrated abundance of this band over the imaged area (Figure 2.7.c.ii). 
Artesunate was not detected in this sample by ATR-FTIR imaging. The presence of 
dypirone and the absence of artesunate in this sample was consistent with the results 
obtained by DESI MS analysis. Dipyrone is a nonsteroidal anti-inflammatory drug that is 
used as a powerful painkiller and antipyretic. It has been associated with adverse effects, 
such as agranulocytosis, and is banned in some countries.200 Administration of this drug 
might temporarily mitigate some symptoms of malaria, but it does not cure the disease. 
 Results from the analysis of the sample 12 PAS P 64/1 (Type 8) is shown in 
Figure 2.8. DESI MS analysis of this sample shows two major peaks, at m/z 249.2 and 
311.2 corresponding to protonated pyrimethamine and sulfadoxine, respectively (Figure 
2.8.a). By probing different spots on the surface of this sample with the DESI spray 
plume, different m/z 249.1-to-m/z 311.2 peak intensity ratios were observed suggesting 
inhomogeneities in the composition of the sample (Figure 2.8.b). Artesunic acid was not 
detected in this sample by DESI MS analysis. Pyrimethamine-sulfadoxine, detected in 
this sample is an antimalarial, which is no longer efficacious in SE Asia. 
 FTIR analysis of the sample 12 PAS P 64/1 shows only one strong band at 
1403 cm-1 assigned to the asymmetric stretching mode (ν3) of the carbonate ion. The 
abundance of this band was used to obtain an image of the distribution of carbonate in the 
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sample by ATR-FTIR imaging (Figure 2.8.c). No active ingredient was detected in this 
sample by ATR-FTIR imaging; however, the detection of the carbonate excipient 
complements the DESI MS results. The inability of detecting pyrimethamine-sulfadoxine 
in this sample by FTIR is probably because of the large carbonate signal. 
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Figure 2.8. Analysis of a fake artesunate Type 8 (12 PAS P 64/1) by (a) reagentless 
DESI MS in positive ion mode, (b) reagentless DESI MS in positive ion mode for 
different x-y positions on the tablet surface, (c) Micro-ATR-FTIR imaging showing the 
distribution of the band at 1403 cm-1. The size of the image is approximately 64x64 µm2. 
The representative spectrum at the location indicated by the arrow is also shown and 
compared with the reference spectrum of pure calcium carbonate. 
 
 
DESI MS analysis of the sample S 40/1 (Type 13) shows peaks at m/z 305.1 and 
587.3 corresponding to sodiated artemisinin monomer and dimer respectively 
(Figure 2.9.a). The characteristic artesunate precursor ion peak at m/z 407.2 was not 
observed by DESI MS analysis of this sample. These results were validated and 
complemented by ATR-FTIR imaging analysis (Figure 2.9.b). FTIR analysis of the 
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sample S 40/1 shows a sharp band at 1735 cm-1 which corresponds to the characteristic δ-
lactone carbonyl ν(C=O) vibration mode of artemisinin, the artesunate precursor.239 The 
abundance of the band at 1735 was then integrated over the imaged area to obtain a 
distribution of artemisinin on the surface of the sample. The FTIR data also shows a 
sharp band at 1008 cm-1 corresponding to talc whose distribution is shown in 
Figure 2.9.b.ii. Artesunate was not detected in this sample by ATR-FTIR. Artemisinin 
has a low bioavailability than artesunate, because of its poor water solubility, and is 
therefore less effective in antimalarial treatments. Its use especially in very small doses 
can easily facilitate the emergence of artemisinin based antimalarial drug resistance. 
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Figure 2.9. Analysis of fake Type 13 (SMRU 40-1) by (a) DESI MS in positive ion 
mode, (b) Micro-ATR-FTIR imaging showing the distribution of the absorbance of the 
bands at (i) 1735 cm-1 and (ii) 1008 cm-1. The size of each image is approximately 
64x64 µm2. The representative spectra at the location indicated by the arrows are also 
shown and compared with the reference spectrum of pure talc. 
 
2.4.8. Counterfeit Artesunate Containing Insufficient Amount of Active Ingredient 
The sample S 12/2009 (Type 9) constitutes an example of a fake artesunate 
sample containing insufficient amounts of active ingredient, which was previously 
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determined by HPLC to contain 10 mg artesunate per tablet instead of the usual 50 mg 
per tablet.198 Figure 2.10 shows results from the analysis of this sample by DESI MS and 
ATR-FTIR imaging. Analysis of this sample by DESI MS shows a peak at m/z 152.1 
identified as protonated acetaminophen (Figure 2.10.a). The characteristic artesunate ion 
precursor peak at m/z 407.2 was not detected under these conditions (i.e spraying with a 
solution of 75:25 CH3CN:H2O). DESI analysis of this sample was then evaluated using 
an alternative, higher sensitivity “reactive” DESI approach by the addition of 
dodecylamine into the DESI spray solvent. Primary amines have been shown to form 
stable noncovalent complexes with artemisinins during electrospray ionization.240 Thus, 
in reactive DESI mode, DDA dissolved in the charged spray microdroplets reacts directly 
with artesunate molecules exposed on the tablet surface. Analysis of this sample by 
reactive DESI shows a peak at m/z 570.3 assigned as the proton-bound noncovalent 
artesunic acid complex with dodecylamine ([artesunic acid + DDA + H]+), 
(Figure 2.10.b). This peak assignment was verified by DESI MS/MS analysis, which 
gives the protonated amine (m/z 186.2) and protonated artesunic acid (m/z 385.3) species 
as the major peaks in the spectrum through a charge competition process 
(Insert Figure 2.10.b). A peak at m/z 337.1 corresponding to the species 
[acetaminophen + DDA + H]+ was also observed in the reactive DESI spectrum. The 
implications of the long-term administration of low doses of artesunate could genetically 
select artesunate-resistant parasite strains, rendering this last-resource antimalarial 
medicine ineffective. 
Complementary analysis of the sample S 12/2005 (Type 9) by ATR-FTIR shows 
two major bands, one sharp band at 1008 cm-1 ascribed to the presence of talc with its 
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abundance integrated over the imaged area to give its distribution as shown in 
Figure 2.10.c.i. There is a second band at 970 cm-1, which suggests the use of ducting 
powder as excipient. The ATR-FTIR image shown in Figure 2.10.c.ii, is obtained from 
plotting the abundance over the imaged area for the band at 1148 cm-1 corresponds to the 
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Figure 2.10. Analysis of a fake artesunate Type 9 (SMRU 12/2005) by (a) reagentless 
DESI MS, (b) reactive DESI MS (insert shows the MS/MS spectrum of the peak at 
m/z 570.3), (c) Micro-ATR-FTIR imaging showing the distribution of the bands at 
(i) 1008 cm-1, (ii) 1148 cm-1. The size of each image is approximately 64x64 um2. The 
representative spectra at the location indicated by the letters are also shown and 
compared with the reference spectrum of talc. M = artesunic acid. 
 
2.4.9. Counterfeit Artesunate Containing No Active Ingredient 
The sample Lao 05/03 (Type 11) constitutes an example of a sample which 
contains no active ingredient. This sample was analyzed exclusively by DESI MS using 
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various spray solvent systems. DESI MS analysis of this sample by spraying the sample 
with a solution of 75:25 CH3CN:H2O resulted in a very noisy spectrum showing peaks at 


















































Figure 2.11. Analysis of a fake artesunate Type 11 (Lao 05/03) by reagentless DESI MS 
by spraying the sample with a solution of (a) 75:25 CH3CN:H2O), (b) 100 % MeOH. The 
insert in (b) corresponds to the MS/MS spectrum generated from the peak at m/z 365.3 
for (i) the sample (Lao 05/03) and (ii) lactose standard. 
 
Because DESI, relies on the solubility of the analyte in the spray solution various 
solvent compositions containing decreasing proportions of water were accessed for the 
analysis of this sample resulting in a spray solvent composed of 100 % MeOH giving the 
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best signal with the corresponding spectrum shown in Figure 2.11.b. The spectrum shows 
intense peaks at m/z 303.5 (SNR = 99) and 707.2 (SNR = 366), which were assigned as 
sodiated lactose monomer and dimer respectively. This assignment was verified by DESI 
MS/MS analysis of this sample (Figure 2.11.i.) against a lactose standard 
(Figure 2.11.b.ii). No active ingredient was detected in this sample by both reagentless 
and reactive DESI MS.  
 
2.5. Conclusions 
This initial study demonstrated the capabilities of DESI MS for the rapid 
qualitative screening of antimalarial artesunate tablets for their facile typing as either 
counterfeits, which contain wrong active ingredient(s), insufficient amounts of the active 
ingredient(s) or no active ingredient(s). The dependence of the analyte solubility in DESI 
on the spray solvent composition can be advantageously exploited to allow efficient 
sampling of surface chemicals. The ability to also detect various tablet excipient 
components by ATR-FTIR imaging in a non-destructive manner complemented the high 
sensitivity provided by DESI MS for reliable routine drug quality analysis applications. 
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CHAPTER 3. REACTIVE DESI LINEAR ION TRAP MS OF 
LATEST-GENERATION COUNTERFEIT ANTIMALARIALS VIA 
NONCOVALENT COMPLEX FORMATION 
 
3.1. Abstract 
Presented in this chapter is a detailed characterization of a reactive DESI MS 
approach for application in the screening of artemisinin-based antimalarial tablets. The 
method is based on the formation of stable noncovalent complexes between linear 
alkylamines dissolved in the DESI spray solvent and artemisinins exposed on the tablet 
surface. Depending on the amine type and concentration, a sensitivity gain of up to 170x 
can be obtained, in comparison to reagentless DESI, without compromising throughput. 
Evidence from the analysis of a broad range of different artemisinins and tandem MS 
experiments indicated that complex formation in reactive DESI occurred by hydrogen 
bonding between the primary amine hydrogens and the ether-like moieties within the 
artemisinin lactone ring. The selectivity for the detection of artemisinins can be improved 
by operating the mass spectrometer in the selected reactions monitoring (SRM) mode. 
The combined selectivity and sensitivity improvement provided by this approach afford a 
robust screening tool for the efficient determination of artemisinin-based antimalarial 
tablets for drug quality control applications.  
 
3.2. Introduction 
The 2006 appearance of a new type of artesunate counterfeit (Type 9), containing 
subtherapeutic amounts of active ingredient spurred great concern following its 
   52 
detection.198 This was mainly because its widespread circulation could quickly excite the 
natural selection and spread of artemisinin-resistant parasites, ridding the world of 
effective treatment options for multidrug resistant falciparum malaria. It has been 
hypothesized that the administration of artemisinins as monotherapies, even at their 
proper dosage, could also result in drug resistance. As such, the World Health 
Organization (WHO) now recommends their administration as combination therapies. 
Combination therapies with antimalarial medicines are based on the simultaneous 
use of two or more blood schizonticidal drugs with independent modes of action and 
different biochemical targets in the parasite. Artemisinin-based combination drugs 
(ACTs), base their success on the synergistic or additive potential of two or more active 
ingredients, to improve therapeutic efficacy and delay the development of resistance to 
the individual components of the combination. For instance, the probability of a parasite 
arising that is resistant simultaneously to two drugs with unrelated modes of action is the 
product of the per parasite mutation frequencies multiplied by the total number of 
parasites exposed to drugs. For example if the probability of a parasite being resistant to 
drug A is one in 106 and to drug B is one in 106 then the probability that a parasite will be 
simultaneously resistant to both is one in 1012, representing a million-fold reduction in 
probability.241 
Artesunate is a crucial component of ACTs, and is still commonly used 
inappropriately as monotherapy outside of national malaria programs.200 The initial 
detection of artesunate monotherapy counterfeits containing small amount of active 
ingredient, was hypothesized to have been an “innovation” introduced by the 
counterfeiters in an attempt to deceive the colorimetric authentication tests used in the 
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field. Therefore, the exploration of new approaches for antimalarial tablet screening is 
central to rapidly ensuring the quality of the genuine product, and for the early detection 
of fakes artemisinin-based monotherapies or combination therapies that may contain 
small amounts of active ingredient. 
In Chapter 2 a reagentless DESI MS protocol was investigated for the rapid 
screening of antimalarial tablets, which enabled the distinction between different types of 
fakes. This method, however, was not able to determine counterfeits which contain 
insufficient amounts of active ingredient. This was partly because artesunate undergoes 
appreciable in-source fragmentation, which lowers the sensitivity, limiting its detection in 
such counterfeits. 
One of the potential avenues to mitigate in-source artesunate fragmentation during 
DESI MS is to exploit DESI modalities that take advantage of selective solution phase 
chemistry. Cooks et al. first reported that, if the DESI spray is doped with selective 
chemical reagents, it is possible to perform ion/molecule reactions between the charged 
microdroplets and an analyte exposed on a solid sample surface.242 In most cases, this 
results in improved sensitivity due to increase ion evaporation rates and/or reduced 
fragmentation. Because reactive DESI enjoys the same sample throughput as 
conventional DESI, it is particularly well suited for the forensic analysis of counterfeit 
drugs, with the added benefit of increased specificity and sensitivity. 
In this Chapter an extensive characterization of a highly sensitive reactive DESI 
MS method for the rapid screening of antimalarial tablets, enabling the determination of 
subtherapeutic counterfeits is presented. The method makes use of the reaction between 
primary alkylamines and artemisinins, forming proton-bound non-covalent complexes. 
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This study also provides valuable insight on the ion generation processes occurring 
during the collision of reactive charged microdroplets with the solid sample surface. 
 
3.3. Experimental Details 
3.3.1. Samples and Reagents 
All reagents were used without additional purification. HPLC grade acetonitrile 
(Fisher, Hampton NH), dodecylamine (DDA), hexylamine (Hex) and octadecylamine 
(ODA) (Sigma-Aldrich, St. Louis MO) were used for reactive DESI MS experiments. 
Ultrapure water (18.2 MΩ cm-1) was obtained from a Nanopure purification unit 
(Barnstead, San Jose CA). Genuine artesunate tablets manufactured by Guilin 
Pharmaceutical Co. Ltd. (50 mg per average 250 mg tablet, Guilin, Guangxi, PR China) 
were used for all characterization and optimization studies. Preliminary assessment of the 
authenticity of samples by packaging inspection was performed following the procedure 
described in section 2.3.2. The following collection code samples: S 35/1 (Type 9), S 29 
(Type 9), S 40/2 (Type 13), S 45 (Type 9), S 40/1 (Type 13), S 47/2 (Type 14), S 47/1 
(Type 14), Lao 06/04 (Type 10) and Lao 12012 (Type 6) were evaluated in this study 
(see Figure 2.2 for sample collection location). The samples were all labeled on their 
blister packs to contain 50 mg of artesunate per tablet. Two additional samples: Kenya 
07/01 (Collected in Kenya) and Lao 07/20/2 (collected in Laos), which were labeled on 
their blister packs as dihydroartemisinin and artemether tablets respectively, were also 
evaluated in this study. Tablets were stored at 4oC until analysis. 
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3.3.2. DESI MS and LC-MS 
The DESI set-up described in section 2.3.3 was interfaced to a LiT mass 
spectrometer (Thermo Finnigan, San Jose CA) and operated using similar settings and 
experimental conditions as described in section 2.3.4. Reagentless DESI experiments 
were performed by spraying samples with a solution of 75:25 CH3CN:H2O. 100 µM 
amine was added to the above spray solution for reactive DESI MS experiments unless 
stated otherwise. For each amine, the mass spectrometer was auto tuned in order to obtain 
maximum signal intensity for their corresponding protonated amine-artemisinin-based 
noncovalent complex. DESI MS/MS experiments were collected at a normalized 
collision energy of 10%. Suspected drug samples were also analyzed by LC-MS, 
following the sample preparation method described by Hall et al.222 and the LC 
conditions described by Ortelli et al.243 
 
3.4. Results and Discussions 
3.4.3. Reagentless vs. Reactive DESI MS of Genuine Artesunate Tablets 
Figure 3.1.a shows the positive ion mode reagentless DESI spectrum of a genuine 
artesunate tablet. In this mode of operation, the overall sensitivity was low, primarily 
because the ionic signal due to artesunic acid species was spread into various channels 
with the major peaks in the spectrum corresponding to sodiated monomeric and dimeric 
artesunic acid adducts, and their fragment ions.  
Corresponding reactive DESI spectra obtained by spraying genuine tablets 
successively with spray solutions containing 100 µM of each of the various alkylamine 
evaluated including Hex, DDA, and ODA are shown in Figure 3.1.b. For each of the  
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Figure 3.1. DESI spectra of a genuine artesunate tablet analyzed in (a) reagentless DESI 
MS mode, by spraying the tablet with a solution of 75:25 CH3CN:H2O and (b) reactive 
DESI MS mode by spraying tablets with a solution containing 100 µM of (i) hexylamine 
(Hex), (ii) dodecylamine (DDA) and (iii) octadecylamine (ODA) in 75:25 CH3CN:H2O. 
A = C4H6O4, B = C2H4O2. The inserts represent MS/MS spectra of the [M + amine + H]
+ 
ions with m/z 486.3, 570.3 and 654.5 respectively. M = artesunic acid. 
 
alkylamines, the base peak corresponding to a 1:1 artesunic acid-alkylammonium 
noncovalent complex ion was observed. Analysis with Hex presented a very intense peak 
at m/z 486.3 corresponding to the species [M + Hex + H]+ , followed by a less intense 
peak at m/z 870.1 assigned as [2 M + Hex + H]+ (Figure 3.1.b.i). In Figure 3.1.b.ii, the 
peaks at m/z 570.3 and 954.5 correspond to the species [M + DDA+H]+ and 
[2 M + DDA + H]+ respectively. Similar results were observed for ODA, with peaks at 
m/z 654.5 and m/z 1038.0 (Figure 3.1.b.iii). The relative intensity of the 
[2 M + amine + H]+ signal with respect to [M + amine + H]+ was found to be dependent 
on the chain length of the amine used, decreasing with an increase in amine chain length 
from C6 to C12. This is probably due to increased steric hindrance for dimerization, with 
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increased amine length. A further increase in chain length from C12 to C18, produced 
insignificant changes in the relative intensity of the dimeric complex ion. 
The generation of noncovalent complex ions by reactive DESI arises by 
cationization from ion-molecule reactions between alkylammonium ions in the spray 
solution and analyte molecules on the tablet surface. The observed bunching of the 
analyte signal intensity into a single peak is due to the relatively strong interaction 
between alkylammonium ions and electron-rich moieties in the artesunic acid molecule.  
The inserts in Figure 3.1.b depict the DESI MS/MS spectra of each of the three artesunic 
acid-alkylammonium complexes. Following ion activation, the artesunic acid side chain 
(C4H6O4) was readily lost from the complex ions, forming different fragments. It appears 
as though the interaction energy in the complexes was high enough so that the internal 
energy imparted in the MS/MS experiment was sufficient to cause fragmentation of the 
artesunic acid butanedioic side chain without loss of the amine ligand.244 Some fragment 
ions retained the alkylamine ligand, indicating that the amine-artesunic acid complex is 
not formed by interaction with the side chain carbonyl groups, but with the ether or 
endoperoxide moieties of the sesquiterpene lactone ring system. Other artemisinins 
including artemisinin, dihydroartemisinin and artemether, which contain different side 
chains from that in artesunic acid were also observed to form complexes with 
alkylamines (vide infra) thus reinforcing this hypothesis. 
A very large signal intensity gain follows droplet pickup and complexation of 
artesunic acid by alkylammonium ions. This highly improved analyte signal can be 
attributed to two effects: first, the localization of the positive charge of the complex at the 
alkylamine nitrogen atom results in minimum or no fragmentation of analyte molecules 
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by in-source collision-induced dissociation (CID). Secondly, the addition of a positively 
charged, hydrophobic alkylamine ligand enhances the ion evaporation process after 
artesunic acid pick-up by the DESI spray droplets. Overall, the signal gain with respect to 
the intensity of the [M + Na]+ ion observed in reagentless DESI mode was above 60x, 
170x, and 70x for Hex, DDA and ODA respectively. Interestingly, a lower signal gain 
was observed for ODA (Figure 3.1.b.iii) than for DDA (Figure 3.1.b.ii), probably due to 
increased ionization suppression caused by the more hydrophobic [ODA + H]+ ions. 
The noncovalent complex signal intensity was found to increase with the 
concentration of amine in the spray solvent. Figure 3.2 shows the effect of different  
 

































Figure 3.2. Positive ion mode reactive DESI of genuine artesunate tablets at different 
Hex, DDA and ODA concentrations. The bar graphs represent the intensities of the ions 
at m/z 486.3, 570.3, 654.5 obtained by spraying 1, 5, 50 and 100 uM slutions of each of 
the amines dissolved in 75:25 CH3CN:H2O. 
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alkylamine concentrations on the reactive DESI ion yield. A signal plateau was obtained 
at lower concentrations of more hydrophobic alkylamines, suggesting that artesunic acid 
complexation efficiency is related to the activity of alkylamine molecules on the DESI 
droplet surface. This observation supports the hypothesis that reactive DESI of artesunic 
acid could proceed via a pickup mechanism where heterogeneous reactions between 
alkylamines on the droplet surface and artesunic acid molecules on the tablet are 
responsible for initial artesunic acid desorption, followed by noncovalent complex 
formation. Computational fluid dynamic simulations have confirmed the droplet pick-up 
mechanism in DESI.100, 101 
The gas-phase stability of the artesunic acid-alkylammonium complexes was also 
investigated. Figure 3.3 presents the fragmentation efficiency curves245 for the different  
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Figure 3.3. Fragmentation efficiency curves [(sum of fragment intensities)/(total 
intensities)] for various artesunic acid-alkylammonium complexes. M = artesunic acid. 
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complexes studied. The results suggest that the stability of these complexes increases in 
the order, [M + Hex + H]+ < [M + DDA + H]+ << [M + ODA + H]+, following the 
increase in chain length of the amine ligand, consistently with the trends in basicity of 
alkylamines in the gas phase.246 Stabilization of the conjugate base (alkylammonium) 
increases with the alkyl chain length, leading to an increase in stability of the complex. 
 
3.4.4. Experimental Variables Affecting Artesunic Acid Ion Yield in Reactive DESI MS 
The effects of various experimental variables on the artesunic acid-
alkylammonium complex ion yield, including solution flow rate, nebulizer gas flow rate, 
and spray voltage, were investigated using genuine artesunate antimalarial tablets. 
Dodecylamine was chosen for all optimization studies based on the higher intensity of its 
[M + amine + H]+ complex ion compared to those of the other amines. The intensity of 
the artesunic acid-alkylammonium complex ion was found to rapidly increase with 
solution flow rate, reaching a maximum between 5 and 6 µl min-1, followed by a rapid 
decrease (Figure 3.4.a). Chen et al. have also observed a similar change in DESI response 
with spray solution flow rate,140 but with the maximum response shifted to higher rates. 
This could be assigned to differences in the tablet hardness and/or wettability of the 
pharmaceutical tablets investigated here. A flow rate of 5 µL min-1 was used for all our 
subsequent experiments. 
Figure 3.4.b shows the dependence of the artesunic acid-alkylammonium complex 
ion yield on the nebulizer gas flow, which was found to increase with an increase in the 
nebulizer gas velocity. This increase suggests that an increasing amount of material is 
desorbed or ablated from the tablet surface as absolute droplet velocity increases, or that  
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Figure 3.4. Intensity dependence of the [M + DDA + H]+ adduct ion (m/z 570.3) with (a) 
spray solution flow rate; error bars represent the standard deviation for 3 repeat 
measurements, (b) nebulizer gas flow, (c) spray solution charging voltage. Experiments 
were performed by spraying a solution of 100 µM dodecylamine in 75:25:CH3CN:H2O 
onto genuine artesunate tablets. M = artesunic acid. 
 
faster droplets have a different takeoff trajectory, which improves droplet/ion collection 
efficiency.100  A nebulizer gas velocity of 356 mL min-1 was adopted for all experiments. 
Higher nebulizer gas velocities typically resulted in visible damage to the tablet surface, 
and were thus avoided. 
The artesunic acid-alkylammonium complex ion yield was also observed to 
increase with solution spray voltage over the entire range investigated (0 - 4.5 kV, Figure 
3.4.c). This general increase in ionic current with voltage can be attributed to an 
increasing number of charges on the droplet surface, probably caused by the increased 
rate of solvent oxidation processes induced at higher spray charging potentials. Venter et 
al. have also shown reports on the effect of the DESI signal at varying spray voltage, 
where it was observed that the average charge state, and amount of desorbed melittin 
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increased with increasing voltage. This also suggests that pH changes within the DESI 
charged droplets occur when the spray voltage is increased, and that these changes affect 
the amount and nature of the desorbed ions.  Interestingly is the fact that the artesunic 
acid-alkylammonium complex ion signal was observed even in the absence of charging 
voltage (Figure 3.4.c). Chen et al. have previously reported this phenomenon for 
conventional DESI,140 where they assigned this behavior to a sonic spray-type 
mechanism,33 which forms the basis of Desorption Sonic Spray Ionization (DeSSI).40  
 
3.4.5. Reactive DESI MS of Other Artemisinins 
The optimized reactive DESI MS protocol was then evaluated for the analysis of 
other artemisinins. The samples evaluated included a counterfeit artesunate sample with 
collection code Lao 12012 (previously determined to contain artemisinin, Figure 3.5.a), 
and two other samples with collection code Kenya 07/01 (Figure 3.5.b) and Lao 07/20/2 
(Figure 3.5.c), indicated on their blister packs to contain dihydroartemisinin and 
artemether respectively. Reactive DESI MS analysis of each of these samples showed 
intense peaks at m/z 468.4, 470.4 and 484.4 assigned as 1:1 dodecylammonium 
complexes of the various artemisinins including artemisinin, dihydroartemisinin and 
artemether respectively. These assignments were verified by DESI MS/MS analysis as 
shown by the inserts in each of the spectra. For each complex MS/MS generated 
predominantly the product ion peak at m/z 186.2 corresponding to the dodecylammonium 
ion following the neutral loss of the artemisinin present in each of the sample. For 
dihydroartemisinin and artemether, peaks corresponding to a loss of their respective 
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Figure 3.5. Reactive DESI spectra of artemisinin-based antimalarials tablets collected in 
Laos and Kenya with collection codes: (a) Lao 12012, (b) Kenya 07/01, (c) Lao 07/20/2. 
Spectra were obtained by spraying tablets with a solution containing 100 µM DDA in 
75:25 CH3CN:H2O. The inserts represent the MS/MS spectra of the ions with at m/z 
468.4, 470.4 and 484.4 observed from each spectrum respectively. The peaks at m/z 
750.5, 754.5 and 782.6 correspond to the dodecylammonium complexes of dimeric 
artemisinin, dihydroartemisinin and artemether respectively. 
   
water and methanol side chains from the complex (occurring without loss of the 
dodecylamine ligand) were also observed. This further verified that the interaction 
between alkylamine and artemisinins occur within the endoperoxide moieties of the ring 
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system. The ability to selectively and sensitively identify each of these artemisinins 
indicates the utility of reactive DESI as a powerful approach for the reliable analysis of 
the whole spectrum of artemisinins. 
 
3.4.6. Rapid Screening of Field-collected Artesunate Tablets by Reactive DESI MS 
The performance of the reactive DESI MS methodology was then evaluated for 
applications in the rapid screening of various artesunate samples collected in the field. 
First, reactive DESI MS/MS analysis in the selected reaction monitoring (SRM) mode 
was performed on two genuine artesunate samples manufactured by Guilin 
Pharmaceutical (samples codes “Gen-1”, and “Gen-2”), and on a genuine tablet from a 
different manufacturer, Mekophar (Hanoi, Vientnam), with sample code “Gen-3”. The 
SRM analysis was performed by monitoring the characteristic m/z 570.3 
([M + DDA + H]+)  m/z 452.1 ([M - C2H4O2 + DDA + H]
+) transition, which provided 
an additional level of selectivity. Repeated analyses were performed by manually 
positioning the sample holder, so that the sample would be exposed to the DESI spray, 
and removing it after approximately 50s. Despite the manual sample positioning method 
used, the SRM traces indicated a relatively good reproducibility (Figure 3.6). The 
between-run relative standard deviations observed for the “Gen-1”, “Gen-2” and “Gen-3” 
samples were 17%, 7% and 10%, respectively. Different batches of the Guilin 
Pharmaceutical product (Gen-1, and Gen-2) showed similar relative intensities in the 
SRM traces with a difference in the mean intensities of 8.4%. DESI SRM analysis of the 
genuine Mekophar sample (Gen-3, stated to contain 50 mg of artesunate per average 320 
mg tablet) resulted in a lower average signal (34%). This difference could be attributed to 
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Figure 3.6. SRM traces obtained by reactive DESI MS/MS analysis of different genuine 
artesunate samples. The m/z 570.3m/z 452.1 transition was used for monitoring the 
presence of artesunic acid. 
  
the different hardness, surface morphology and/or the lower concentration of artesunic 
acid in this tablet, compared to the previously tested tablets. 
With the objective of determining if, artesunic acid could be detected or not at the 
expected levels, reactive DESI MS and MS/MS in SRM mode was applied to various 
suspicious artesunate tablet. The samples were collected on the Thai/Burma border and 
on the Lao PDR/China border (collection codes: Lao 06/04, S 35/1, S 29, S 40/2, S 45, S 
40/1, S 47/2 and S 47/1). A genuine sample (sample code Gen-3) collected in the same 
area was also included in the analysis as a positive control. A Type 8 counterfeit 
artesunate tablet (sample code 12 PAS P 64/1), collected in a previous survey and which 
did not contain detectable amounts of artesunic acid (as verified by LC experiments), was 
used as a negative control. The DESI SRM trace generated from screening each of the 
indicated tablets in duplicate is shown in Figure 3.7.  Minute background signals could be 
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observed for most of the counterfeits, which were comparable to that of the negative 
control, except for sample S 47/1 (note the y-axis break in Figure 3.7). This suggests the 
absence of artesunic acid in detectable amounts in all the counterfeits except for sample 
S 47/1. The large signal deviation for the duplicate measurements for sample S47/1 
comes from the low levels of artesunic acid on the surface of this sample which is quickly 
consumed by the high velocity of the DESI jet after the first exposure of the sample. 
Although the reactive DESI method presented in this study doesn’t allow direct  
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Figure 3.7. Reactive DESI SRM trace corresponding to the duplicate analysis of last 
generation counterfeit artesunate samples collected in the Thai Burma border, together 
with a genuine sample. Sample codes: A: Control, B: Lao 06/04, C: S 35/1, D: S 29, 
E: S 40/2, F: S 45, G: S 40/1, H: S 47/2, I: S 47/1, J: Genuine (Gen-3). SRM was carried 
out following reactive DESI MS/MS by monitoring the m/z 570.3m/z 452.1 transition. 
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quantitation (the subject of investigations in Chapter 4), inspection of the observed signal 
intensity for sample S 47/1 with respect to the signal observed for Gen-3 clearly indicated 
that the amount of artesunate in this sample was substandard. The difference in hardness 
of this tablet did not appear to be sufficient to explain the observed difference in signal 
intensity. Subsequently, the exterior of this tablet was scraped with a scalpel, and 
subjected to LC-MS analysis, together with material from the tablet bulk. Although 
artesunic acid was not detected in the bulk of this sample, triplicate analysis of the tablet 
surface scrapings indicated the presence of artesunic acid at a level of 4.5 ng mg-1. This 
very small amount of artesunic acid on the surface of this tablet could have been 
introduced onto this particular fake as a residue left over from the press used to prepare 
other tablets with higher amounts of artesunic acid. Clearly, for this particular sample 
DESI screening produced information that would not have been obtainable using the 
conventional analysis protocol. 
 
3.5. Conclusions 
This study demonstrated the capability of reactive DESI as an effective high 
throughput approach for screening antimalarial tablets. This method is highly suited for 
the verification of the quality of the large number of artemisinin-based antimalarial 
dosage units distributed worldwide by governmental, non-governmental, and commercial 
organizations, and for the early detection of counterfeits containing artesunate. From the 
mechanistic point of view, it was observed that the ion generation processes in 
alkylamine-mediated reactive DESI are affected predominantly by the amine surface 
droplet activity.  
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CHAPTER 4. DIRECT QUANTITATION OF ACTIVE 
INGREDIENTS IN SOLID ARTESUNATE ANTIMALARIALS BY 
NONCOVALENT COMPLEX FORMING DESI MS 
 
4.1. Abstract 
 In this Chapter, a rapid throughput approach for the direct quantitation of active 
ingredients in solid artesunate antimalarial formulations by reactive DESI MS is 
presented. The applicability of DESI MS for direct quantitative analysis of solid 
pharmaceutical tablets is complicated by the dependence of the DESI signal on various 
geometrical settings and morphological sample properties. The signal dependence on 
geometrical settings was circumvented following synthesis of an internal standard (IS) 
and the development of a controlled IS deposition method for sample pretreatment prior 
to reactive DESI MS analysis. Following the homogenous dispersion of the IS on the 
sample surface using this deposition protocol, the analyte-to-internal standard signal ratio 
was observed to be largely independent of all DESI variables. However, the signal ratio 
still showed some dependence on sample properties notably, the sample hardness. By 
using a correction scheme this dependence was also circumvented enabling the 
application of this methodology for the direct quantitation of field-collected artesunate 
tablets with a 6% (n=4) precision and 94% accuracy. 
 
4.2. Introduction 
The development of methodologies that allow the quantitative determination of 
physiologically active analytes in complex matrices is an ongoing trend in analytical and 
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biological mass spectrometry. This chapter presents discussions on the capabilities of 
DESI MS for the rapid quantitative analysis of pharmaceutical tablets for the 
determination of substandard and subtherapeutic counterfeit medications.  
Although DESI MS has been shown to be a powerful tool for the qualitative 
analysis of a broad range of analytes and sample types,247 its applicability for direct 
quantitative analysis remains limited.  This being largely because of the dependence of 
the DESI signal on various experimental parameters (see Figure 1.1) including the spray 
tip-to-surface distance (d1), sample-to-spectrometer orifice distance (x), MS 
orifice-to-surface distance (d2), spray incident angle (α) and collection angle (β). Fixed-
geometry DESI probes, might somewhat mitigate this problem.93-95 However, in the case 
of pharmaceutical tablets there is an additional dependence of the DESI signal on sample 
properties such as hardness and sample shape, the latter influencing α and β. Cooks and 
co-workers first suggested that the use of an isotopically labeled internal standard (IS) to 
circumvent these limitations in order to enable quantitative applications by DESI MS. 
They demonstrated this capability in a proof-of-concept application in the quantitation of 
phenylalanine that was codeposited with IS from solution onto glass substrates.1 Similar 
proof-of-concept studies have also been shown for the quantitative analysis of 
pharmaceuticals compounds spiked in various matrices including diluted urine and 
porcine brain lipid extracts.156, 157 The application of DESI MS for quantitative analysis 
of agrochemicals in foodstuff extracts has also been reported.144  
In this Chapter, the applicability of DESI MS for the direct quantitative analysis 
of artesunate in solid pharmaceutical formulations is explored by leveraging the 
advantages provided by the reactive DESI MS protocol presented in Chapter 3. Due to 
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the challenge posed by the incorporation of a controlled, well-dispersed amount of IS into 
a solid tablet, several deposition methods were explored and compared for the 
development of a quantitative analytical tool for the direct sampling of solid antimalarial 
formulations. The large dependence of the DESI signal intensity with various 
experimental variables and sample properties was overcome by the homogeneous 
deposition and co-crystallization of a deuterated IS on the tablet surface enabling direct 
quantitive determination. The DESI MS results were validated using liquid 
chromatography.  
 
4.3. Experimental Details 
4.3.1. Samples and Reagents 
All reagents were used as received. HPLC grade acetonitrile (Fisher, Hampton, 
NH) and dodecylamine (DDA, Sigma-Aldrich, St. Louis, MO) were used for DESI and 
reactive DESI experiments. Ultrapure water (18.2 MΩ cm-1) was obtained from a 
Nanopure purification unit (Barnstead, San Jose, CA). Genuine artesunate tablets 
manufactured by Mekophar Chemical Pharmaceutical Joint-Stock Co. (Ho Chi Minh 
City, Vietnam), stated to contain 50 mg of artesunate per tablet with an average total 
tablet weight of 320 mg, were used for all characterization and optimization studies. A 
previously reported LC procedure198 was used to predetermine the amount of artesunic 
acid in these samples. Dihydroartemisinin (AApin Chemicals Ltd, UK), d4-succininc 
anhydride, triethylamine, tetrahydrofuran, acetic acid, anhydrous sodium sulfate, 
ethylacetate and hexane (Sigma-Aldrich, St. Louis, MO) were used in the synthesis of d4-
artesunic acid. Cab-o-sil, talc, magnesium stearate (Acros Organics, Morris Plains, NJ), 
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microcrystalline cellulose (Mallinckrodt Baker Inc., Phillipsburg, NJ), croscarmellose 
sodium, and spray-dried lactose (FMC Corp., Newark, DE) were used as excipients for 
the preparation of artesunate tablet standards. Artesunic acid (M) was purchased from 
AApin Chemicals Ltd. All genuine and standard artesunate tablet samples were stored at 
4oC until analyzed.  
 
4.3.2. Synthesis of Isotopically Labeled Internal Standard (IS) 
The IS, d4-artesunic acid, was synthesized by the base catalyzed esterification of 
dihydroartemisinin with d4-succinic anhydride according to the scheme shown in 
Figure 4.1. A previously reported procedure248, 249 for the synthesis of artesunic acid was 
followed with some modifications, using dihydroartemisinin as the starting material. In a 
typical synthetic procedure, 250 mg of dihydroartemisinin were stirred for 2 minutes in 5 
mL of tetrahydrofuran (THF). 125 mg of d4-succinic anhydride and 500 µL of 
triethylamine were then added to the reaction flask and stirred for 3 hours at room 
temperature. At the end of the reaction, 20 mL of cold water, previously adjusted to 
pH4.0 using dilute acetic acid, was added to the mixture, and the pH finally adjusted to  
 
 
Figure 4.1. Reaction scheme for IS synthesis. 
   72 
4.0. Product extraction was performed on ice using three separate 20 mL portions of 
60:40 ethylacetate:hexane. The extract was washed with three10 mL portions of chilled 
water previously adjusted to pH 4.0 and then dried over anhydrous sodium sulfate. The 
solvent was then evaporated in a Rotavap (30o C) to an estimated final volume of 5 mL, 
after which the solvent was swapped by 3 separate additions and evaporations of 10 mL 
portions of hexane. The solvent volume was then reduced to 3 mL, and left to evaporate 
to dryness in a hood at ambient temperatures. The crude product was purified by 
recrystalization in hexane. Purity was assessed by electrospray ionization MS of a 50:50 
CH3CN:H2O solution containing 1 µM of the product in 100 µM DDA. Compared to 
similar analysis of an artesunic acid standard, which showed a peak at m/z 570 
corresponding to [M + DDA + H]+ (Figure 4.2.a), the ESI spectrum of the reaction  
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Figure 4.2. ESI spectra of 1µM (a) artesunic acid standard, (b) reaction product from IS 
synthesis. M = artesunic acid. 
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product also showed predominantly a single peak at m/z 574 corresponding to [d4-
M + DDA + H]+ (Figure 4.2.b). The detection of just one peak in the former indicates a 
high purity of the reaction product, which also showed the expected 4 mass unit shift 
relative to M (Insert Figure 4.2.a).  
 
4.3.3. Preparation of Standard Artesunate Tablets 
Standard artesunate tablets were prepared in collaboration with Dr. Sameer Late 
and Ajay Banga in the Department of Pharmaceutical Sciences, Mercer University. 
Artesunate tablet standards were composed of three major constituents: excipient mixture 
A, spray dried lactose, and artesunic acid. Excipient mixture A was composed of 69% 
microcrystalline cellulose, 1% fumed silicon dioxide (cab-o-sil), 5% talc, 20% 
croscarmellose sodium and 5% magnesium stearate. This mixture was prepared as 
follows: microcrystalline cellulose, cab-o-sil, and croscarmellose sodium were passed 
through a 20 mesh sieve and mixed together in a zip-lock bag for 5 minutes. Talc and 
magnesium stearate were also passed through the 20 mesh sieve, added to this bag and 
mixed with the other components for 2 minutes. Prior to tablet pressing, spray dried 
lactose, and artesunic acid were also passed through a 20 mesh sieve and mixed with 
excipient A in a zip-lock bag for 3 minutes. Tablets were composed of 20% excipient A, 
and variable amounts of artesunic acid and spray dried lactose to obtain tablets with 
variable properties such as hardness, amount of active ingredient, diameter, and shape. 
Tablets were pressed using a B2 rotary tablet press (Globe Pharma, New Brunswick, NJ) 
at 60 rpm. Tablet hardness was measured using a Monsanto hardness tester 
(Tab-Machines Ltd., Bombay, India). 
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4.3.4. Sample Pretreatment with IS and DESI MS 
For quantitation purposes, all samples were treated with 25 µL of 100 mM IS in 
neat acetonitrile, unless stated otherwise. The IS solution was kept in a -80oC freezer at 
all times, and placed on ice during use to minimize evaporation. The preferred IS spiking 
method consisted of addition of the IS solution by pipette deposition, creating a thin 
solution film on the surface of the samples (Figure 4.3). The thin film then diffuses into 
the sample at a rate that was observed to be dependent on the tablet porosity. Samples 
were allowed to air dry at room temperature before analysis. This procedure is further 
discussed and compared to other IS deposition approaches in the Results section. 
DESI MS was performed using the DESI ion source described in section 2.3.3, 
using settings similar as those described in section 2.3.4. The ion source was coupled to 
an LCQ DECA XP+ quadrupolar ion trap mass spectrometer (Thermo Finnigan, San 
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Figure 4.3. (a) Sample pretreatment with IS: (i) pipette deposition of a solution of 
d4-artesunic acid in neat acetonitrile onto the sample surface, (ii) air drying of sample 
after treatment with IS, and (iii) reactive DESI MS analysis of air-dried samples; 
(b) DESI MS interface showing various DESI set-up variables. 
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DESI MS was performed by spraying samples with a solution of 75:25 CH3CN:H2O. 
This solvent mixture was doped with 100 µM dodecylamine for reactive DESI 
experiments. For all experiments, the spray solution flow rate was set to 2 µLmin-1 unless 
stated otherwise. Except for initial comparative investigations, all experiments were 
performed by reactive DESI. The mass spectrometer was set to acquire data in full scan 
mode via the Xcalibur software (version 2.0, Thermo Finnigan). The ion transfer 
capillary was set to 300oC. The instrument was set to collect spectra in automatic gain 
mode for an ion trap injection time of 200 ms at 2 microscans spectrum-1. All DESI 
characterization experiments were performed using genuine artesunate tablets. The 
assessment of the effect of sample properties on the DESI signal, and the development of 
a calibration method were done using artesunate tablet standards with the same surface 
geometry as the genuine samples.  
 
4.4. Results and Discussions 
4.4.5. Reagentless DESI vs. Reactive DESI of IS Treated Artesunate Tablets 
Figure 4.4 shows results of the initial investigation of the type of ionic species 
generated by reagentless and reactive DESI of IS treated artesunate tablets. Samples were 
pretreated with IS following the pipette deposition procedure depicted in Figure 4.3. 
Analysis by reagentless DESI MS shows peaks corresponding to various sodiated analyte 
and IS monomeric and dimeric species at m/z 407, 411, 791, 795 and 799 including a few 
fragment peaks (Figure 4.4.a). The spread of the analyte ion signal into various channels 
and the observed variation of relative intensity of the different adducts in-between 
experiments made it complicated to choose an ion peak for quantitative analysis. Similar  
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Figure 4.4. DESI spectra of genuine artesunate tablets pretreated with 25 µL, 100 mM 
solution of IS following analysis in (a) reagentless DESI mode and (b) reactive DESI 
mode. 
 
analysis of the IS treated genuine artesunate tablet by reactive DESI showed 
predominantly one peak for the analyte and one for the IS with close to two orders of 
magnitude improvement in signal intensity compared to reagentless DESI (Figure 4.4.b). 
The simplicity of the reactive DESI spectrum together with the improved sensitivity 
resulted in an easy choice of analyte ion signal for further quantitative analysis. As such 
all subsequent experiments were performed by reactive DESI MS. 
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4.4.6. Comparison of Internal Standard Deposition Methods 
Various methods were explored for the pretreatment of sample with IS following 
quantitative investigations by DESI MS including: (i) pneumatically-assisted electrospray 
deposition, (ii) addition of IS directly into the DESI spray solution and, (iii) pipette 
deposition of neat acetonitrile IS solution. The performance of each of these deposition 
methods was assessed by evaluating the temporal stability of the signal intensity ratio of 
the ion at m/z 570 to that at m/z 574 at different spray solution flow rates and positions 
across the sample surface. 
Nebulizer assisted electrospray deposition of IS resulted in a very unstable signal 
intensity ratio (Figure 4.5.a). The ratio rises very rapidly with time, suggesting that this 
deposition method results in a very thin coat of IS on the sample surface, but not 
sufficient interdispersion with the tablet surface material. This thin layer is quickly 
depleted by the DESI jet with the depletion rate increasing with spray flow rate. To 
obtain a uniform coat of material on the sample surface, this approach required very 
careful control of various variables including the nebulizer gas flow rate, the spray 
tip-to-sample surface distance, and the elimination of any air draft currents in the room 
where the sample was being processed. Because of these difficulties, it was quickly 
realized that it would be tricky to reproduce the amount of IS deposited on different 
samples, which would translate into a poor day-to-day reproducibility. 
Addition of a small amount of IS to the reactive DESI spray solution also resulted 
in an unstable signal intensity ratio (Figure 4.5.b), with instabilities becoming more 
prominent at higher flow rates. Because the reactive DESI spray probes the same spot on 
the sample in this scenario, this spot becomes progressively contaminated by the IS  
   78 
time (min)















































Figure 4.5. Normalized traces of the ion intensity ratio of the ion at m/z 570 to that at m/z 
574 for various internal standard deposition methods at various DESI spray solution flow 
rates. (a) Spray deposition from a solution of 75:25 CH3CN:H2O (b) Doping of the DESI 
spray solution with the internal standard. 
 
contained in the spray, which results in a decreasing analyte-to-IS signal ratio with time. 
The method of choice adopted for these studies involved the pipette deposition of 
the IS dissolved in neat acetonitrile (Figure 4.3). After application of the IS, the 
acetonitrile solution flows across the sample surface forming a homogenous liquid thin 
film, which is then observed to diffuse into the sample. This process requires an 
estimated 20 seconds for a genuine artesunate tablet. No significant disintegration of the 
tablets was observed during this process. After deposition, the samples are allowed to air 
dry at room temperature. For consistency across tablets of different hardness, 30 minutes 
were allowed for this step, which doesn’t necessarily decrease throughput significantly as 
several samples could be dried in parallel. Following IS deposition, 4 spots on the tablet 
surface were probed by reactive DESI, one on each tablet quadrant. Reactive DESI 
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analysis of four surface spots required an estimated 3 minutes per tablet with a manual 
x-y stage. 
Reactive DESI analysis of samples spiked by this deposition method at various 
solvent flow rates ranging from 1-3 µL min-1 resulted in analyte and IS ionic signals 
which basically tracked each other (Figure 4.6.a), resulting in a highly stable signal 
intensity ratio (Figure 4.6.b).  Similar analysis at various nebulizer gas pressures from 
100-200 psi resulted in an unstable time trace when the analyte and IS signal intensities 
were summed (Figure 4.7.a), but produced a stable signal intensity ratio at all nebulizer 
gas flow rates investigated (Figure 4.7.b). The intensity ratio was also found to be largely 
stable for different positions across the sample surface, with a relative standard deviation 






























































Figure 4.6. Normalized ion intensity traces at various solution flow rates by reactive 
DESI. (a) Relative intensity of ions at m/z 570 (black trace) and m/z 574 (gray trace), 
(b) intensity ratio of the ion at m/z 570 to that at m/z 574. 































































Figure 4.7. Normalized ion intensity traces at various nebulizer gas pressures by reactive 
DESI. (a) Sum of ion intensities generated from the ions at m/z 570 and m/z 574, 
(b) intensity ratio of the ion at m/z 570 to that at m/z 574. 
 
sample. This ratio was also largely stable for a wide range of DESI spray flow rate and 
nebulizer gas pressures, with relative standard deviations of 5.1% (n=7) and 5.0% (n=6) 
respectively, as shown in Table 1. Depth profiling of a genuine artesunate sample treated 
with IS following the pipette deposition protocol showed a stable analyte-to-IS signal 
intensity ratio when the same spot on the sample was interrogated with the reactive DESI 
jet for up to 60 min. This resulted in a crater of approximately 0.3 mm in depth (Figure 
4.8). This suggests a minimum penetration of the IS up to this depth. All subsequent 
experiments were performed by this IS deposition method at a DESI spray solution flow 
rate of 2 µL min-1 and a nebulizer gas pressure of 110 psi. 
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Figure 4.8. Depth profiling of a genuine artesunate tablet treated with a IS: (a) Sum of 
ion intensities of the ions at m/z 570 and m/z 574. (b) intensity of ions at m/z 570, and 
m/z 574 respectively, (c) intensity ratio of ion at m/z 570 to that at m/z 574. The intensity 
values were normalized for each plot. 
 
4.4.7. Effect of DESI Geometrical Settings on the Analyte-to-Internal Standard Signal 
Ratio 
Summarized in Table 1 below are results of the effect of the various experimental 
and DESI set-up variables including d1, d2, x, α, β on the analyte-to-IS signal intensity 
ratio in comparison to the absolute signal, as stated by their relative standard deviation. 
For the variables α and β, the relative standard deviations observed for the normalized 
signal intensity ratio were 11.4% (n= 6) and 6.4% (n=7), as opposed to 82.1% and 72.6% 
respectively when the absolute signals were monitored. For the variables d1, d2 and x, the 
observed relative standard deviations were 10.6% (n=6), 7.8% (n=4), and8.8% (n=6) for  
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Table 4.1. Comparison of the reproducibility of the absolute DESI signal vs. the signal 
intensity ratio of analyte-to-IS for various DESI variables. 
RSD (%)




I570/I574I570 + I574DESI Variable
11.482.1Spray incident angle (α)
6.472.6Collection angle (β)
8.866.8Sample-to-spectrometer orifice distance (x)
 
 
the signal intensity ratio as opposed to 33.6%, 46.4% and 66.8% respectively for the 
absolute signal. These results show lower relative standard deviations when the 
analyte-to-IS signal intensity ratio was monitored compared to the sum of the absolute 
signals corresponding to the analyte and IS. This indicates a significant independence of 
the analyte-to-IS intensity ratio for all DESI spray condition and geometrical parameters, 
and suggests the potential of this approach for the direct quantitative analysis of active 
ingredients in solid pharmaceutical tablets. 
 
4.4.8. Effect of Sample Properties on the Analyte-to-Internal Standard Intensity Ratio 
In Chapter 3, it was observed that the DESI signal shows appreciable dependence 
on various sample properties including hardness, surface morphology etc. Because of 
these dependencies, an investigation of the effect of each of these variables on the 
reactive DESI analyte-to-IS signal ratio is imperative in order to establish conditions 
under which robust quantitative results can be obtained.  
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Figure 4.9 shows the effect of sample hardness on the analyte-to-IS signal 
intensity ratio for artesunate tablet standards containing three different amounts of the 
active ingredient. All samples were treated with identical amounts of IS and analyzed by 
reactive DESI at a spray solution flow rate of 2 µL min-1. An almost linear decrease in 
signal intensity ratio was observed for hardness values below 5 kg.  For harder tablets, 
the signal ratio becomes relatively constant, and depends on the analyte concentration. 
The IS solution was observed to percolates into the sample at a rate that depended on the 
sample porosity. Because the sample porosity increases with decreasing hardness, the IS 
percolates deeper and faster into the body of softer samples. The end result of this is a 
more “dilute” superficial IS zone for softer tablets resulting in a larger m/z 570 to m/z 574 
signal intensity ratio following reactive DESI analysis. For samples prepared with 
hardness values larger than 5 kg, the results shown in Figure 4.9 suggest a quasi-constant 
 
Hardness (Kg)














50 mg M/250 mg tablet
40 mg M/250 mg tablet
30 mg M/250 mg tablet
 
Figure 4.9. Dependence of the m/z 570 to m/z 574 ion intensity ratios following reactive 
DESI MS analysis of artesunate tablet standards with varying hardness. The intensity 
ratios were normalized to that of the maximum value. 
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degree of percolation of the IS into the tablet body. In this case, the rate of evaporative 
loss of the IS solution solvent is larger than the percolation rate, which determines the 
amount of material migrating into the tablet. 
To further examine the distribution of the IS into the tablet sample, depth 
profiling analysis was performed at two different spray solvent rates (2 and 6 µl min-1) for 
samples prepared at three different hardness values (2.7, 5.9, and 8.0 kg, Figure 4.10). At 
2 µL min-1 the analyte-to-IS signal ratio was stable, with relative standard deviations 
below 10% for all hardness values investigated. This indicated a homogenous distribution 
of the IS within the outermost tablet layers probed at this flow rate (Figure 4.10.a). 
Significant disintegration of the sample surface was not observed in this case. However, 
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RSD = 8.3 %
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RSD = 7.1 %
 
Figure 4.10. Depth profiling of standard artesunate tablets prepared at different hardness 
values. Samples were treated with 100 µM d4-artesunic acid followed by DESI MS 
analysis. Plots show the intensity ratio of the ion at m/z 570 to that at m/z 574 for 
different DESI spray solution flow rates including: (a) 2 µL min-1, (b) 6 µL min-1. 
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observed to gradually increase over time (Figure 4.10.b). This validates our hypothesis 
that a gradient of the IS is established within the tablet surface. Tablets with different 
hardness showed a different temporal evolution of the analyte-to-IS signal ratio due to 
differences in the rate at which the spray ablates the surface. To ensure optimum 
dissolution properties, and optimum dosage and absorption, pharmaceutical tablets are 
usually prepared with hardness lower than 5 kg. This means that the relative hardness of 
samples and standard must be used as a correction factor for performing quantitative 
DESI MS. 
Quantitative analysis via pipette deposition of an IS solution requires that all 
samples be treated with the same amount of IS per unit tablet area. It was thus also 
necessary to evaluate the change in analyte-to-IS signal intensity ratio as a function of the 
surface area treated with IS. Figure 4.11.a shows results obtained from the reactive DESI 
analysis of duplicate tablets at two different diameters (9 and 11 mm) treated with 
identical amount of IS. The results indicate that the analyte-to-IS signal intensity ratio 
increases with increasing tablet diameter. The average intensity ratio of analyte-to-IS 
observed for 9 mm and 11 mm diameter, tablets containing 50 mg artesunic acid per 250 
mg tablets were 4.5 and 7.7 respectively.  Because in both cases the analyte solution is 
completely dispersed over the whole tablet surface, a lower amount of IS percolated per 
unit surface area when the tablet diameter was increased. 
In addition to tablet diameter, the effect of tablet shape on the analyte-to-IS signal 
intensity ratio was investigated. Standard tablets of the same diameter, which had flat and 
convex topology were treated with identical amounts of IS solution and analyzed by 
reactive DESI. The results showed a negligible change in analyte-to-IS signal intensity  
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Figure 4.11. Dependence of the m/z 570 to m/z 574 ion intensity ratios following reactive 
DESI MS analysis of artesunate tablet standards with varying tablet surface (a) diameter, 
(b) topology. 
 
ratio with convex tablets showing slightly higher ratios compared to flat ones 
(Figure 4.11.b). The observed average percentage increase in the intensity ratio was 
9.9 %. This is probably due to the larger surface area of the convex sample which results 
in a lower amount of IS per surface area, and thus a higher analyte-to-IS signal intensity 
ratio. 
 
4.4.9. Calibration and Direct Quantitation of Artesunic Acid in Pharmaceutical 
Tablets by Reactive DESI MS 
The large independence of the analyte-to-IS signal intensity ratio observed for all 
DESI variables promises applicability of reactive DESI for direct quantitative screening. 
As a first step in establishing the quantitative capabilities of the approach proposed here, 
a calibration curve for the prediction of unknown samples was generated. This was done 
using 250 mg tablet standards with varying artesunic acid amounts, prepared at a 
hardness close to that of genuine samples (2.4 ± 0.2 kg), with a flat surface shape, and 
diameters of 9 mm (area=63.6 mm2). Three replicate tablets were prepared at each level 
of the active ingredient in the range 0.02-0.32 mg artesunic acid mg-1 tablet. The 
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calibration curve showed good linearity over the investigated concentration range with a 
correlation coefficient of 0.9985 (Figure 4.12.a). The limit of detection defined as the 
analyte concentration giving a signal equal to the blank signal plus three standard 
deviations was calculated from the calibration curve to be equal to 0.018 mg artesunic 
acid mg-1 tablet (4.5 mg artesunic acid /250 mg tablet).  A set of test samples, with 
amounts of artesunic acid that fell in the calibration curve range, was prepared for  
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LOD = 0.0184 mg M/mg tablet 
r = 0.9971




Figure 4.12. (a) Calibration curve obtained from standard samples prepared at a hardness 
of 2.4 Kg. The response is plotted as the signal intensity ratio divided by the product of 
tablet hardness by tablet surface area. (b) Method validation: plot of the amount of 
artesunic predicted from the calibration curve to the known amount present for a 
validation sample set. Error bars represent standard deviations for three different tablets. 
Each sample was probed on four quadrant and the signals averaged. 
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validation purposes. Results showed a good correspondence between the expected and 
the predicted amounts of artesunic acid present in the validation sample set, with a 
correlation coefficient of 0.9971, and y-intercept and slope values of 0.0109±0.0197 and 
1.139±0.108 respectively (Figure 4.12.b). These results validate the applicability of this 
quantitative DESI MS  approach to samples with known (or constant) hardness, surface 
area, and shape, such as those encountered in a quality control laboratory setting. 
A more challenging application of this DESI approach is the quantitation of active 
ingredients in samples with hardness not exactly matched to the calibration standards. 
This would be the case, for example, of drugs suspected of being counterfeit which are 
collected in the field for further off-field forensic analysis. The performance of the 
proposed quantitative approach was accessed using three different artesunate tablet 
samples from Mekophar pharmaceutical collected in the field. The samples had a 
measured hardness of 2.7±0.2 kg and diameter of 10.1 mm. The samples were treated 
with IS solution and analyzed by reactive DESI against a calibration curve created with 
standard tablets. The calibration sample set had a hardness of 2.4 ± 0.2 kg and diameter 
of 9 mm. Table 2 summarizes the results of these analyses. An average relative standard 
deviation of 6% was obtained for the predicted amount of artesunic acid present in the 
three samples, which compares relatively well with the 2% observed for HPLC analysis. 
Comparison of the predicted amount of artesunic acid to the amount determined by 
HPLC showed significant deviations (35% on average) if uncorrected by tablet hardness 
and surface area. Upon normalization of the sample DESI analyte-to-IS signal ratio by 
the tablet hardness and surface area, and comparison to the 50 mg/tablet standard, the 
difference between the artesunic acid amount determined by DESI and the expected  
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Table 4.2. Quantitation of artesunic acid in genuine sample by DESI MS compared with 
the expected amount present in the sample. 
HPLCPredicted with 
correction
Predicted with no 
correction
Sample
Artesunic acid (mg tablet-1)
53 ± 258 ± 373 ± 4 Tablet 1
56 ± 258 ± 473 ± 5Tablet 2
50 ± 253 ± 368 ± 4Tablet 3
 
 
amount was reduced to 6% on average. This is a clear indication that the sample physical 
properties play a critical role in quantitative analysis by DESI. When corrected, the 
average accuracy obtained by reactive DESI MS quantitation can be considered sufficient 
for determining active ingredient content with a good degree of accuracy (94%) which is 
acceptable for a high throughput pharmaceutical screening assay such as this. 
 
4.5. Conclusions 
This study demonstrated the capability of reactive DESI MS as a high throughput 
quantitative approach for the direct screening of antimalarial tablets. The controlled 
deposition of an internal standard enables to perform quantitative measurements 
independent of the DESI set-up variables. The method shows a precision of 6% (n=4) and 
an accuracy of 94% which is largely acceptable for the rapid quantitation of active 
ingredients in drug tablets. Sample hardness and surface area are important factors to be 
taken into account when implementing this method. Although correction schemes to take 
into account, tablet hardness and shape are feasible it is preferable that whenever 
possible, the calibration sample set has the same characteristics as the unknowns. 
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CHAPTER 5. DESI REACTIONS BETWEEN HOST CROWN 
ETHERS AND THE NEURAMINIDASE INHIBITOR 
OSELTAMIVIR FOR THE RAPID SCREENING OF TAMIFLU® 
 
5.1. Abstract 
This chapter presents an extension of the application of DESI MS to the 
development of a rapid screening method for other popular drugs, which are also being 
counterfeited. This is the case for Tamiflu®, which contains oseltamivir as the active 
ingredient. Oseltamivir is an orally active neuraminidase inhibitor antiviral commonly 
administered as treatment for the avian influenza and swine flu. The high cost and 
demand of this drug around the world has made it a target for counterfeiters requiring the 
development of rapid and sensitive tools for Tamiflu® authentication. In this study, 
competitive host-guest chemistry on a DESI MS platform is presented as the basis for a 
rapid and quantitative screening method for assessing the quality of Tamiflu® capsules. 
The method is based on the selective recognition of oseltamivir by crown ethers added to 
the DESI spray solvent. Crown ethers with various ring sizes were evaluated, all being 
observed to form stable host-guest complexes with oseltamivir. Competitive experiments 
with various pairs of crown ethers were used to assess their relative binding selectivities 
for oseltamivir. The abundance ratio of the formed complexes was observed to be 
dependent on the amount of analyte present on the surface of the sample, and 
independent of DESI geometric factors. These competitive reactions were then 
successfully tested as a means for the rapid quantitation of oseltamivir in field-collected 
Tamiflu capsules by reactive DESI MS without the need for an internal standard. 
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5.2. Introduction 
The 20th century witnessed three influenza outbreaks, with the most devastating 
occurring during the 1918-1920 period, believed to be responsible for an estimated 20-50 
million deaths. The recent outbreaks of the avian influenza, H5N1 and the pandemic 
swine influenza, H1N1 have rapidly increased the demand for neuraminidase inhibitor 
antivirals, with stockpiling leading to shortage of supply. With Tamiflu® being the 
leading orally-active antiviral in the market,250 its high cost and demand quickly made it a 
preferred target for drug counterfeiters. Reports of counterfeit Tamiflu® capsules, which 
were shown to not contain oseltamivir, but vitamin C, have already appeared.251 Current 
pandemic preparedness plans rely on strategies for influenza control based on the wide 
distribution of effective medication. Thus, reports of counterfeit Tamiflu® have led to an 
urgent need for rapid and sensitive authentication tools to ensure the quality of the drugs 
available to the public and healthcare authorities. 
The quality of Tamiflu® capsules has been previously assessed using standard 
drug testing methods based on high performance liquid chromatography (HPLC),252 thin 
layer chromatography combined with disintegration assay253 and colorimetric 
authentication tests for field drug quality screening.254 However, chromatographic 
methods suffer from low sample throughput, and many TLC or colorimetric tests are 
meant only to provide a pass/fail response, but are not designed to unequivocally identify 
unknowns or for failsafe selectivity. In this study, crown ether host-guest chemistry in a 
reactive DESI MS platform is being explored as an alternative approach for the rapid, 
sensitive and selective detection of oseltamivir in pharmaceutical preparations. The 
formation of a specific noncovalent complex, coupled with consecutive reaction 
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monitoring (CRM) mode; where an oseltamivir fragment generated by an MS/MS/MS 
experiment is monitored, ensures the highest degree of selectivity. This is useful in 
qualitative pass/fail forensic experiments where the presence or absence of the correct 
active ingredient is assessed. 
In order to gain more insight of the products formed during reactive DESI, the 
relative gas phase stability of crown ether-oseltamivir complexes was studied via ab 
initio calculations and breakdown curve experiments. Taking advantage of competitive 
reactions between two crown ethers with different affinities for oseltamivir, a linear 
relationship was obtained between the logarithmic ionic signal intensity ratio and the 
amount of oseltamivir present or deposited on a solid substrate, enabling the acquisition 
of rapid semi-quantitative results without the need for an internal standard.  
 
5.3. Experimental Details 
5.3.1. Reagents and Samples 
All reagents were used as acquired. High purity HPLC grade methanol and 
acetonitrile, 99.9+% (Honeywell Burdick & Jackson, Muskegon, MI) were used for DESI 
and reactive DESI experiments. Ultrapure water (18.2 MΩ cm-1) was obtained from a 
Nanopure purification unit (Barnstead, San Jose, CA). The crown ether hosts: 12-crown-4 
(12-C-4), 15-crown-5 (15-C-5) (Alfa Aesar, Ward Hill, MA), 18-crown-6 (18-C-6) (TCI 
America, Portland, OR) and 2,5-dibenzo-21-crown-7 (2,5-DB-21-C-7) (Acros Organics, 
Morris Plains, NJ) were used for reactive DESI experiments. Genuine Tamiflu® capsules 
stated to contain 75 mg oseltamivir free base per capsule (166±4 mg ea.) and 
pharmaceutical grade oseltamivir phosphate, used for characterization and optimization 
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studies were a generous donation from Roche Pharmaceuticals. Depicted in Figure 5.1 
are the structures of oseltamivir (Figure 5.1.a) and the crown ethers evaluated in this 
study (Figure 5.1.b). The excipients mixture described in section 4.3.3 was used in 
preparing reserpine (Sigma Aldrich Corp., St. Louis, MO) tablets for hardness 
optimization studies. Tamiflu® samples were purchased over the Internet according to the 
collection protocol described by Green at al.254 All the samples were in capsule form and 
stated to contain 75 mg of oseltamivir free base per capsule. Quantitative DESI MS 
measurements were validated by HPLC analysis of the same samples. HPLC analysis 
was performed by Dr. Michael Green in the Division of Parasitic Diseases, Center for 
Disease Control and Prevention (CDC), using the method described by Green et al.254 All 
samples were stored at 4oC until analyzed. 
 
 
Figure 5.1. Structures of (a) oseltamivir and (b) crown ethers investigated in this study. 
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5.3.2. Substrates and Samples Preparation 
Polytetrafluoroethylene (PTFE) substrates were prepared by cutting a PTFE rod 
(McMaster-Carr, Atlanta, GA) into 2.6 mm thick, 9.6 mm diameter discs. Disc surfaces 
were finished by rubbing on 220C grit sand paper (Norton Abrasives, Worcester, MA). 
PTFE discs were then sonicated in acetone, rinsed extensively in acetonitrile, and allowed 
to air dry prior to use. Glass substrates were made in an in-house glass shop by cutting a 
glass rod into 3.9 mm thick, 9.1 mm diameter discs with one of their surfaces etched. 
These were cleaned by the same procedure as with the PTFE substrates. Unless stated 
otherwise, glass or PTFE substrates were spotted with 10 µL of 1 mg/mL of an 
oseltamivir phosphate standard solution and allowed to air dry prior to analysis. The 
diameter of sample spots on the PTFE surface was 4.6±0.3 mm and on the glass surfaces 
9.1±0 mm. Tamiflu® capsules were pressed using a KBr press (Int. Crystal Labs., 
Garfield, NJ) in 7 mm dyes at a hardness of 73±7 kg/m2 unless stated otherwise. 
 
5.3.3. DESI MS 
A custom-built DESI ion source with imaging capabilities, described in section 
6.3.2, was interfaced to an LCQ DECA XP+ QiT MS (Thermo Finnigan, San Joss CA), 
and used for all experiments. The ion source and mass spectrometer were operated using 
settings similar to those described in section 2.3.3 and 4.3.4 respectively. Briefly, the ion 
source consisted of a motorized stage (Prior Scientific, Rockland, MA) for sample 
positioning and high performance sprayer mounted on an XYZ manual translation stage 
(Thorlabs, Newton, NJ) for spray positioning. The spray solvent flow rate was set to 
5 µl/min and was biased to +3 kV for all experiments. 
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The standard LCQ ion transfer capillary was replaced by an extended version 
(762 µm i.d., 1588 µm o.d., Small Parts Inc., Miramar, FL). All experiments were 
performed in positive ion mode. Data were acquired data via the Xcalibur software 
(version 2.0, Thermo Finnigan) for a total acquisition time of 15 s unless stated 
otherwise. All experiments were performed using high purity acetonitrile (99.9+%) as the 
spray solvent unless stated otherwise. Initial characterization experiments were 
performed by adding 100 µM of each of the crown ethers investigated to the DESI spray 
solvent. For competitive reactive DESI experiments, equimolar concentrations of various 
crown ether pairs were utilized. Mass spectral data were collected on 4 different spots 
(one on each quadrant) of the sample and averaged. A 10 µM 15-crown-5 and 5 µM 18-
crown-6 solution was used for oseltamivir quantitation. 
 
5.3.4. Computational Calculations 
Computational calculations were performed by Edward Hohenstein, a graduate 
student in Dr. Sherrill`s group in the School of Chemistry and Biochemistry, Georgia 
Institute of Technology. Binding energies for complexes of oseltamivir with 12-crown-4, 
15-crown-5, 18-crown-6, and 2,5-dibenzo-21-crown-7 were computed at the 
B3LYP-D/6-311++G** level of theory,255 where the “-D” denotes the inclusion of 
empirical terms to account for the dispersion interactions neglected by the B3LYP 
functional.256 The counterpoise correction scheme of Boys and Bernardi was applied in 
the computation of binding energies.257 Complex geometries were fully optimized at the 
B3LYP-D/6-31G** level of theory while including the empirical dispersion correction. 
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The proton affinities were computed at the B3LYP-D/6-31G** level of theory. 
Computations were performed using PS13,258 Q-CHEM259 and Jaguar.260 
 
5.4. Results and Discussion 
5.4.5. Effect of Spray Solvent Composition/Substrates on DESI MS Signal 
The development of any DESI MS methodology requires considerations on 
several factors including spray solvent composition and flow rate, choice of substrate 
material, and solvent used to deposit the analyte. Particularly important in this study was 
the choice of the DESI spray solvent. Exploratory experiments were performed with 
various solvents containing 100 µM 18-crown-6 to probe oseltamivir standards deposited 
onto PTFE substrates. It was observed that solvent mixtures containing water or 
methanol, regardless of their proportion, resulted in the formation of competitive crown 
ether complexes with ubiquitous metal cations such as Na+ and K+. Crown ethers are well 
known to form stable complexes with these alkali metal ions, which survive in the gas 
phase.261 Na+ and K+ compete with oseltamivir for the formation of crown ether 
complexes, limiting the amount of reagent available for reaction with the analyte, 
potentially reducing the analyte signal, and complicating the mass spectrum. Neat, high 
purity acetonitrile (99.9+%) was chosen as the spray solvent of choice due its negligible 
alkali metal ion content. Acetonitrile is also know to coordinate metal cations including 
Na+ and K+,262, 263 thus its use as reactive DESI spray solvent may assist in sequestering 
these cations. This potentially allows effective reactivity of the crown ether with the 
analyte. Because of its aprotic nature, acetonitrile is also supposed to cause minimum 
interference with the hydrogen bonding interactions between the crown ether hosts and 
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analyte.264 In terms of the sample deposition substrate, PTFE discs were observed to 
show negligible signal for crown ether-alkali metal complexes. This was not the case for 
etched glass substrates. This was possibly due to the metal ions intrinsically present in 
glass compositions. As such, all following characterization experiments were performed 
using PTFE surfaces and neat acetonitrile as the DESI spray solvent. 
 
5.4.6. Conventional vs. Reactive DESI MS of Oseltamivir Standards 
Preliminary investigations involved performing the analysis of oseltamivir 
phosphate standards in the conventional (i.e reagentless) DESI MS mode, for subsequent 
comparison with reactive DESI MS experiments. Figure 5.2.a shows results from this 
analysis. It was observed that the analyte ion signal was spread into a variety of channels 
corresponding to various oseltamivir species with the most abundant being the protonated 
monomer at m/z 313. The peak at m/z 625 corresponds to the proton-bound dimer. 
Various oseltamivir fragment ions generated by in-source decay, can also be observed in 
the spectrum. The peak at m/z 225 corresponds to the loss of the 3-pentanol side chain 
(A) to give the [M-A+H]+ species, while the peak at m/z 208 corresponds to the loss of 
the 3-pentanol side chain and ammonia (B) thus giving the species [M-A-B+H]+. An ion 
at m/z 166 corresponding to the loss of 3-pentanol and acetamide (C) to give the species 
[M-A-C+H]+ was also detected. The observation of these fragment ions generated by in-
source decay suggests a certain lability of the protonated monomer. Fragment ion 
connectivity was further investigated by performing MS/MS and MS/MS/MS analyses by 
collision-induced dissociation (CID). MS/MS analysis of the protonated oseltamivir 
monomer (m/z 313) generated predominantly the ion at m/z 225 (Figure 5.2.b). Minute 
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Figure 5.2. DESI spectra of oseltamivir phosphate standard (10 µL, 1mg/mL) deposited 
onto PTFE surfaces and interrogated with a solution of neat acetonitrile; (a) Full MS 
spectrum, (b) MS/MS of the precursor ion at m/z 313, (c) MS/MS/MS of the precursor 
ion at m/z 225. M = oseltamivir, A = 3-pentanol (C5H12O), B = ammonia (NH3), 
C = acetamide (C2H5NO). 
 
peaks at m/z 296 (loss of ammonia) and m/z 208 can also be seen in this spectrum. 
MS/MS/MS analysis on the fragment ion at m/z 225 resulted in signals at m/z 208 and 
m/z 166, which correspond to the losses of ammonia and acetamide respectively 
(Figure 5.2.c). The formation of the ions at m/z 208 and 166 from their 
precursor (m/z 225) is a competitive reaction, indicating that the charge in the protonated 
oseltamivir monomer probably shuttles between the primary amine and acetamide side 
chains. This assertion was also suggested by the B3LYP-D/6-31G** optimized structures 
of the protonated oseltamivir molecule where an intramolecular hydrogen bond was 
observed to bridge the primary amine nitrogen and the oxygen of the acetamide side 
chain (Figure 5.3). The greater abundance of the ion at m/z 208 observed in the 
MS/MS/MS spectrum is probably due to the greater leaving group lability of ammonia 
compared to acetamide. 
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H-bonding
 
Figure 5.3. Optimized structure of the protonated oseltamivir molecule from ab initio 
molecular modeling calculations. 
 
The spread of the analyte signal intensities due to in-source fragmentation and 
formation of dimer species in reagentless DESI complicates the mass spectrum and 
potentially result in insufficient sensitivity for detecting oseltamivir. Furthermore, 
because the active ingredients in pharmaceutical formulations are embedded in an 
excipient mixture, the matrix components could compete with the analyte for charge, 
potentially reducing the analyte signal. These complications were circumvented by 
performing the experiments in the reactive DESI MS mode where crown ethers were 
added to the spray solvent to serve as selective recognition agents for analyte signal 
enhancement. Various crown ethers including 12-C-4, 15-C-5, 18-C-6 and 2,5-DB-21-C-
7 (Figure 5.1.b) were assessed for the detection of oseltamivir by reactive DESI MS. 
Figure 5.4 shows spectra obtained by probing oseltamivir phosphate standards deposited 
onto PTFE surfaces with spray solutions containing 100 µM of crown ethers in neat 
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acetonitrile. All crown ethers investigated generated exclusively 1:1 complexes with 
oseltamivir and were the predominant species.  Figure 5.4.a shows the spectrum obtained 
when 12-C-4 was added to the spray solvent as host. A peak at m/z 489 is evident in the 
spectrum corresponding to the species [M+(12-C-4)+H]+.  In Figure 5.4.b, the crown 
ether 15-C-5 was employed as host, and a peak at m/z 533 corresponding to a protonated  
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Figure 5.4. Reactive DESI of oseltamivir phosphate standard (10 µL, 1mg/mL) deposited 
onto PTFE surfaces and interrogated after solvent evaporation with a solution of 100 µM 
of (a) 12-crown-4, (b) 15-crown-5, (c) 18-crown-6 and (d) 2,5 dibenzo-21-crown-7. The 
inserts represent the corresponding MS/MS spectra of the [M + crown ether + H]+ ions at 
m/z 489, 533, 577, and 717 respectively. M = oseltamivir, A = 3-pentanol (C5H12O). 
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1:1 complex between this host and oseltamivir was observed. With 18-C-6 as host, an ion 
at m/z 577 generated by reactive DESI was also detected (Figure 5.4.c). This ion 
corresponds to the species [M+(18-C-6)+H]+. Figure 5.4.d shows the reactive DESI 
spectrum where 2,5-DB-21-C-7 was employed as host. A peak at m/z 717 corresponding 
to the species [M+(2,5-DB-21-C-7)+H]+ was observed. Some low abundance signals 
(indicated by an asterisk) were also observed, assigned as complexes of the 
corresponding crown ethers with NH4
+ and Na+. These signals originate from impurities 
present in the spray solvent or the reagents used, or from small amounts of dust in the 
ambient lab environment. The signal for the ammonium complex could also be due to 
decomposition of the spray solvent. However, these signals are very minute and largely 
negligible. 
The formation of complexes between oseltamivir and crown ethers occurs by 
hydrogen bonding interactions between the protonated oseltamivir primary amine moiety 
and hydrogen bond acceptors in the crown ethers. As previously discussed, the charge in 
the protonated oseltamivir species seems to shuttle between the primary amine and 
acetamide side chains. However, complex formation with crown ether leads to 
localization of the charge on the primary amine group. This assertion was supported by 
B3LYP-D/6-31G** optimized structures of the protonated oseltamivir-crown ether 
complexes, where the charging proton was observed to be closer to the primary amine 
side chain than to the acetamide side chain. Localization of the positive charge on the 
amine leads to an overall improvement in the stability of the analyte, and reduced in-
source CID fragmentation. Also, complex formation results in an increase in the number 
of degrees of freedom for the molecule, also decreasing fragmentation rates. In addition, 
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the formation of oseltamivir-crown ether complexes appears to increase their surface 
activity; increasing ion yields, and allowing an improved sensitivity for oseltamivir 
detection. The increased ion yields may also be due to the tendency of the crown ether to 
strongly localize the charge on the complex, inhibiting oseltamivir deprotonation in 
solution. These two combined effects are evident from the higher signals observed in the 
reactive DESI spectra, when compared to reagentless DESI. Sensitivity gains of 14x, 
3.9x, 1.6x and 1.4 x were observed respect to reagentless DESI when 12-C-4, 15-C-5, 
18-C-6 and 2,5-DB-21-C-7 were used as reactive DESI reagents, respectively. For these 
four reagents, the S/N gains observed were 10x, 13x, 10x and 13x, resulting in detection 
limits of 0.3, 0.2, 0.3 and 0.2 mg oseltamivir/capsule respectively. The observed 
detection limit for reagentless DESI was 3.3 mg/capsule. 
The inserts in Figure 5.4.(a-d) show the tandem MS spectra for each of the 
[M+crown ether+H]+ precursor ions. Following ion activation, the neutral crown ether is 
readily lost from the complex generating predominantly the protonated analyte species. 
The charge stays exclusively with the analyte in this case due to its higher proton affinity 
compared to all crown ethers investigated (see Table 5.1). The peak at m/z 225 
corresponding to an oseltamivir fragment was also observed. However, no peaks 
corresponding to oseltamivir fragment species were observed in the full scan reactive 
DESI spectra. This indicates that the interaction of oseltamivir with the assayed crown 
ethers is sufficiently strong to form stable gas phase complexes which survive transport 
through the mass spectrometer atmospheric pressure interface and can only be dissociated 
following activation in the ion trap. 
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5.4.7. Gas Phase Stability of Oseltamivir -Crown Ethers Complexes 
The analysis of binding selectivities to determine which crown ether most 
selectively binds oseltamivir provides valuable information for quantitative applications, 
which require the detection of this molecule in an excipient matrix. It is well known that 
binding selectivities are largely determined by the relative thermodynamic stability of 
complexes formed between crown ethers and various guest molecules.265 Energy resolved 
collision induced dissociation was used to establish the relative dissociation energies of 
oseltamivir with various crown ethers. CID was performed for 2.5 ms. Short activation 
times, typically below 10 ms are known to result in a linear relationship between the 
threshold activation voltage and the minimum dissociation energies of complexes.266, 267 
Longer activation times may allow ions with a small excess of internal energy to decay. 
Fragmentation efficiency curve analysis of each of these complexes was performed on 
the same day to minimize any effects caused by instrumental variation.267 Figure 5.5 
shows the obtained fragmentation efficiency curves. The Ec
50% values, which represent 
the activation energy at which half of the isolated complex has been dissociated, are 
presented in Table 5.1. It is well known that compounds with more degrees of freedom 
(DOF), require more energy to break a bond within the same time frame.  As such, the 
Ec
50% values were also corrected for DOF differences with the oseltamivir-12-C-4 
complex, chosen as reference.267, 268 These values are presented in parenthesis in 
Table 5.1. The binding energies for each of these complexes obtained from 
B3LYP-D/6-311++G** computations together with the proton affinities269 and cavity 
size244 for each of the crown ethers are also presented in Table 5.1. 
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Normalized collision energy (%)
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Figure 5.5. Fragmentation efficiency curves [(sum of fragment intensities)/(total 
intensities)] for various crown ether-oseltamivir complexes. The fragmentation fraction 
was normalized to 100%. 
 
From the fragmentation efficiency curve results, it was observed that the gas phase 
stability of the oseltamivir crown ether complexes increases in the order 
[M+(12-C-4)+H]+ << [M+(15-C-5)+H]+ << [M+(18-C-6)+H]+ < 
[M+(2,5-DB-21-C-7)+H]+. The retention of charge on the oseltamivir molecule after 
activation indicates that the analyte has a higher proton affinity compared to all the crown 
ethers investigated. Quantum-mechanical computations of the proton affinity of 
oseltamivir performed in this study verified this assertion (Table 5.1). It is also well 
known that, the larger the differences in the proton affinity of the interacting species, the 
longer the hydrogen bond length, the weaker the formed hydrogen bond, and the more 
unstable the formed complex.264, 267 The relative gas phase stabilities of the protonated 
oseltamivir-crown ether complexes are consistent with this trend.  
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Table 5.1. Comparison of the relative stability of oseltamivir-crown ether complexes in 
the gas phase versus B3LYP-D computations. 
aActivation energy where half of the complex is dissociated (%). Ec50% values corrected for the degrees of freedom are given 
in parenthesis. bCorrelation coefficient of fitting curves. cCavity size of crown ethers (Å). dProton affinity (PA) of various 
crown ethers (kcalmol-1); the value for [M + 2,5-DB-21-C-7 + H]+ was computed at the at the B3LYP-D/6-311++G** level 
of theory. e∆PA computed as PA(oseltamivir) - PA(host). The proton affinity for oseltamivir computed at the B3LYP-D/6-
311++G** level of theory was 252.43 kcal mol-1
67.980.999035.2±1.3 (48.5±1.8)6.69245.741.68-2.12[M + 2,5-DB-21-C-7 + H]+






















[M + 15-C-5 + H]+




 The binding energy trends determined by fragmentation efficiency curves were 
also observed in the computed B3LYP-D/6-311++G** binding energies, with the 
exception of the 2,5-DB-21C-7 complex, where density functional theory predicted a 
relatively lower binding compared to 18-C-6. In Figure 5.6, the optimized structures of 
the oseltamivir crown ether complexes are presented. It is observed that for the 12-C-4 
and 15-C-5 complexes, the crown ethers do not bind with the amine strongly enough to 
break the intramolecular hydrogen bond. In the case of 12-C-4, two of the oxygen atoms 
interact directly with the protonated amine, while the other two have a bifurcated 
interaction with two of the amine hydrogen atoms. Similar behavior is observed for the 
15-C-5 complex; however, there are now three oxygen atoms on the crown ether in a 
bifurcated configuration. The increase in binding energy, seen in Table 5.1, from the 
12-C-4 to the 15-C-5 complex is caused by the interaction of an additional oxygen atom 
with the amine as well as the increased dispersion from the larger crown ether. The 
binding of 18-C-6 with protonated oseltamivir is significantly stronger because the 
interaction between the crown ether and the amine is energetically favorable to an extent 
that allows the intramolecular hydrogen bond to be broken. From its geometry  
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(a) (a)
(d)(c)  
Figure 5.6. Complex geometries optimized at the B3LYP-D/6-31G** level of theory: 
(a) [M + 12-C-4 + H]+, (b) [M + 15-C-5 + H]+, (c) [M + 18-C-6 + H]+, 
(d) [M + 2,5-DB-21-C-7 + H]+. 
 
(Figure 5.6.c), it is observed that the symmetry of 18-C-6 is such that three of its oxygen 
atoms have a direct interaction with a hydrogen atom in the amine group. The remaining 
three oxygen atoms have bifurcated interactions with the amine group. The 
2,5-DB-21-C-7 complex is predicted to bind less strongly than the 18-C-6 complex. 
While the cavity in the 18-C-6 molecule is the optimum size for interactions with the 
protonated oseltamivir molecule, the 2,5-DB-21-C-7 molecule is somewhat larger than 
the optimum for the ideal interactions to occur. Here three oxygen atoms can interact 
directly with the protonated amine, while two others are in bifurcated configurations. Of 
the remaining two oxygen atoms, one shows some longer-range interactions with the 
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amine, while the other is pointed away from it. Although the trends in the binding 
energies and predicted cavity sizes do not agree completely with the experimental 
stabilities with respect to the ordering of the 2,5-DB-21-C-7 complex, the fragmentation 
efficiency curve results are in good agreement with ∆PA values (Table 5.1). 
 
5.4.8. Solution Phase Selectivity for Oseltamivir by Crown Ethers 
Although gas phase stabilities can offer insight into solution phase selectivity, this 
may not always be the case, as hydration shell displacement also plays a significant role. 
In this sense, solution phase selectivities are often determined by performing competitive 
experiments, which were performed by adding two crown ether hosts at a time to the 
DESI spray solvent. Figure 5.7.a shows results for these competitive experiments 
indicating that the relative selectivity for oseltamivir was 2,5-DB-21-C-7 > 18-C-6 >> 
15-C-5 >> 12-C-4 . This trend was further verified by performing experiments where 
variable amounts of oseltamivir were deposited on the PTFE substrate. Decreasing the 
surface concentration of analyte with respect to the amount of crown ether sprayed 
should favor even more the formation of the more thermodynamically stable complex 
leading to an increase in the signal intensity ratio as observed in Figures 5.7.b.(i-ii). 
Additionally, experiments were performed where the concentration of the equimolar 
mixture of crown ethers sprayed was increased, while the amount of oseltamivir on the 
surface was kept constant Figure 5.8.(a-c). The results obtained by both approaches were 
consistent, supporting the aforementioned stability order. Moreover, the trend observed 
for the solution phase stabilities followed the trend observed in gas-phase studies. A 
log-log plot of the signal intensity ratio versus the surface concentration results in a linear 
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curve (inserts Figures 5.7.b.(i-ii)). The logarithmic transformation applied to the spectral 
data, results in a method with intermediate sensitivity (∆response/∆log([oseltamivir]). 



























































































































Y = -0.2150x + 0.3154
         r
2
=0.9915
Y = -0.2251x + 0.327
         r
2
=0.9930
Y = -0.2274x + 0.3184     











Figure 5.7. (a) Reactive DESI spectra of oseltamivir standards deposited onto PTFE 
surfaces with various pairs of equimolar concentration (10 µM) of crown ethers 
(i) 18-C-6 and 2,5-DB-21-C-7, (ii) 18-C-6 and 15-C-5, (iii) 15-C-5 and 12-C-4. (b) Effect 
of the amount of oseltamivir present on the substrate on the signal ratio of various pairs 
of oseltamivir-crown ether complexes: (i) 18-C-6 and 2,5-DB-21-C-7, (ii) 15-C-5 
and 18-C-6, (iii) 12-C-4 and 15-C-5. The inserts represent the logarithmic plots of the 
corresponding signal ratio versus the amount of oseltamivir present on the substrate. The 
signal ratio was normalized to that of the maximum value. 










































Figure 5.8. Effect of increasing the concentration of each crown ether in equimolar 
solutions of crown ether pairs on the signal intensity ratio from the reactive DESI MS 
analysis of fixed amounts (10 µL, 1 mg/mL) of oseltamivir deposited onto PTFE 
substrates. The crown ether pairs investigated include (a) 18-C-6 and 2,5-DB-21-C-7, 
(b) 18-C-6 and 15-C-5, (c) 15-C-5 and 12-C-4. The signal ratio was normalized to that of 
the maximum value. 
 
5.4.9. Samples Preparation/Rapid Qualitative Screening of Field-Collected Samples by 
Reactive DESI CRM MS 
DESI involves a microscopic dissolution/extraction step between the liquid thin 
film on the surface and the solid sample. A compromise optimum thus exists for substrate 
surface hardness, which determines (a) the mass transport rates to the film and (b) the 
proper droplet scattering angles for maximum secondary droplet sampling efficiency. The 
hardness optimum was determined by the analysis of reserpine-containing tablets, 
prepared in a standard excipient mixture at varying hardness using a commercial KBr 
press (Figure 5.9.i). An optimum tablet hardness of 73±7 kg/m2 (insert Figure 5.9) was 







































Figure 5.9. (i) Sample preparation; (ii) reactive DESI MS. The insert shows the 
dependence of the reserpine DESI MS signal intensity on pellet hardness. Plotted are the 
intensities for the observed protonated reserpine species that has been normalized for the 
pellet hardness. 
 
determined and was adopted for preparation of all field-collected samples for subsequent 
reactive DESI MS experiments (Figure 5.9.ii). The error in the hardness measurement 
was based on the accuracy associated with reading the scale of the KBr press. In practical 
terms, an estimated 2 min/pellet are required for the preparation of samples. The prying 
of the capsule was the limiting factor in the sample preparation protocol, but the speed of 
carrying out this step improves with practice. 
 Results on the implementation of the reactive DESI protocol for the qualitative 
screening of potentially counterfeit tablets purchased over the Internet are shown in 
Figure 5.10. Selectivity was enhanced by using the consecutive reaction 
monitoring (CRM) mode of the ion trap instrument. Figure 5.10.a shows the steps 
involved in CRM for oseltamivir detection by reactive DESI. This starts with the 
   111 
selective recognition of the analyte, leading to complexation to generate an ion at m/z 577 
(Figure 5.10.a.i). MS/MS analysis of this complex lead to the neutral loss of the crown 
ether, with the charge resting on the analyte to give an ion at m/z 313 corresponding to 
the intact protonated oseltamivir molecule as the major peak in the spectrum  
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Figure 5.10. (a) Reactive DESI mass spectra of an oseltamivir phosphate standard (10 
µL, 1mg/mL) interrogated with a solution of 100 µM 18-crown-6: (i) Full spectrum, 
(ii) MS/MS spectrum of the ion at m/z 577, (iii) MS/MS/MS spectrum generated from the 
ion at m/z 313 (iv) CRM isolation of the oseltamivir fragment at m/z 225 generated by 
MS/MS/MS. (b) CRM traces obtained by reactive DESI MS analysis of a genuine 
Tamiflu® capsule and capsules purchased over the Internet. 
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(Figure 5.10.a.ii). The high abundance of this ion and the fact that it corresponds to the 
intact analyte was advantageously exploited for further fragmentation to afford an 
additional level of selectivity. Fragmenting this ion (m/z 313) by MS/MS/MS generates a 
protonated oseltamivir fragment at m/z 225 as the predominant species (Figure 5.10.a.iii). 
This ion is generated from the neutral loss of the 3-pentanol side chain from its precursor. 
The oseltamivir fragment ion (m/z 225) can then be isolated (Figure 5.10.a.iv). Setting the 
mass spectrometer to monitor the ion at m/z 225 generated by the transition 
577313225 provides a highly selective approach for screening for the presence of 
oseltamivir in the capsules. Results on the implementation of this approach are shown in 
Figure 5.10.b. Samples were secured on the motorized stage and each sample was 
analyzed in duplicate by the sequential positioning, on and away from the DESI spray 
plume using the sample stage joystick. All samples were observed to contain oseltamivir 
as shown by the CRM traces (Figure 5.10.b), with relatively good reproducibility. The 
competitive complexation of oseltamivir using a pair of crown ethers was then assessed 
as a means for the direct quantitation of the amount of active ingredient in these samples 
by reactive DESI MS. 
 
5.4.10. Effect of Signal Ratio of Oseltamivir-Crown Ether Complexes on DESI 
Experimental Variables 
 In Chapter 4, it was shown that the dependencies of the DESI signal on various 
experimental variables and sample properties could be removed by addition of an 
isotopically labeled internal standard to the sample allowing rapid quantitative analysis 
by DESI MS. However, the need for an internal standard limits the widespread 
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applicability of this method. Here the effect of the various DESI variables on the 
distribution ratio of oseltamivir-crown ether complexes was investigated by spraying 
sample using two different crown ethers. This was done by interrogating genuine 
Tamiflu® capsules pressed into pellets with a spray solution containing an equimolar 
mixture of 18-C-6 and 15-C-5. The results are presented in Table 5.2. A lower relative 
standard deviation for the distribution ratio compared to the sum of absolute signal for the 
complexes was observed for all the variables investigated indicating its applicability for 
direct quantitative analysis. 
 
Table 5.2. Comparison of the robustness of the absolute DESI signal versus the signal 
intensity ratio of two different oseltamivir-crown ether complexes. Reactive DESI was 
performed by interrogating a genuine Tamiflu® capsule, pressed into a tablet, with an 
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5.4.11. Direct Quantitation of Oseltamivir in Field-Collected Tamiflu Capsules by 
Reactive DESI MS  
The quantitative capability of this reactive DESI MS approach was assessed by 
evaluating its performance for predicting the amount of active ingredient present in 
Tamiflu® samples collected over the Internet. Predictions were based on measuring the 
response ratio in comparison to that of a genuine oseltamivir pellets used as external 
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standards. Figure 5.11 shows the selected ion intensity trace for the protonated 
oseltamivir crown ether complexes generated from this analysis. The predicted amounts 
of oseltamivir in each sample were then compared with the amount predicted by HPLC 
with diode array detection.254 The results from these analyses are summarized in Table 
5.3 showing that similar results are obtained by both techniques, with an average 
accuracy of 91%. Overall, these results indicate that this reactive DESI methodology 
shows potential as a rapid, sensitive and semi-quantitative pharmaceutical quality 
assessment tool for screening Tamiflu® capsules. 
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Figure 5.11. Selected ion chromatogram traces obtained by reactive DESI of a genuine 
versus potentially counterfeit Tamiflu® capsules purchased over the Internet. Samples 
were interrogated with a solution of 10 µM 15-C-5 and 5 µM 18-C-6. The traces 
correspond to complexes of oseltamivir with 15-C-5 (m/z 533) and 18-C-5 (m/z 577) 
respectively. Samples were placed in a line on the microscope stage and sequentially 
exposed to the DESI spray. 
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Table 5.3. Quantitation of the amount of oseltamivir in various Tamiflu® capsules 
purchased over the Internet by DESI MS compared with the amount present in each 
sample determined by HPLC-UV.  The standard deviation of the concentrations reported 
by DESI was calculated from the precision observed for the intensity ratio of the two 
complexes measured in each mass spectrum obtained across the pellet while its surface 
















This study demonstrtated the capabilities of molecular recognition via 
host-guest complexation reactions by DESI MS as a rapid, highly selective and 
sensitive method for screening the quality of Tamiflu® samples. Various crown ether 
hosts including 12-crown-4, 15-crown-5, 18-crown-6 and 2,5-dibenzo-21-crown-7 
were assessed as selective chemical agents for the recognition of oseltamivir (guest). 
The formed host-guest complexes were held together predominantly by hydrogen 
bonding interactions. Solution and gas-phase studies and ab initio molecular 
modelling calculations indicated that, the stability of the gas phase complexes 
increased in the order: [M + 12-crown-4 + H]+ << [M + 15-crown-5 + H]+ << 
[M + 18-crown-6 + H]+ < [M + 2,5-dibenzo-21-crown-7 + H]+. Quantitative 
predictions using mixtures of crown ethers in the spray solution were 91% accurate 
when compared to HPLC determinations. 
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CHAPTER 6. APPLICATION OF REAGENTLESS AND REACTIVE 




This chapter presents the implementation of DESI MS in imaging mode for the 
specific and sensitive determination of the two-dimensional distribution of analytes 
present on various surfaces. Its capabilities are showcased in the analysis of artesunate 
pharmaceutical drug tablets for anticounterfeiting and drug quality control applications 
and for the determination of secondary metabolites directly from the surface of alga 
tissues in order to shed some light on antimicrobial defense mechanisms.  
 
6.2. Introduction 
Molecular imaging using MS allows correlations to be drawn between the 
chemical identity of each analyte and its spatial distribution at or near the sample surface. 
In this chapter, an implementation of DESI MS in imaging mode is presented with its 
utility demonstrated in two different applications.  
The first application involves utilization of the optimized reagentless DESI MS 
protocol presented in Chapter 2 for the determination of the distribution of various 
components observed in artesunate pharmaceutical tablets for drug quality control and 
anticounterfeiting applications. Techniques that have become popular for imaging 
pharmaceutical tablets include Raman spectroscopy270 and attenuated total reflectance 
Fourier transform infrared (ATR-FIR) spectroscopy.149 These techniques allow both 
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spatial and chemical information to be obtained simultaneously, however they are limited 
by their intrinsic low specificity based on their recognition of specific functional groups. 
Chemical imaging using DESI MS takes advantage of the exquisite high specificity 
provided by MS detection for the visualization of the distribution of chemicals, directly 
from an intact surface without the need for chemical labeling or prior chemical treatment. 
Because of the less than ideal conditions under which counterfeit drugs are expected to be 
manufactured, fake tablets could be unevenly mixed to some degree. This would be 
reflected as an inhomogeneous color distribution in its DESI MS image. Sample 
properties such as the hardness-dependent dissolution profiles are also contributing 
factors that influence ion yields in DESI,148 and these conditions would be directly 
reflected by DESI molecular images in a spatially resolved fashion. In the case of 
genuine samples, the information on the spatial distribution and homogeneity of different 
chemical species on a tablet surface is extremely valuable for drug quality control. For 
instance, some antimalarial therapies recommend that the tablets be split to optimize the 
dosage and/or reduce the upfront cost to the patient. Under these circumstances, an 
inhomogeneous distribution of the API would result in an incorrect dosage being 
administered. 
The second application of DESI MS imaging presented here involves the 
development of a reactive DESI MS imaging protocol for the determination of the 
distribution of bromophycolide natural products. Bromophycolides are diterpene 
benzoate macrolides presented by the Fijian red alga, Callophycus serratus. Twenty 
different bromophycolide natural products including bromophycolides (A-I) and 
debromophycolide A have thus far been isolated from this alga, the most abundant ones 
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being bromophycolide A and B.271-273 Except for debromophycolide A, which contains 
no bromine, all other bromophycolides identified from this alga contain 2-3 bromine 
atoms. The presence of bromines has been shown to be vital for their moderate anticancer 
and antimicrobial activities providing them with the potential for pharmaceutical drug 
candidacy.271 Furthermore, bromophycolides have also been observed to be very effective 
antifungal agents, especially against the marine pathogenic fungus Lindra thalassiae, 
with IC50 values at or below whole tissue natural concentrations.
166 As such, 
bromophycolides have been implicated in anti-microbial chemical defense; however, the 
chemical defense mechanisms are not yet completely understood. Here a reactive DESI 
MS protocol for molecular imaging of bromophycolides on the surface of C. serratus 
tissues is developed with the aim of shedding some more light into the processes involved 
in the chemical defense mechanisms used by this and other algal species. This 
investigation is supplemented with an assessment of the factors that influence sensitivity 
for the detection of bromophycolides by DESI MS. In order to gain more insight on the 
species formed during reactive DESI, the relative gas phase stabilities of different 
bromophycolide complexes were compared via ab initio computational calculations. 
 
6.3.  Experimental Details 
6.3.1. Samples and Reagents 
All reagents were used as received without additional purification. High purity 
HPLC grade methanol 99.9+% (Honeywell Burdick & Jackson, Muskegon, MI, USA) 
was used for all reagentless DESI MS experiments. Ammonium chloride (Sigma-Aldrich, 
St. Louis, MO), hydrobromic acid (Mallinckrodt Baker Inc., Phillipsburg, NJ) and 
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trifluoroacetic acid (Fisher Scientific, Fair Lawn, NJ) solutions in methanol were used for 
reactive DESI MS experiments. A genuine artesunate tablet (Mekophar Chemical 
Pharmaceuticals Joint-Stock Co., Ho Chi Minh City, Vietnam) and a counterfeit tablet 
(collection code Lao 12060, Type 8 fake) investigated in the first imaging application 
were collected in Southern Laos. In the second study, pure bromophycolides A, B and E 
were isolated from the Fijian red alga, Callophycus serratus following previously 
reported procedures.271, 272 Algal samples were collected in February 2008 off Yanuca 
Island in Beqa Lagoon, Fiji (18° 23’ 57” S, 177° 57’ 59” E). Samples were preserved in 
10 % v/v formalin:sea water and stored at room temperature. Samples were rinsed in 
ultrapure water and allowed to air dry prior to analysis. 
 
6.3.2. DESI Imaging Ion Source 
The DESI imaging ion source consisting of a joystick and software-controlled 
motorized microscope XY stage (Prior Scientific, Rockland, MA) and a high-
performance sprayer (Figure 6.1). The sprayer, affixed to a post was fitted with a high 
precision rotation mount (Thorlabs, Newton, NJ) for manual adjustment of the spray 
impact angle. The aforementioned post was attached to a MicroBlock 3-axis positioner 
(Thorlabs, Newton, NJ) for manual adjustment of the emitter position in the XYZ 
coordinates with respect to the capillary inlet. This sprayer holder assembly was mounted  
on a breadboard. The microscope stage on which samples were held was mounted onto a 
heavy-duty lab jack (Thorlabs, Newton NJ) for manual adjustment of the sample position 
in the z-axis. The lab jack-microscope stage assembly was also affixed to the breadboard. 
For DESI MS imaging of pharmaceutical tablets, samples were held in place using two  







Figure 6.1. DESI MS imaging set-up. (i) Extended capillary (760 µm i.d. x 33cm), (ii) 
Prior Scientific microscope stage (iii) off-the-shelf  Thorlabs parts, (iv) high performance 
sprayer. 
 
Al sample holders (110x10x3 mm) mounted on the sample plate of the microscope stage. 
Alga tissue samples were affixed to glass slides using double sided tape for DESI MS and 
imaging of bromophycolides and alga tissues. The DESI geometrical settings were 
similar to those described in section 2.3.3. The DESI ion source was coupled to an LCQ 
Deca XP+ quadrupole ion trap mass spectrometer (Thermo Finnigan, San Jose CA) 
operated using the Xcalibur version 2.0 software. The standard ion transfer capillary was 
replaced by an extended version (762 µm i.d., 1588 µm o.d., Small Parts Inc., Miramar, 
FL). The capillary-scattered droplet collection angle was ~10o. Samples were positioned 
for DESI analysis so that the atmospheric sampling capillary of the mass spectrometer 
was ~0.5 mm from the sample surface. A CCD camera (JAI Inc., San Jose, CA) was used 
to monitor the spray plume and the DESI-sampled spot. 
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6.3.3. DESI MS Imaging of Artesunate Tablets 
DESI MS imaging experiments were performed with Dr. Asiri Galhena, a 
postdoctoral associate in our group. Image reconstruction was performed using 
MATLAB software written by Dr. Mitchell Parry, a post doctoral associate in Dr. 
Wang’s group in the Department of Biomedical Engineering, Georgia Institute of 
Technology. The genuine artesunate tablet evaluated was comprised of a flat surface with 
somewhat tilted edges and was thus imaged directly without any prior sample 
manipulation. The counterfeit tablet (Lao 12060) had a more convex shape. This tablet 
was sanded down to a flat surface using super fine P400 sandpaper (Norton Abrasive, 
Worcester, Massachusetts) and the particulates released during sanding blown off using 
N2 from a gas cylinder. No sample contamination was evident due to sanding. The DESI 
MS imaging experiment was performed in positive ion mode. Mass spectra were acquired 
in profile mode with automatic gain control (AGC) turned off. The ion injection time was 
set at 40 ms. Imaging data were acquired using a “looped”-stage scanning mode. The 
sample area imaged was 15 mm x 10 mm. The following scan sequence was used for 
imaging: (i) a forward, and (ii) a reverse scan lines in the x-direction (15 mm) 
perpendicular to the MS inlet, followed by (iii) a 200 µm step displacement in the 
y-dimension, away from the MS inlet. The stage scan speed in both dimensions was set to 
80 µm s-1. Overlapping forward and reverse scan segments were utilized in order to avoid 
any image artifacts that might be caused by sample scanning directionality, but only data 
from the forward scan segments were used to construct the images. Using these settings a 
lateral resolution of 75 µm was achieved, as determined by scanning a calibrated test 
image printed on glossy paper. The flow rate of the spray solvent used for the imaging 
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experiments was 3 µL min-1. The recorded individual mass spectra scans were finally 
processed and assembled into an image using an in-house written MATLAB program 
(version R2008a, MathWorks, Inc. Natick, MA). 
 
6.3.4. DESI MS Analysis of Bromophycolides and Imaging of Alga Tissue Samples 
Reagentless DESI MS experiments of bromophycolides were performed using 
100 % MeOH. For reactive DESI MS analysis of bromophycolide standards, various 
additives including NH4Cl (100 µM), HBr (10 µM) and CF3COOH (0.001 % v/v = 135 
µM) were added to the spray solvent (MeOH) at the concentrations in parenthesis unless 
stated otherwise. The 100 µM NH4Cl methanol solution was used for reactive DESI MS 
profiling and imaging of alga tissues. The spray solvent flowing at a rate of 5 µL/min was 
electrically charged externally to -3 kV. Bromophycolide working solutions were 
prepared in MeOH and 10 µL, 1 mg/mL of each standard were deposited onto PTFE 
surfaces and air dried prior to analysis. For the reactive DESI MS profiling and imaging 
analyses of Callophycus serratus samples, small pieces of tissue were affixed to glass 
slides using double sided tape and analyzed by exposing different positions of their 
surfaces to the DESI spray plume. All experiments were performed on an LCQ DECA 
XP+ ion trap mass spectrometer (Thermo Finnigan, San Jose CA) operated in negative 
ion mode. DESI MS analysis of bromophycolide standard and profiling of alga tissue 
samples were performed with AGC on for an ion trap injection time of 200 ms at 
2 µscans per spectrum. For the DESI MS imaging analysis of alga tissue (10 mm x 
4 mm), mass spectra were acquired in profile mode with automatic gain control (AGC) 
turned off and the ion injection time set to 40 ms. The same LabView controlled 
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motorized stage scan sequence and image assembly protocol described in section 6.3.3 
was used. 
 
6.3.5. Estimation of the Concentration of Bromophycolides in Surface Patches of 
Untreated Alga Tissue by Reactive DESI MS 
The concentration of bromophycolides A + B for individual sites on algal surfaces 
were estimated by comparing integrals from chloride adduct reactive DESI MS signals 
for these bromophycolides with a standard calibration curve. The calibration curve was 
developed by depositing known concentrations of bromophycolides A and B in a 2:1 
ratio (1 µL, 1:0.5 mg/mL) on an intact patch-free algal surface (9.4 mm2). The 2:1 ratio 
of bromophycolides A and B represented a reasonable approximation based on the 
average 2.2:1 ratio observed by LC-MS for these compounds in extracts.166 Triplicate 
analyses of 4 different surface concentrations of this bromophycolides mixture spanning 
the range 2.4-119.5 pmol mm-2 were evaluated by reactive DESI MS to give a calibration 
curve with an r2 value of 0.97. 
 
6.3.6. Computational Calculations 
Computational calculations were performed by Edward Hohenstein, a graduate 
student in Dr. Sherrill`s group in the School of Chemistry and Biochemistry, Georgia 
Institute of Technology. The geometries of bromophycolides A, B, and E were optimized 
at the B3LYP-D/6-31+G* level of theory, where the “-D” denotes the inclusion of 
empirical terms to compensate for the inability of the B3LYP functional to account for 
dispersion interactions. The empirical dispersion terms developed by Grimme256 were 
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used in this work. The complexes of bromophycolide A, B, and E with Cl-, Br-, and 
CF3COO
- were fully optimized at the B3LYP-D/6-31+G* level of theory. Binding 
energies were computed at the B3LYP-D/6-31+G* level of theory using a Lebedev grid 
with 302 angular points for each of 100 radial points. This grid was chosen to avoid 
errors related to numerical integration. Counterpoise correction was applied to all binding 
energies according to the scheme of Boys and Bernardi.257 Geometries of 
bromophycolide A, B, and E dimers were optimized at the B3LYP/6-31+G* level of 
theory. All computations were performed using QChem 3.1259 and Jaguar 5.5.260 
 
6.4. Results and Discussion-Case Study 1: Reagentless DESI MS 
Imaging of Artesunate Pharmaceutical Tablets 
6.4.7. Reagentless DESI MS Imaging of a Genuine Artesunate Tablet 
Figure 6.2.a shows a representative DESI spectrum of a genuine artesunate tablet, 
which shows peaks corresponding to sodiated artesunic acid monomer (m/z 407.2) and 
dimer (m/z 791.2). Peaks corresponding to sodiated lactose monomer (m/z 365.3) and 
dimer (m/z 707.2) are also observed in the spectrum. The corresponding DESI MS 
images of the genuine tablet constructed for four relevant ionic species are shown in 
Figure 6.2.b. All four images are shown on the same relative intensity fake color scale 
(there is no correlation between the actual color of the formulations and their DESI MS 
chemical images), thus allowing a qualitative comparison between species. Figures 
6.2.b.i and 6.2.b.ii show DESI images generated from the peaks at m/z 407.2 
([artesunic acid + Na]+) and 791.2 ([2 artesunic acid + Na]+). As indicated by these two 
images, artesunic acid seemed to be distributed on the surface of the genuine sample 
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quite homogenously. The formation of artesunic acid dimer was observed to be favored 
over the monomer, resulting in a more uniform and intense image (Figure 6.2.b.ii). The 
preferential formation of artesunic acid dimer is largely dependent on the tablet surface 
hardness. Lower sample hardness improves the mass transport efficiency between the 
solid tablet phase and the liquid film formed by the DESI sprayer. This increases the 
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Figure 6.2. (a) Representative DESI spectrum of a genuine artesunate tablet 
manufactured by Mekophar Pharmaceuticals. (b) DESI MS images of the tablet 
constructed using the spatial relationship between various spectral features and their 
intensity, with data acquisition in full-scan MS mode: (i) sodiated artesunic acid (m/z 
407.2), (ii) sodiated artesunic acid dimer (m/z 791.2), (iii) sodiated lactose (m/z 365.3) 
and (iv) sodiated acetaminophen (m/z 174.1). All images are shown in false color scale 
and pixilated format. 
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concentration of active ingredients in secondary droplets, favoring dimerization during 
ion evaporation from charged droplets. The DESI MS image reconstructed from the peak 
at m/z 365.3 ([lactose + Na+]) shows the spatial distribution of lactose in this sample, also 
revealing a small degree of heterogeneity (Figure 6.2.b.iii). The DESI MS image of a 
common wrong active pharmaceutical ingredient, m/z 174.1, which corresponds to 
sodiated acetaminophen is also shown (Figure 6.2.b.iv). The image clearly indicates the 
absence of acetaminophen in this sample, as expected. In all images (Figure 6.2.b) the 
tablet edges appear darker. This is an artifact introduced by the somewhat tilted tablet 
edges, which lead to an increase in the sprayer tip-to-surface distance, reducing 
sensitivity. 
 
6.4.8. Reagentless DESI MS Imaging of a Counterfeit Artesunate Tablet 
Figure 6.3.a shows a representative DESI spectrum of a counterfeit artesunate 
tablet with collection code, Lao 12060. The spectrum shows peaks at m/z 174.1 and 325.1 
corresponding to sodiated acetaminophen monomer and dimer respectively. The 
spectrum also shows peaks at m/z 363.3 and 707.2 corresponding to sodiated lactose 
monomer and dimer respectively. The DESI MS images of the counterfeit sample are 
presented in Figure 6.3.b. Figures 6.3.b.i and 6.3.b.ii show DESI MS images that were 
reconstructed for the peaks at m/z 174.1 ([acetaminophen + Na]+) and 325.1 
([2 acetaminophen + Na]+). Both indicated a relatively homogeneous distribution of 
acetaminophen in the sample. Such findings indicate that counterfeit drug manufacturers 
are using fairly sophisticated formulation techniques as part of their operations. The 
spatial distribution of lactose was also homogeneous, as observed in the DESI MS image 
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that was reconstructed for the species at m/z 365.3 ([lactose + Na]+, Figure 6.3.b.iii). 
Figure 6.3.b.iv shows the DESI MS image that was constructed for the ion signal 
corresponding to sodiated artesunic acid. DESI MS imaging analysis of such a large area 
across the sample surface shows unambiguously that artesunic acid is not present in the 
sample. Trace amounts of artesunic acid has previously been detected on the surface of 
other types of fakes artesunate samples. A heterogeneous distribution of artesunic acid in 
such sample would require DESI MS imaging analysis to enable the unambiguous 
determination of such subtherapeutic counterfeits.  
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Figure 6.3. Representative DESI spectrum of a fake artesunate tablet (collection code, 
Lao 12060, type 8 fake). (b) DESI MS images of the tablet constructed based on the 
spatial relationship between various spectral features and their intensity, with data 
acquisition in full-scan MS mode: (i) sodiated acetaminophen (m/z 174.1), (ii) sodiated 
acetaminophen dimer (m/z 325.1), (iii) sodiated lactose (m/z 365.3) and (iv) sodiated 
artesunic acid (m/z 407.2). All images are shown in false color scale and pixilated format. 
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6.5. Results and Discussion-Case Study 2: DESI MS Analysis of 
Bromophycolides and Imaging of Alga Tissue  
The higher abundance of bromophycolides A and B relative to other 
bromophycolides in extracts of the alga Callophycus serratus273 suggested a higher 
chance for their detection from alga tissue by DESI MS. For this reason, they were 
chosen for the initial optimization and characterization experiments together with the less 
abundant bromophycolide E, depicted in Figure 6.4. 
 
 
Figure 6.4. Structures of a subset of bromophycolides extracted from the Fijian red alga 
Callophycus serratus.273 
 
6.5.9. Conventional vs. Reactive DESI MS Analysis of Bromophycolides/Gas Phase 
Structure of Observed Species 
Initial conventional DESI MS analysis of pure bromophycolides was explored in 
both positive and negative ion modes. However, ionization and detection of 
bromophycolides was significantly more efficient in the latter, presumably due to the 
presence of a phenolic acid functionality in their macrolide structure in which the 
conjugate phenolate anion is electronically stabilized by resonance. No appreciable 
ionization was observed in positive ion mode even in the presence of various 
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concentrations of organic acids or various cations such as Na+ and NH4
+ which, when 
added to the spray solution, could potentially enhance ionization efficiency by 
cationization.121 As such, all subsequent experiments were performed in negative ion 
mode. 
Figure 6.5 shows the reagentless DESI MS, MS2 and MS3 spectra of purified 
bromophycolides deposited on PTFE substrates, obtained following interrogation with a 
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Figure 6.5. Conventional DESI MS, MS2, and MS3 spectra of bromophycolide standards. 
(a) Full MS of bromophycolide A and (b) corresponding MS2 of m/z 665 precursor (MS3 
of m/z 583 precursor inserted), (c) full MS of bromophycolide B and (d) corresponding 
MS2 of m/z 665 precursor (MS3 of m/z 583 precursor inserted), (e) full MS of 
bromophycolide E and (f) corresponding MS2 of m/z 583 precursor.  
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The spectrum consists of two major isotopic clusters, with base peaks at m/z 665 and m/z 
1329. These clusters correspond to the deprotonated monomeric and dimeric species of 
bromophycolide A, respectively. The insert in Figure 6.5.a shows the isotopic distribution 
of the deprotonated bromophycolide A monomer together with the theoretical isotopic 
pattern based on its elemental formula. As seen in the insert, bromophycolide A shows a 
unique isotopic distribution consistent with the presence of three bromine atoms in its 
structure,271, 272 matching the theoretical distribution. Deprotonation of bromophycolide A 
is predicted to preferentially occur on the phenyl hydroxyl group due to the ability of the 










Figure 6.6. Geometries of (a) bromophycolide A (b) deprotonated bromophycolide A 
dimer, optimized at the B3LYP/6-31+G* level of theory. 
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was calculated to be about 38 kcal mol-1 more favorable than at the macrolide hydroxyl 
group resulting in the structure shown in Figure 6.6.a., which was calculated at the 
B3LYP-D/6-31+G* level of theory.  
The structural connectivity of the deprotonated bromophycolide A monomer can 
be further evaluated by performing sequential ion trap MSn experiments by 
collision-induced dissociation (CID). Figure 6.5.b shows the MS2 spectrum of the 
deprotonated bromophycolide A monomer, which gives rise to a fragment ion cluster 
with a base peak at m/z 583 corresponding to the elimination of HBr from its precursor. 
Inserted in Figure 6.5.b is the MS3 spectrum generated from CID analysis of the ion 
cluster at m/z 583, which shows intense fragment ion clusters with base peaks at m/z 503 
and m/z 421, corresponding to the elimination of 1 HBr and 2 HBr molecules 
respectively. MS4 analysis of the cluster at m/z 503 generated the ion at m/z 421 as the 
predominant species in the spectrum, corresponding to the elimination of HBr from its 
precursor ion (data not shown). The sequential elimination of HBr indicates a lability of 
the C-Br bonds in the precursor ion molecule, presumably due to their relatively longer 
bond lengths compared to all other bonds in this molecule.272 MS5 analysis of the isotopic 
cluster centered at m/z 665 generated ions at m/z 377 (loss of CO2) and m/z 359 (loss of 
H2O, Figure 6.7.a). 
Bromophycolide B is a constitutional isomer of bromophycolide A, containing a 
16-membered macrolide within a diterpene-benzoate framework as opposed to a 15-
membered macrolide for bromophycolide A.272 Figure 6.5.c shows the DESI MS 
spectrum for pure bromophycolide B, which shows isotopic clusters with base peaks at 
m/z 665 and 1329 corresponding to the deprotonated monomer and dimer respectively.  




















































Figure 6.7. DESI MS5 spectra of pure bromophycolides, (a) bromophycolide A, 
(b) bromophycolide B. 
 
Shown as insert in Figure 6.5.c is the isotopic distribution of the deprotonated monomer, 
which is almost identical to that obtained for bromophycolide A, thus verifying their 
isomeric relationship. Mass spectrometric distinction between isomeric species can 
sometimes be accomplished via MSn analysis274 but, as shown in Figure 6.5.d and 6.7.b, 
stepwise CID analysis (up to MS5) of bromophycolide B led to elimination of the same 
species as for bromophycolide A at each stage, thus eliminating this possibility. Figure 
6.5.e shows the DESI MS spectrum of bromophycolide E, which revealed isotopic 
clusters with base peaks at m/z 583 and 1167, corresponding to the deprotonated 
bromophycolide E monomer and dimer respectively. MS2 analysis of the isotopic ion 
cluster with a base peak at m/z 583 generated a cluster with a base peak at m/z 503 due to 
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the elimination of 1 HBr molecule (Figure 6.5.f). Also observed in this spectrum is a peak 
at m/z 421 corresponding to the completely debrominated species resulting from the 
elimination of 2 HBr molecules from the precursor ions (Figure 6.5.f). 
The potentially low abundance of bromophycolides on the algal tissue surface 
necessitates an appreciably sensitive detection means. As shown above, the most 
abundant bromophycolides; A and B, produced the deprotonated dimer as the base peak 
in their DESI spectra (Figure 6.5). Declustering of such dimers by in-source CID could 
lead to an increase in the abundance of the deprotonated monomer thus improving the 
sensitivity for the detection of bromophycolides.275, 276 In-source CID experiments were 
performed by varying the DC voltage offset of the ion source ion transfer octopole 
between 0-60 V (Figure 6.8).  This resulted in an overall decrease in the signal intensity  
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Figure 6.8. Effect of ion source collision induced dissociation energy in the multipole 
region for various DC offset voltages on the intensity of various bromophycolide A ionic 
species including: [bromophycolide A - HBr - H]- at m/z 583, [bromophycolide A - H]- at 
m/z 665 and [2 bromophycolide A - H]- at m/z 1329. The intensity values were 
normalized to that of the maximum observed. 
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of the deprotonated bromophycolide A dimer and only in a slight increase in the intensity 
of the deprotonated monomer ion, with a maximum at 40 V (Figure 6.8). Higher voltages 
resulted in the concomitant formation of the fragment at m/z 583. Even at the maximum 
DC offset investigated (60 V) an appreciable signal was still observed for the dimer ion, 
indicating a significant stability. This stability can be attributed to a strong hydrogen 
bond between the phenyl hydroxyl group of one bromophycolide molecule and the 
deprotonated phenyl hydroxyl group of the other, contributing roughly 30 kcal mol-1 to 
the stability as demonstrated by theoretical studies at the B3LYP/6-31+G* level of theory 
(Figure 6.6.b). Additionally, the stabilization due to dispersion interaction between the 
two bromophycolide units could be larger than 10 kcal mol-1. 
Performing the analysis in the reactive DESI mode provides an alternative 
approach of improving sensitivity by improving ionization efficiency or increasing ion 
survival during transport through the atmospheric pressure interface.102 Addition of 
halides to the spray solvent has been found beneficial in improving the ionization of 
target analytes such as explosives.206 In this study, various anions including: Cl-, Br-, and 
CF3COO
- were explored as additives to investigate their effect on the various 
bromophycolide signals. Results from the reactive DESI analysis of bromophycolide A 
standards deposited onto PTFE with various anions are shown in Figure 6.9.  When 
ammonium chloride was added to the DESI spray solvent (Figure 6.9.a), the DESI 
spectrum showed signals at m/z 701 and 1365, corresponding to 
[bromophycolide A + Cl]- and [2 bromophycolide A + Cl]- respectively.  A peak at m/z 
1329 corresponding to the deprotonated bromophycolide A dimer was also observed. The 
identity of the peak at m/z 701 was verified by DESI MS2 (Figure 6.9.b), where the  
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Figure 6.9. Reactive DESI MS and MS2 spectra of bromophycolide A standards 
interrogated with spray solutions of various anions in methanol. (a) 100 µM NH4Cl, and 
(b) corresponding MS2 spectrum of the m/z 701 precursor, (c) 10 µM HBr, and 
(d) corresponding MS2 spectrum of the m/z 745 precursor, (e) 0.001 %v/v (135 µM) 
CF3COOH and (f) corresponding MS
2 spectrum of the m/z 779 precursor. 
 
 
non-covalently bound chloride was eliminated as HCl to give the ion at m/z 665 
corresponding to deprotonated bromophycolide A.  The addition of a low concentration 
of hydrobromic acid to the DESI spray solvent resulted to peaks at m/z 745 and 1411 
assigned to the complexes of bromide with bromophycolide A monomer and dimer 
respectively (Figure 6.9.c). DESI MS2 analysis of the ion at m/z 745 generated 
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predominantly the ion at m/z 665 corresponding to deprotonated bromophycolide A via 
loss of HBr (Figure 6.9.d). Peaks at m/z 779 and 1443 corresponding to bromophycolide 
A monomer and dimer adducts with trifluoroacetate were observed when trifluoroacetic 
acid was added to the DESI spray solvent (Figure 6.9.e). A peak at m/z 1329 
corresponding to the deprotonated bromophycolide A dimer was also observed in the 
spectrum (Figure 6.9.e). The identity of the peak at m/z 779 was verified by DESI MS2 
analysis, which gave the deprotonated bromophycolide A monomer by elimination of a 
trifluoroacetic acid molecule (Figure 6.9.f).  
Figure 6.10 shows the B3LYP-D optimized structures of bromophycolide A 
(Figure 6.10.a), together with its Cl- (Figure 6.10.b), Br- (Figure 6.10.c) and CF3COO
-  











Figure 6.10. Optimized geometries for: (a) bromophycolide A, and its complexes with 
(b) Cl-, (c) Br- and (d) CF3COO
- optimized at the B3LYP-D/6-31+G* level of theory. 
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complexes with Cl-, Br-, and CF3COO
- showed in all cases a preference for hydrogen 
bonding between each of these anions with the phenolic hydroxyl over the macrolide ring 
hydroxyl group. This preference is due in part to the delocalization of the partial negative 
charge transferred from the anion, over the phenyl ring, as indicated by Mulliken charge 
analysis.  Another reason for the preference for binding to the phenolic hydroxyl is that 
anion binding to the macrolide ring hydroxyl disrupts the intramolecular hydrogen 
bonding between this hydroxyl and the neighboring macrolide ring bromine atom. This 
gives rise to a less stable conformation thereby making anion binding to this site less 
favorable by roughly 10 kcal mol-1. Also, hydrogen bond lengths resulting from anion 
binding to the phenyl hydroxyl were about 0.2 Ǻ shorter for complexes with Cl- and 
CF3COO
- compared to similar complexes where anion binding occurs at the macrolide 
hydroxyl group. Similarly, for the Br- complexes, hydrogen bond lengths for the phenyl 
hydroxyl were shorter by about 0.1 Angstrom. Table 6.1 presents the binding energies for 
the various bromophycolide-anion complexes together with their corresponding 
intermolecular hydrogen bond lengths. In general, chloride complexes showed the highest 
binding energies and bromide complexes the lowest.  The former were observed to show 
greater charge delocalization compared to the bromide complexes, probably accounting 
 
Table 6.1. Binding energies for various bromophycolide-anion complexes obtained from 
geometry optimizations at the B3LYP-D/6-31+G* level of theory. The intermolecular 
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for the higher binding energies.  This observation is consistent with the higher sensitivity 
that was obtained by reactive DESI MS when chloride was added to the spray solvent 
(vide infra). In the case of the CF3COO
- complex, despite the anion oxygen atoms 
showing two favorable interactions with the phenolic hydrogen atom of the 
bromophycolide, the anion tends to retain more of its negative charge, which might 
account for their slightly lower binding energies compared to the chloride complexes. 
Figure 6.11 shows the effect of the DESI spray solvent Cl- concentrations on the 
intensity of the corresponding bromophycolide A adduct (m/z 710) and the deprotonated 
dimer (m/z 1329). The intensity of the Cl- adduct increases with the concentration of 
chloride, reaching a maximum at approximately 100 µM NH4Cl.  Above 100 µM NH4Cl, 
the intensity of both species decrease, possibly due to increased analyte suppression 
effects as the electrolyte concentration increases. When HBr and CF3COOH were each 
added to the DESI spray the optimum concentration for the formation of bromide and 
trifluoroacetate adducts with bromophycolide A were 10 µM and 135 µM respectively. 
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Figure 6.11. Effect of Cl- concentration on the intensity of the [bromophycolide A + Cl]- 
and [2 bromophycolide A - H]- ions. The intensity values were normalized. 
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.  
The S/N of all the investigated bromophycolide anion adducts obtained by 
reactive DESI together with those of their corresponding deprotonated counterparts 
obtained by reagentless DESI are shown in Figure 6.12. At the optimized concentration 
of each of the investigated anions the chloride adducts gave the highest S/N. This resulted 
in S/N gains for the chloride adduct of 10x, 19x and 7x for bromophycolide A, B and E, 
respectively when compared to the corresponding deprotonated species. The high S/N for 
the chloride adducts is probably due to the comparably smaller size and high 
electronegativity of the chloride anion. The presence of chloride in the spray solvent also 
somewhat inhibits the formation of the deprotonated  
 

























Figure 6.12. Signal-to-noise ratios observed for various bromophycolide species 
obtained from the DESI MS analysis of pure bromophycolides standards; spraying with a 
solution of 100 % MeOH, (i and ii) and spraying with a solution of methanol containing 
various anions including Cl- (100 µM), Br- (10 µM) and CF3COO- (135 µM) (iii, iv and 
v) respectively. 
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dimer species potentially resulting in the improvement of the signal for the monomer 
adduct. The LOD values (S/N ≥ 3) for all the investigated species are shown in Table 6.2.  
The addition of chloride into the DESI spray clearly results in a very sensitive approach 
potentially allowing the direct and rapid detection for bromophycolides on the alga tissue 
surface. 
 
Table 6.2. Limits of detection (S/N ≥ 3) for various bromophycolides obtained by 
monitoring different species by DESI MS in negative ion mode: [a] reagentless DESI, [b] 
reactive DESI where various anions including Br-, CF3COO
- and Cl- were added to the 
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6.5.10. Direct Reactive DESI MS Profiling of Untreated Alga Tissue Samples 
The applicability of the optimized reactive DESI MS protocols was then 
evaluated for the direct detection of bromophycolides from the surface of untreated 
Callophycus serratus samples. No appreciable bromophycolide signals were observed 
when analysis was performed by scanning the 400-1500 m/z range. This was probably 
due to the fact that trapping within such a wide m/z range effectively results in a low 
number of bromophycolide species trapped in the QiT mass analyzer. Analysis was then 
performed in the 550–750 m/z range, and signals corresponding to bromophycolide 
species were unambiguously observed (Figure 6.13). The peak at m/z 701 was assigned 
as the chloride adduct of bromophycolides A and/or B. This assignment is consistent with 
the theoretical isotopic distribution of these species. However, there could also be  
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Figure 6.13. (a) Typical spatially-resolved reactive DESI spectra of C. serratus surface. 
(b) Representative reactive DESI spectrum from patch-free algal surface prior to and 
following mechanical damage. Ion clusters centered at 701, 619 and 583 correspond to 
[bromophycolide A(B) + Cl]- , [bromophycolide E + Cl]- and [bromophycolide E - H]- 
respectively. 
 
contributions from the less abundant bromophycolides D and H, which have the same 
elemental formula.166, 271 An intense peak was also observed at m/z 619 and this was 
assigned as the chloride adduct of bromophycolide E, consistent with its theoretical mass 
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and isotopic distribution. Some minute peaks were also observed at m/z 665 and 583, 
corresponding to [bromophycolide A(B) - H]- and [bromophycolide E - H]- respectively. 
The bromophycolide signal intensity was not homogeneous throughout the sample 
surface, with some regions showing no signal whatsoever (Figure 6.13.a). Reactive DESI 
MS imaging analysis (vide infra) further confirmed this observation. In addition, no 
bromophycolide signal was observed for samples, which showed no white patches on 
their surfaces. However, when the surface of such samples was scraped with a razor blade 
resulting in the exposure of underlying internal tissues, bromophycolide signals were 
readily observed in all cases (Figure 6.13.b) suggesting an endogenous origin for 
bromophycolides.  
The combined concentration of bromophycolides A and B on patch surfaces was 
estimated to be 36±23 pmol mm-2. This was calculated from the integral DESI MS 
signals of the Cl- adducts of these two bromophycolides measured from 3 independent 
patches and predicted from a standard curve. The large standard deviation in 
bromophycolide surface concentrations suggests a high natural variability within the 
bromophycolide-rich patches. These results are consistent with LC-MS data, which 
indicates substantial variation of bromophycolide concentrations among extracts of whole 
algal tissues.166 An evaluation of the antifungal activity (against L. thalassiae) of 
combined bromophycolides A and B coated onto nutrient agar substrates revealed a mean 
IC50 value of 17 pmol mm
-2.166 The IC50 being approximately half the measured 
concentration of bromophycolides on patches indicates that these compounds are present 
in surface patches at sufficient levels to inhibit L. thalassiae and other susceptible fungi. 
 
   143 
6.5.11. Reactive DESI MS Imaging of Untreated Alga Tissue 
Figure 6.14.a shows the optical image of a Callophycus serratus tissue sample, 
which shows a heterogeneous distribution of white patches on the tissue surface. Figure 
6.14.b shows a representative reactive DESI spectrum obtained form the sample, which 
shows peaks corresponding to chloride adduct of bromophycolide A and/or B (m/z 701) 
and bromophycolide E (m/z 619). Figure 6.14.c shows the reactive DESI MS image 
constructed for the peak at 701, which indicate the distribution of its corresponding 
species over the tissue sample. As observed in the DESI MS image, the sites 
corresponding to the highest bromophycolide signal as shown by the color intensity scale 
matches relatively well with white patches seen in the optical image. This further 
confirms the presence of bromophycolides on alga tissue in association exclusively 
within the distinct light-colored patches attached to Callophycus serratus surfaces. The  
 



















Figure 6.14. (a) Callophycus serratus optical image. (b) Representative reactive DESI 
spectrum of a light-colored patch on the Callophycus serratus surface. (b) Reactive DESI 
MS image reconstructed for the ion at m/z 701. The ion clusters centered at 701 and 619 
represent [bromophycolide A(B) + Cl]- and  [bromophycolide E + Cl]- respectively. 
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detection of bromophycolides among heterogeneous patches on algal surfaces and within 
algal tissues leads to the hypothesis that Callophycus serratus maintains these 
compounds internally and releases them at sparsely distributed surface sites. There are a 
number of possible explanations for the heterogeneous distribution of bromophycolides 
across C. serratus surfaces. One possibility is that bromophycolide rich sites represent a 
targeted response to microbial challenge at these sites. Another possibility is that patches 
are associated with sites of localized algal damage from which bromophycolides have 
leaked, providing antifungal defenses where tissues are vulnerable to waterborne 
microbes. Whichever hypothesis prevails, reactive DESI MS imaging presented here 
provides direct evidence for localization of chemical cues on biological surfaces in 
concentrations sufficient for targeted antimicrobial defense. 
 
6.6. Conclusions 
This study demonstrated the capabilities of chemical imaging by DESI MS as a 
highly specific and sensitive approach in the determination of the 2-dimensional 
distribution of various chemical species enabling application in a wide variety of fields. 
DESI MS imaging of pharmaceutical drug tablets provides information on the 
homogeneity of active ingredient enabling applications in pharmaceutical drug quality 
control. The degree of product homogeneity also provides information on the caliber of 
counterfeit-drug manufacturing practice. The large sample area evaluated during DESI 
MS imaging analysis is suggested to facilitate the determination of subtherapeutic 
counterfeit drugs especially those in which the API is inhomogeneous distributed. 
Sensitivity and selectivity enhancement during DESI MS imaging can be enhanced by 
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performing the experiment in the reactive mode. Application of reactive DESI MS 
imaging in the analysis of Callophycus serratus provided an unprecedented ability to map 
secondary metabolites to distinct surface sites. Reactive DESI MS imaging revealed that 
bromophycolides are not homogenously distributed across Callophycus serratus surfaces 
but instead are associated within distinct surface patches at concentrations sufficient for 
targeted antimicrobial defense. This suggests a role of bromophycolides in Callophycus 
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CHAPTER 7. DESORPTION ELECTROSPRAY/METASTABLE- 
INDUCED IONIZATION (DEMI):  A FLEXIBLE MULTIMODE 
AMBIENT IONIZATION TECHNIQUE 
 
7.1. Abstract 
This Chapter presents a new multimode ambient ion source termed Desorption 
Electrospray/Metastable-Induced Ionization (DEMI), which integrates the benefits and 
circumvents some of the limitations of Desorption Electrospray Ionization (DESI, 
polarity range limited) and DART-type Metastable-Induced Chemical Ionization (MICI, 
molecular weight limited). This ion source allows three unique operation modes, each 
with unique capabilities, including: spray (DESI-like)-only, MICI-only and DEMI 
(multimode), and can be thus operated in each of these modes allowing the detection of a 
wider range of analytes of interest. Ion source operation in the MICI-only mode is 
particularly well suited for the analysis of low polarity, low molecular weight compounds 
in powdered, solid or dissolved samples. Operation of the ion source in spray-only mode 
shows superior performance for the analysis of high molecular weight, high polarity 
compounds over the MICI-only mode. Heating the nebulizer gas in spray-only mode 
allows improved analyte solubility in the spray solvent, enabling up to an order of 
magnitude improvement in sensitivity. Perhaps the most appealing mode of operation of 
the ion source is the DEMI mode, which allows the simultaneous detection of compounds 
within a much broader range of polarities and molecular weights than each of the 
individual modes. For drug quality screening and counterfeit detection applications, 
operation in the DEMI mode results in the generation of both protonated and sodiated 
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analytes. The observation of such complementary ionic species facilitates compound 
identification when investigating unknowns. 
 
7.2. Introduction 
In recent years, there has been an increasing demand on analytical technologies to 
become more universal, enabling the simultaneous detection of a broader range of analyte 
chemistries. In the realm of mass spectrometric analysis, efforts toward meeting this goal 
have been directed towards combining more than one ionizer type at the front end of the 
mass spectrometer.277 Presented in this Chapter is the implementation of a novel 
multimode ambient ion source; DEMI, which consolidates the complementarity between 
DESI and DART enabling the simultaneous analysis of a broader range of compound 
classes. 
Multimode ionization sources combining electrospray ionization with 
atmospheric pressure chemical ionization (ESI/APCI),277, 278 electrospray ionization with 
atmospheric pressure photoionization (ESI/APPI),279, 280 for probing high complexity 
samples by liquid LC-MS281 have been reported, and are now commercially available. 
However, they are still limited by the intrinsic low throughput performance of LC 
separations, which precede sample ionization/MS analysis. Ambient MS methods on the 
contrary are particularly attractive because of their rapid throughput capability and their 
ability to investigate samples of odd shapes and sizes, while preserving their intrinsic 
chemical information content. DESI is particularly powerful for analyzing thermally 
labile, non-volatile, polar molecules in a mass range reported to be as high as 45 kDa.127 
DART, on the other hand, has been shown to be best suited for the analysis of molecules 
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with a broad range of polarities in a mass range of up to 800 Da,183 approximately. The 
complementarity between DART and DESI mechanisms therefore suggests a potential 
advantage in combining the two techniques into a hybrid approach. 
In this Chapter, a novel ambient multimode ionization technique; DEMI, together 
with first insights into its associated ion generation mechanisms is presented. This 
technique combines features of DESI- and DART-type ionization, but with the unique 
capability of enabling the simultaneous and direct detection of molecules within a 
broader range of polarities and molecular weights than these techniques alone, without 
loss of throughput or spatial resolution. 
 
7.3. Experimental Details 
7.3.1. Samples and Reagents 
All reagents were used without additional purification. HPLC grade methanol 
(EMD Chemicals, Gibbstown, NJ, USA), ACS grade acetone (Mallinckrodt Baker, 
Phillipsburg , NJ, USA), and ultrapure water (18.2 MΩ cm-1), obtained from a Nanopure 
purification unit (Barnstead, San Jose, CA) were used as spray solvent in the spray-only 
and DEMI experiments.  Characterization of capabilities of various ion source operation 
modes was investigated using the following: Tylenol® tablets (500 mg acetaminophen, 
McNeil-PPC, Inc., Fort Washington, PA, USA), counterfeit artesunate antimalarial 
tablets collected in Cameroon and Southern China, Halfan® tablets (250 mg halofantrine 
hydrochloride, GlaxoSmithKline, London, UK), multivitamin tablets (Pharmelle 
Pharmaceutical Company, Gilbert, AZ, USA), trans-10, 11-dibromodibenzosuberone,  
dibenzosuberenone, cholesterol, angiotensin I (Sigma Aldrich, St. Louis, MO, USA) and 
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spray dried lactose (FMC Corp., Newark, DE, USA). Unless stated otherwise, high-purity 
He (99.999% Airgas, Atlanta, GA) was used to generate metastables in MICI and DEMI 
experiments. Industrial grade N2 (99.998% Airgas, Atlanta, GA) was used as nebulizer 
gas for the sprayer. 
 
7.3.2. DEMI Ion Source 
The experimental setup is shown in Figure 7.1. The DEMI ion source was 
constructed by interfacing a custom-built glow discharge chamber to produce He 
metastables187 to a custom-built DESI-type ion source modified by the addition of a 
resistive flow-through heater to the nebulizer gas line. The glow-discharge chamber (held 
at room temperature) was connected to a 3/8 in. Swagelok® T-union, fitted with a 10 cm 
glass capillary (i.d. = 3.8 mm, o.d. = 6.4 mm). The T-union was sealed onto the glass 
capillary at one end, with the glass capillary extending up to the edge of the opposite, 
unsealed end. The glass capillary was tapered from the sealed end to a final 1.5 mm i.d, 
2.8 mm o.d., creating a concentric clearance for the metastable gas stream flow. This 
assembly was mounted onto an xyz manual translational stage, with the glass capillary 
exit aligned with the mass spectrometer capillary inlet. The distance between the glass 
capillary exit and the MS capillary inlet was 10 mm unless stated otherwise. The spray 
emitter consisted of an 11.5 cm long inner liquid capillary (83 µm i.d., 190 µm o.d.), 
surrounded by an outer nebulizer gas capillary (381 µm i.d., 1588 µm o.d.), both made of 
stainless steel. These were fitted into a ¼ in. Swagelok® T-union (Swagelok Company, 
Solon, OH, USA) with the inner capillary fixed to its proximal part, and the outer 
capillary fixed to the distal part, offset by ~0.2 mm from each other. One port of this  
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Figure 7.1. Schematic of the DEMI ion source coupled to a quadrupole ion trap mass 
spectrometer (only inlet shown). 
 
union was connected through an in-line T type air process heater (Omega Engineering, 
Stamford, CT, USA, not shown in Figure 1) to a N2 gas cylinder using Teflon
® tubing to 
provide heated/unheated nebulizer gas. The temperature of the heated gas was monitored 
using a 1/8 in. stainless steel K-type thermocouple probe connected to a benchtop model 
CSC-321-K controller (Omega Engineering, Stamford, CT, USA). The spray solution 
was delivered to the sprayer through a short piece of 127 µm i.d. PTFE tubing that was 
connected to one port of a PEEK T-union (Upchurch Scientific, Oak Harbor, WA, USA). 
The second port of this PEEK union was connected through a longer piece of PTFE 
tubing to a 250 µL glass syringe (Hamilton Company, Reno, NV, USA) from which the 
spray solution was delivered. The spray solution was biased to +3000 V via an external 
high-voltage power supply (SRS PS350, Sunnyvale, CA). This power supply was in 
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electrical contact with the spray solution through a third port of the PEEK T-union. The 
sprayer assembly was mounted through posts onto a second xyz manual translational 
stage. The motorized stage employed in Chapter 6 was used for sample positioning 
relative to the sprayer. Analytes dissolved by the charged solvent spray, thermally 
desorbed or aerosolized by the nebulizer gas are transported towards the mass 
spectrometer inlet through the glass transport capillary. Upon exiting this glass capillary, 
the dispersed droplets, particulates or sublimated neutrals become entrained with the 
metastable stream emanating from the glow-discharge source. 
 
7.3.3. Mass Spectrometry 
All experiments were performed on a Thermo Finnigan LCQ Deca XP+ 
quadrupole ion trap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) 
operated in positive ion mode using Xcalibur version 2.0 software. The standard ion 
transfer capillary was replaced with an extended version (20.5 cm long, 762 µm i.d., 1588 
µm o.d., Small Parts Inc., Miramar, FL, USA) that was heated to 300oC. Samples were 
positioned for analysis so that the glass sampling capillary of the DEMI ion source was 
~0.5 mm from the edge of the mounted sample at a collection angle of 0o. The sprayer tip 
was positioned 4–6 mm from the glass capillary inlet and 1–3 mm away from the surface 
of the sample at an angle of 55o. Unless stated otherwise, the spray solvent was composed 
of 90:10 MeOH:H2O, at a flow rate of 12 µL/min. The nebulizer gas pressure was set to 
150 psi and heated to a temperature of 71oC unless stated otherwise. Spectra were 
collected in full scan mode with automatic gain control turned on for a maximum 
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injection time of 200 ms, and 2 microscans per spectrum. Data were acquired for a total 
time of 15 s unless stated otherwise. 
 
7.4. Results and Discussion 
7.4.4. DEMI Ion Source Operation Modes 
The DEMI ion source allows operation in three different modes (Figure 7.2), 
including: (i) metastable-induced chemical ionization (MICI)-only, (ii) spray-only 
(DESI-like) and (iii) DEMI multimode. In MICI-only mode, analyte 
desorption/ionization can be achieved via (a) aerosolization with unheated nebulizer gas 
(for fine powders) followed by reactions of solid aerosol particles with reactant ions, or 
(b) thermal desorption using heated nebulizer gas (for non-dispersible solids). In spray-
only mode the glow discharge voltage is kept off, while analytes are sampled by micro-
extraction into the charged solvent stream produced by the pneumatic sprayer. Operation 
in this mode can be achieved with the nebulizer gas unheated or heated to modify analyte 
solubility. In DEMI mode, the shortcomings of MICI (limited in mass range) and 
spray-only (limited in polarity range) modes are mitigated. Each of these ion source 
operation modes enable unique capabilities presented in the following sections. 
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Figure 7.2. Pictorial representation of the different DEMI operation modes, and the 
corresponding ion generation mechanisms believed to be prevalent in each case. 
 
7.4.5. Reagent Ion Generation/Source Optimization 
Figure 7.3 shows a typical background mass spectrum generated by metastable He 
atoms, when the ion source is operated in positive ion mode. Signals corresponding to 
protonated water clusters ((H2O)nH
+, n=2-4) were observed with n=2 dominating the 
spectrum. These clusters serve as reagent ions for analyte ionization, which occurs by a 
process whose efficiency depends on the proton affinity of the analyte being greater than  
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m/z 42 = [CH3CN + H]
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Figure 7.3. Mass spectrum showing typical reagent ions for source operation in the MICI 
and DEMI modes. 
 
 that of the reagents. It has been reported that the proton affinities of (H2O)nH
+ increase 
with increasing n, and that the cluster with n=2282 presents the largest reaction cross 
section.282, 283 The predominance of smaller-size clusters in the spectrum (n=2-3) should 
therefore be advantageous for efficient proton transfer. Minute peaks at m/z 42 and 59 
(marked with asterisks) corresponding to protonated acetonitrile and acetone were also 
observed, originating from trace amounts of these chemicals in the laboratory 
environment. Their relatively low proton affinities282, 283 also make them readily available 
for proton transfer reactions. 
 In order to maximize dynamic range and minimize ion suppression during direct 
ionization, the effect of various experimental variables on the total reactant ion intensity 
was investigated by performing single measurements at each particular setting. Of 
particular interest was the effect of glow discharge gas flow rate on both the reactant ion 
signal intensity and the ion trap analyzer pressure. The pressure in the quadrupole ion 
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trap analyzer region showed a minimum at a gas flow rate of 4 L/min (Figure 7.4.a, right 
axis), coinciding with the maximum reagent ion cumulative signal, for both He or 
N2-supported glow discharges (Figure 7.4.a, left axis). Lower flow rates were 
detrimental, with the analyzer pressure spiking to values of up to 7.7x10-5 Torr. The 
decrease in analyzer pressure for flows higher than 2 L/min was probably caused by the 
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Figure 7.4. Optimization of the total reactant ion signal for the ion source operating in 
MICI-only mode (a) as a function of He or N2 discharge gas flow rate (corresponding 
normalized intensity scale on left ordinate). The dotted lines show the effect of He gas 
flow rate on the ion trap analyzer pressure (scale on the right ordinate) for different 
source-to-MS inlet distances (DAB). The effect of (b) the glow-discharge voltage, (c) the 
source-to-MS distance (DAB), (d) the grid voltage and (e) the voltage bias on T-union on 
the total reactant ion intensity is shown on the bottom plots.  For each plot, the total ion 
signals were normalized to that of the maximum value. 
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creation of a low pressure region at the interface with the MS inlet by the glow discharge 
gas flowing around the periphery of the glass transfer capillary and the MS inlet aligned 
with it. This effect limited the load on the pumping system, allowing stable operation. 
Figures 7.4.b-e shows the effect of other experimental variables on the total reagent ion 
signal. The signal increased with the He glow-discharge voltage up to about +1400 V, the 
threshold above which a stable glow discharge was achieved (Figure 7.4.b). The total 
reagent ions signal also increased with the source-to-MS distance (DAB) for the entire 
range investigated (Figure 7.4.c). This is possibly due to an increasing in reaction time of 
He or other metastable species with increasing DAB. A fine balance is therefore required 
to allow generation of sufficient amount of reagent species while minimizes suppression 
and analyte dispersion effects. It is possible to envision losses in sensitivity due to 
dispersion effects especially with an increase in DAB. However, sensitivity losses were 
highly compensated for by the source design due to significantly large cross sectional 
area of the glass capillary inlet into which droplets and thermally desorbed or aerosolized 
powdered analytes were sampled. The sampled analytes were focused into a tighter 
plume before exiting the glass capillary. Efficient sampling of the focused analyte stream 
emanating from the glass capillary was achieved by aligning its exit with the MS 
capillary inlet. The flow of the metastable plume around the periphery of the glass 
capillary also served to focus the analyte plume upon exit, minimizing dispersion. As 
such no evident losses in sensitivity were observed in this set-up when the source was 
operated in the DESI-only and/or MICI-only modes, when compared to traditional DESI 
and DART experiments. The standard capillary inlet has a cross-sectional area which is 
25 times smaller than the glass capillary inlet presented here. The total reagent ion signal 
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was also observed to decrease with increasing grid (Figure 7.4.d) and T-union 
(Figure 7.4.e) voltages probably due to enhanced neutralization of reagent ions. Based on 
these studies, the following optimum settings were used for all experiments unless stated 
otherwise: He glow discharge voltage = +1400 V, voltage on T-union = 0 V, 
grid voltage = 0 V, DAB = 10 mm. 
 
7.4.6. Capabilities of Ion Source Operation in the MICI-only Mode 
DEMI operation in the MICI-only modality was observed to be particularly 
advantageous for the analysis of powders by direct aerosolization. In this approach, 
sample particles propelled by the nebulizer gas flow are captured by the transfer glass 
capillary and transported towards the downstream ionization region for reaction with 
(H2O)nH
+ ions. Figure 7.5 exemplifies the successful analysis of low polarity compounds 
in powder form, including dibenzosuberenone (Figure 7.5.a), dibromodibenzosuberone 
(Figure 7.5.b), cholesterol (Figure 7.5.c) and the mixture of all three (Figure 7.5.d) in 
which the various analytes were detected as either protonated and/or ammoniated species. 
The detection of all three low polarity compounds in the mixture (Figure 7.5.d) 
showcases the performance of the MICI-only mode in the analysis of mixtures resulting 
in minimal suppression effects. Powder analysis in the MICI-only mode was further 
exemplified by the analysis of some pulverized samples including: spray dried lactose 
(Figure 7.6.a), a chloroquine containing fake artesunate tablet (Figure 7.6.b), and a 
Halfan® antimalarial tablet (Figure 7.6.c), in which the main constituents were detected 
predominantly as protonated species.  A small degree of carryover was observed during 
the analysis of powders in the MICI-only mode. This effect was negligible when small  





































































Figure 7.5. Mass spectra of powders of some low polarity compounds and their mixture 
with the source operating in MICI-only mode. (a) dibenzosuberenone, (b) 
dibromodibenzosuberone, (c) cholesterol (d) mixture of all three. 2 mg powder of each 
sample deposited onto a glass slide were aerosolized and transported by the N2 nebulizer 
gas from the pneumatic sprayer (with spray solvent off) through the glass capillary. 1 mg 
of each compound was used to prepare the mixture. The N2 nebulizer gas temperature 
and pressure were 14oC (unheated) and 150 psi, respectively. 
 
amounts of material were sampled into the glass capillary, but was noticeable when 
increasing the amount of material sampled. Due to the ease with which the glass capillary 
assembly is attached to the rest of the source, carryover was prevented by simply 
unscrewing and rinsing the glass capillary with a solution of 50:50 MeOH/H2O and 
reattaching it in-between runs, if necessary. 
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Figure 7.6. Mass spectra of various powdered samples with the source operating in the 
MICI-only mode. (a) spray dried lactose, (b) powdered chloroquine-containing fake 
artesunate antimalarial tablet, and (c) powdered Halfan® antimalarial tablet containing 
halofantrine. The pressure of the unheated nebulizer gas was 150 psi. 
 
Figure 7.7 shows a direct comparison of the analysis of an intact (Figure 7.7.a) 
and powdered (Figure 7.7.b) multivitamin tablet in MICI-only mode. The intact tablet 
spectrum showed predominantly one peak corresponding to protonated niacinamide, the 
lightest component in the sample. Powder analysis presented more signals corresponding 
to niacinamide, ascorbic acid, thiamine, pyridoxine and biotin, the most abundant 
components in the sample. The observed increase in the number of observable signals can 
be ascribed to the higher surface area interacting with gaseous reagent ions when the  
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Figure 7.7. Direct ionization mass spectra of a multi-vitamin tablet with the source 
operating in the MICI-only mode: (a) intact tablet analyzed with the nebulizer gas heated 
to 83oC, (b) powdered sample deposited on a glass slide and analyzed with the nebulizer 
gas unheated. 
 
sample was aerosolized. For non-dispersible samples, such as intact tablets, analyte ion 
yield in the MICI-only mode was found to largely depend on, and increase with the 
temperature of the nebulizer gas, as shown in Figure 7.8.a for the analysis of an 
acetaminophen tablet. Figure 7.8.b, c and d show the corresponding mass spectra from 
this analysis, at three different temperatures, where the protonated analyte monomer 
(m/z 152) and dimer (m/z 303) were observed as the predominant analyte species in the 
spectra. Some unidentified background peaks were also observed predominantly at low 
nebulizer gas temperatures, possibly resulting from contaminating species desorbed from 
within the gas transfer lines. 
 

















































































Figure 7.8. Left panel: (a) selected ion intensity (m/z 152±0.15) traces obtained from the 
analysis of an intact acetaminophen tablet with the source operating in the MICI-only 
mode. Samples were probed with the nebulizer gas  from the sprayer (solvent off) heated 
to various temperatures with an inline heating element. Right panel: corresponding mass 
spectra obtained for the nebulizer gas heated to (b) 54oC, (c) 71oC, and (d) 77oC. 
 
7.4.7. Capabilities of Ion Source Operation in the Spray-only Mode 
DEMI source operation in the spray-only mode, essentially equivalent to DESI, 
using heated nebulizer gas allows appreciable improvements in the overall analyte signal. 
This was demonstrated by the analysis of an acetaminophen tablet, which shows peaks 
corresponding predominantly to sodiated acetaminophen monomer (m/z 174) and dimer 
(m/z 325, Figure 7.9.a). The detection of predominantly sodiated species by DESI is 
presumable due to the presence of sodiated excipient in the tablet matrix. Greater than an 
order of magnitude improvement in the analytical signal was achieved by heating the 
nebulizer gas up to 71oC (Figure 7.9.b). This reinforced the idea of a prevailing 
DESI-like droplet pick-up mechanism where analyte signal largely depends on its 
solubility in the spray solvent.100, 284, 285 
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Figure 7.9. (a) Typical mass spectrum obtained from the analysis of an acetaminophen 
tablet with the source operating in spray-only mode, (b) Selected ion intensity traces (m/z 
152, 174, 303 and 325) from the analysis of an acetaminophen tablet with the nebulizer 
gas set to ramp from 14oC – 83oC at a rate of ~ 6.5oC/min with the source operated in 
spray-only mode. The window width for all selected ion traces was 0.3 m/z. 
M = acetaminophen. 
 
7.4.8. Capabilities of Ion Source Operation in the DEMI Mode 
Perhaps the most intriguing mode of operation of the ion source is the DEMI 
mode, which mitigates the limitations of the individual MICI and spray-only modes 
enabling the simultaneous detection of a broader range of analyte chemistries. This 
capability was showcased by the analysis of a binary mixture of dibromodibenzosuberone 
and angiotensin I standards deposited onto glass slides. Figure 7.10 shows the spectra 
obtained from the analysis of the above mentioned binary mixture with a nebulizer gas 
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temperature of 71oC, using 90:10 MeOH:H2O at 15 µl/min as the spray solvent. Only the 
low polarity, lower molecular weight protonated dibromodibenzosuberone was observed 
in MICI-only mode (Figure 7.10.a). In the spray-only mode (Figure 7.10.b), only the 
higher polarity, higher molecular weight, singly and doubly protonated angiotensin I 
species were observed. In DEMI mode, both dibromodibenzosuberone and angiotensin I  
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Figure 7.10. Mass spectra of a binary mixture (10 µL, 0.5 mg/mL angiotensin I, 1mg/mL 
dibromodibenzosuberone,  deposited onto a glass slide) analyzed in, (a) MICI-only mode, 
(b) spray-only mode and (C) DEMI mode. (m/z 1319 = [angiotensin I + Na]+). Noted in 
the upper right corner of each plot is the base peak absolute intensity. 
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ionic species were observed (Figure 7.10.c). The limits of detection (LOD) for each of 
the component in this binary mixture for the different operation modes are presented in 
Table 7.1. When the previous experiment was performed with the nebulizer gas unheated, 
only peaks corresponding to angiotensin I were observed both in the spray-only and  
 
Table 7.1. Limit of detection (S/N ≥ 3) for each of the components in a binary mixture of 
angiotensin I (0.5 mg/mL) and dibromodibenzosuberone (1 mg/mL) spotted onto glass 
slides (10 µL) from a solution in 90:10 MeOH:H2O and analyzed with each of the 










DEMI modes (data not shown). The poor solubility of dibromodibenzosuberone in the 
spray solvent is probably the limiting factor preventing efficient analyte pick-up. Similar 
experiments using a spray solvent mixture of lower polarity (50:50 MeOH:acetone) 
resulted in peaks corresponding to singly and doubly protonated angiotensin I in 
spray-only mode (Figure 7.11.a) and peaks for both dibromodibenzosuberone and 
angiotensin I in DEMI mode (Figure 7.11.b). These findings suggest that the higher 
polarity angiotensin I presumably undergoes protonation in solution following desorption 
by ESI-like processes where insufficient basicity of dibromodibenzosuberone precludes 
its ionization. Dibromodibenzosuberone ions were therefore most likely generated by 
metastable-induced chemical ionization of gaseous neutrals produced by thermal 
desorption or following evaporation of the solvent droplets as we further discuss below. 
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Figure 7.11. Mass spectra of a binary mixture (10 µL, 0.5 mg/mL angiotensin I, 1mg/mL 
dibromodibenzosuberone) deposited onto a glass slide and analyzed with a spray solution 
composed of 50:50 MeOH:acetone, in (a) spray-only and, (b) DEMI modes. The 
unheated nebulizer gas pressure was 150 psi and the solvent flow rate was 10 µl/min. 
. 
 
The intensity and types of observed species during DEMI-MS experiments 
showed a solvent flow rate dependency. This was illustrated by the analysis of an 
acetaminophen tablet with the nebulizer gas heated to 71oC (Figure 7.12). Protonated 
acetaminophen species dominate the spectra at lower solvent flow rates while sodiated 
species predominate at higher flow rates. At an intermediate flow rate, both sodiated and 
protonated species were observed (Figure 7.12.c). At low flow rates, the spray solvent 
evaporated quickly before or immediately after impact with the sample surface. This 
resulted in limited partition into the solvent spray and the generation of gas phase analyte  
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I303: [2 acetaminophen + H]
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Figure 7.12. Mass spectra of an acetaminophen tablet with the source operated in DEMI 
mode for different solvent flow rates (a) 5 µL/min, (b) 10 µL/min, (c) 15 µL/min and 
(d) 20 µL/min. The temperature of the nebulizer gas was set to 71oC. 
 
species predominantly by thermal desorption with subsequent ionization by proton 
exchange with reagent ions. Higher solvent flow rates favoured the extraction of analytes 
molecules into droplets from which sodiation occurs predominantly by adduction with 
alkali ions dissolved from the excipient matrix.  
The effect of different DEMI experimental variables on the appearance of various 
ionic species was further investigated by sequentially switching on and off various 
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components of the ion source. No appreciable effect was observed when the spray 
voltage, or the glow discharge gas flow were sequentially switched on and off while 
keeping the discharge voltage off (Figure 7.13.a and b, respectively). Sodiated 
acetaminophen monomer and dimer were the predominant species observed in the 
spectrum in both cases. However, both sodiated and protonated analyte species were 





































Figure 7.13. Selected ion intensity traces (m/z 152, 174, 303, 325 corresponding to 
[M+H]+, [M+Na]+, [2M+H]+, [2M+Na]+ respectively, where M = acetaminophen) from 
the analysis of an acetaminophen tablet under different DEMI ion source operating 
conditions: (a) spray-only mode, while switching the electrospray voltage off and on 
repeatedly, (b) spray-only mode while switching the glow discharge gas flow off and on 
repeatedly while maintaining the glow discharge voltage off, and (c) DEMI mode while 
switching the glow discharge voltage off and on repeatedly.  The nebulizer gas was 
heated to 71oC and the spray solvent flow rate was 12 µl/min. The window width for all 
selected ion traces was 0.3 m/z. 
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response was observed when an acetaminophen standard solution was directly 
electrosprayed into the glass transfer capillary while alternating the discharge voltage 
on/off (Figure 7.14). These findings reinforce the previous idea that protonated species 
observed in DEMI spectra could originate predominantly from the ionization of gaseous 
neutrals produced by microdroplet desolvation, and not from the competitive 
displacement of sodium adducts by protonated water clusters. Sodiated species were 
probably generated by DESI-type mechanisms. Protonated species may be generated in 
parallel from neutrals thermally desorbed from the sample by the heated nebulizer gas 
which later undergo metastable-induced chemical ionization within the interface between 
the glass transfer capillary and the mass spectrometer’s inlet. The detection of protonated 
and sodiated species within the same spectrum by DEMI-MS increases the certainty of  
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Figure 7.14. Selected ion intensity traces (m/z 152, 174, 303, 325 corresponding to 
[M+H]+, [M+Na]+, [2M+H]+, [2M+Na]+ respectively, where M = acetaminophen) 
observed for the infusion of an acetaminophen standard (5 µM) operating the ion source 
in the pneumatically-assisted electrospray/chemical ionization mode while switching the 
glow discharge voltage off and on repeatedly.  The solvent flow rate was 12 µL/min and 
the nebulizer gas temperature and pressure were 61oC and 150 psi respectively. The 
window width for all selected ion traces was of 0.3 m/z. 
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peak assignments, an important feature in forensic applications such as the identification 
of unknown pharmaceutical ingredients. This feature was illustrated by analyzing a 
counterfeit artesunate antimalarial tablet collected in the China/Myanmar border,200 
which was found to contain artemisinin. Peaks corresponding to protonated and 
ammoniated artemisinin species predominated the spectrum for analysis in the MICI-only 
mode (Figure 7.15.a), while sodiated species predominated in the spray-only mode 
(Figure 7.15.b). The complementarity between the MICI and spray-only modes was 
captured for analysis in the DEMI modes where peaks corresponding to protonated, 
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Figure 7.15. Mass spectra of an artemisinin-containing fake artesunate antimalarial tablet 
with the source operated in the: (a) MICI-only mode, (b) spray-only mode and (C) DEMI 
mode. (m/z 265 = [M - H2O + H]
+, m/z 237 = [M - H2O – CO + H]
+ , m/z  209 = 
[M - H2O - 2CO + H]
+;  where M = artemisinin). 
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7.5. Conclusions 
A new ambient multimode ionization technique named Desorption 
Electrospray/Metastable-induced Ionization (DEMI), which combines DESI and 
metastable induced chemical ionization mechanisms, is presented. Three unique 
operation modes are possible (MICI-only, spray-only and DEMI), each with unique 
features. The data obtained thus far supports a DEMI ionization mechanism where 
analytes dissolved from the sample are released either as sodiated, protonated and/or 
neutral species from electrically-charged droplets in positive ion mode. Neutrals undergo 
further reactions with protonated water clusters, producing protonated species. High 
polarity analytes are desorbed and ionized following DESI mechanisms, while less polar 
molecules can be thermally vaporized or dissolved by a low polarity spray mixture, later 
undergoing metastable-induced chemical ionization. 
   171 
CHAPTER 8. CONCLUSIONS AND OUTLOOK 
 
8.1. Abstract 
This Chapter presents a summary of the results of my investigations on DESI and 
DART for applications in the analysis of pharmaceutical compounds. The Chapter is 
concluded with a proposal of potential future directions. 
 
8.2. Accomplishments-Ambient (DESI and DART) MS Investigations  
Ambient MS is a new and growing sub-field in mass spectrometry, which has 
opened new research avenues, particularly for applications relating to the analysis of 
solid samples. Opportunities in this area increase as new ambient ion sources are 
introduced and better characterized. The results presented here indicate that ambient 
ionization techniques such as DESI and DART could serve as complementary tools for 
the forensic characterization of pharmaceuticals with up to two orders of magnitude 
improvement in throughput compared to traditional methods such as liquid 
chromatography mass spectrometry (LC-MS).  
The capabilities of DESI MS for the selective and sensitive, qualitative and 
quantitative analysis and imaging of pharmaceutically important molecules were 
extensively explored. For the qualitative screening/fingerprinting of pharmaceutical drug 
tablets, one of  the most critical attributes that determined sensitivity/selectivity was 
solubility in the spray solvent. As such, the chemistry of the spray solvent mixture could 
be tuned to enable the selective dissolution/detection of specific analytes of interest from 
the tablet matrix.145, 149 Furthermore, the sensitivity of this technique for drug tablet 
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analysis was also observed to be largely dependent on the nebulizer gas velocity, spray 
solvent flow rate and sample hardness. These variables determine the efficiency of 
momentum transfer from the initial primary droplets onto the surface liquid film to 
generate analyte-containing secondary droplets. These secondary droplets are ejected off 
the sample surface and sampled at the inlet capillary of the mass spectrometer.102, 147 As 
such, the nebulizer gas velocity and spray solvent flow rate must be appropriately chosen, 
based on the sample hardness to allow efficient surface sampling. The selectivity of this 
technique can also be enhanced by performing the experiment in the reactive mode. In 
this mode, various chemical reagents are added into the spray solvent to enable the 
selective recognition/reaction with specific moieties in target analytes. These reactions 
usually result in analyte stabilization, inhibiting fragmentation with a concomitant 
enhancement in the analyte surface activity, facilitating their evaporation from secondary 
droplets culminating in an improvement in sensitivity.102, 146, 147   
The capability of DESI MS for the direct quantitative analysis of drug tablets by 
DESI MS was also demonstrated following two different strategies. In the first approach, 
the analyte signal dependency on DESI geometrical set-up variables was mitigated 
following the careful and controlled addition of an isotopically labeled internal standard 
(IS) to the sample resulting to an analyte-to-IS signal ratio, which was largely 
independent of DESI experimental variables.148 Thus, monitoring the analyte-to-IS signal 
ratio as oppose to the absolute signal enabled the direct quantitation of the active 
pharmaceutical ingredient (API) in drug tablets with up to 94 % accuracy when compared 
to LC-UV analysis. In the second approach, the analyte signal dependency on set-up 
variables was mitigated by analyzing samples using a pair of reagents (in the spray 
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solvent), which had different binding affinities for the analyte to provide an analyte 
complex ratio, which was independent on the set-up variables. However, the analyte 
complex ratio was observed to be dependent on the analyte surface concentration, 
allowing direct quantitative analysis of drug tablets, using this approach, without any 
requirement for internal standards.147  
 Following construction of a DESI MS set-up with imaging capabilities, this 
technique was also demonstrated as a very powerful tool for determining the 2-D 
distribution of various pharmaceutically important compounds on tablet and tissue 
surfaces. The ability to map the distribution of molecules of interest by DESI MS has 
very great implications in drug tablet quality control145 and in determining the role of 
chemical signals presented on tissue surfaces.166 The mapping of various chemical 
markers by DESI MS is also showing great prospects in cancer research in determining 
the spread of malignant tissue.162, 286 
DART MS was also explored and observed to be a very powerful tool for the 
rapid forensic characterization of pharmaceutical drug tablets providing an addition to the 
analytical toolbox for such applications.145, 150, 200, 287 Interfacing the DART ion source to 
an accurate mass TOF MS instrument demonstrates the utility of this technique in 
determining the elemental composition of wrong APIs in counterfeit drug samples 
enabling their identification.  
The extensive use of DESI and DART for the various presented applications 
provided some insights into some of the intrinsic limitations of these techniques. DESI 
was observed to be limited to ionizing molecules of medium to high polarities without 
much limitation in terms of mass range, whereas DART is better suited for the analysis of 
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molecules within a broader range of polarities, but within a more limited mass range (up 
to 800 Da approximately) due to the desorption mechanisms involved. To circumvent 
these limitations a novel multimode ambient ion source, desorption 
electrospray/metastable-induced ionization (DEMI), which combines various aspects of 
DESI and DART was constructed and tested. Initial experiments with the DEMI ion 
source have demonstrated its ability to enable the simultaneous analysis of molecules 
within a broader range of polarities and masses than DESI and DART alone.288 
 
8.3. Proposed Future Directions 
  Our research on DESI and DART MS was directed towards exploring the 
capabilities of these techniques, predominantly for the forensic characterization of 
pharmaceutical drug tablets. The pharmaceutical drug class most extensively evaluated 
was the artemisinin based antimalarial monotherapies. Ongoing ventures are geared 
towards extending these efforts to the investigation of antimalarial combination therapies 
containing artemisinins (ACTs), with the aim of further developing improved approaches 
for performing rapid mass spectrometric analysis of these drugs and for other applications 
as follows: 
1. Fixed dose ACTs usually contain two or more APIs in the presence of an 
excipient matrix resulting in a relatively complex sample mixture. The artemisinin 
constituent in the ACTs usually undergo extensive fragmentation following 
DART MS analysis resulting in very similar spectra for all the artemisinins. As 
such, preliminary investigation of such samples by DESI, which is much softer 
than DART is recommended. DESI MS analysis should in principle, allow the 
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detection of intact tablet constituents eliminating any unambiguous identification. 
Analysis of such sample by reactive DART198 could also be employed to mitigate 
this limitation. However, the applicability of either DESI or DART MS for the 
direct analysis of such multi-component samples inevitably suffers from 
ionization suppression. In the case of DESI, this phenomenon arises from the 
different proton affinities and surface activities of the various constituents picked 
up by the DESI spray droplets, resulting in vastly different ionization efficiencies. 
The APIs however, usually have a higher proton affinity and greater solubility (in 
commonly used DESI MS compatible sprays solvents) than the excipient 
constituents resulting in their preferential dissolution/ionization. Nevertheless, the 
presences of more than one API constituent in ACTs could still result in 
preferential detection of APIs with higher solubility and ionization efficiencies, 
precluding the observation of less soluble or ionizable APIs.  As such, proposed 
experiments should be aimed towards determining the sample APIs constituent 
concentration limits for charge competition and the on-set of ionization 
suppression effects to allow a determination of the linear dynamic range of DESI 
MS and its capabilities for the analysis of ACTs. These studies should have 
important implications in the direct quantitation analysis of APIs in ACTs. 
Preliminary investigation of the solubility characteristics of the various API in the 
DESI spray solvent is required in order to decouple, to some degree, the analyte 
desorption/incorporation into secondary droplets from the subsequent 
ionization/charge competition effects.  
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2. For the qualitative analysis of pharmaceutical tablets by DART MS, analyte 
desorption, which is tightly coupled to ionization occurs predominantly by 
thermally heating the sample with the heated metastable gas plume. For the 
analysis of ACTs, sample constituents with greater volatility will be preferentially 
desorbed. Based on their ionization efficiency, they might greatly suppress the 
ionization of the less volatile tablet constituents, which are inevitably less 
abundant in the gaseous phase, precluding their detection. Analysis of the 
pulverized sample should mitigate this limitation enabling the simultaneous 
detection of more tablet constituents. 
3. DART MS was also observed to show a relatively limited mass range due to the 
limited molecular weight range of analytes that can be transformed into the 
gaseous phase following thermal desorption. In addition, DART MS has been 
observed to show superior performance in the analysis of less polar compounds 
than DESI MS. As such one strategy for extending the molecular weight range of 
compounds amenable to DART MS would be to explore spray based desorption 
approaches for high molecular weight, low polarity species, which might not be 
easily ionized in an appropriately chosen spray solvent. In such cases, the role of 
the spray solvent would be to effect analyte pick-up and subsequent 
transformation into gaseous phase following solvent evaporation. Implementation 
of this strategy such as in the DEMI set-up would result in the ionization of the 
gaseous analytes upon interaction with plume from the metastable source.  
4. Analyte desorption in DEMI MS occurs by a combination of thermal and spray 
solvent pick-up, with the subsequent ionization event also occurring following 
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two different strategies.288 Thus, application of this technique for the analysis of 
ACTs should mitigate some of the limitation of thermal desorption and ionization 
discussed above enabling the simultaneous detection of a broader range of sample 
constituents.  
5. An investigation of the size of the analyte-containing solvent droplet emanating 
from the DEMI source under conditions that allow simultaneous operation of both 
ionization approaches is required. This investigation should provide insight into 
the combination of spray solvent, nebulizer gas flow rates and temperatures 
required for efficient surface sampling to allow optimum sensitivity. 
Computational simulation modelling of the interaction of the metastable and 
charge solvent droplet plumes is also required in order to obtain the optimum 
geometrical setting for efficient sampling of the species generated following both 
ionization approaches. 
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APPENDIXES-SURVEY OF OTHER TECHNIQUES USED IN 
COMBINATION WITH AMBIENT MS FOR CHARACTERIZING 
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APPENDIX A. ASSESSMENT OF HAND-HELD RAMAN 
INSTRUMENTATION FOR IN SITU SCREENING FOR 
POTENTIALLY COUNTERFEIT ARTESUNATE ANTIMALARIAL 




This appendix presents an evaluation of the performance of a new portable Raman 
spectrometer (TruScanTM) as a rapid, user-friendly, reliable and inexpensive method for 
drug quality screening. The capabilities of this device are illustrated by its application in 
the chemical characterization of genuine and fake artesunate antimalarial tablets 
following validation by FT-Raman spectroscopy and direct ionization MS.  
 
A.2. Introduction 
An ongoing trend in analytical instrument development has been the deployment 
of portable technologies that allow robust real-time measurements, particularly attractive 
for on-site field applications such as in pharmaceutical drug quality control and 
anticounterfeiting. One key requisite for portable analytical instruments is their 
operational simplicity, to allow various analyses to be readily accomplished by personnel 
with minimum training and expertise. This appendix presents an assessment of the 
capability of a hand-held Raman instrument for the rapid in situ determination of 
counterfeit artesunate antimalarial tablets.  
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Raman spectroscopy is a very powerful chemical analysis technique for the 
analysis of condensed phase samples typically requiring no sample preparation. It is 
based on the Raman effect, which is the inelastic scattering of photons from molecules 
via interaction with the vibrational modes of the analyte molecules. In this process, a 
photon typically transfers a fraction of its energy to a vibrational mode within the 
molecule (Stokes scattering). Consequently, the wavelength of the scattered photon is 
spectrally red-shifted, with the degree of the shift indicating the amount of energy uptake 
by the molecule. Since the vibrational modes are quantized and molecule specific, the 
distribution of observed wavelength shifts is characteristic of that particular molecule. 
The shift pattern serves, in essence, as a unique fingerprint for the molecule, specific to 
its structure and conformation.  
The general applicability of Raman spectroscopy is limited to samples that do not 
exhibit strong fluorescence emission in the Raman spectral region, since this can easily 
overwhelm the relatively weaker Raman signal. However, this problem can be mitigated 
by using near-infrared excitation away from the electronic absorption bands of most 
fluorescing species, thus preventing their excitation and consequently the generation of 
fluorescence emission by these species. Several different portable Raman units are now 
available from different vendors, and are being subject to performance characterization.  
For example, the performance of a mobile Raman instruments has been successfully 
tested for the in situ characterization of art objects.289 
The goal of this study was to evaluate the performance of a small hand-held 
Raman spectrometer to accurately and rapidly screen genuine and fake artesunate 
antimalarial tablets collected in SE Asia, Ghana and southern China. In order to confirm 
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the ability of this type of portable Raman spectrometer to detect excipients and active 
ingredients present in the pharmaceutical tablets evaluated, the results were compared 
and validated by FT-Raman spectroscopy,290 DESI MS and DART MS. Thirty two 
representative antimalarial tablets were characterized following this approaches. 
 
A.3. Experimental Details 
A.3.1. Samples  
Artesunate antimalarial samples, including both genuine artesunate (15) and 
counterfeit tablets (17) were collected in Vietnam, Lao PDR (Laos), Thai/Burma 
(Myanmar), China, Ghana and at the Thailand/Burma border are listed in Table A.1. The 
genuine samples were manufactured by Guilin Pharmaceutical Co. Ltd, (Guilin, PRC), 
Mekophar Chemical Pharmaceutical Joint Stock Co. (Ho Chi Minh City, Vietnam), 
Pharbaco (Hanoi, Vietnam), and Traphaco (Hanoi, Vietnam). 
 
A.3.2. Portable Raman Spectroscopy 
Portable Raman Spectroscopy measurements on each of the samples were 
performed by Felicia Yang, a high school student at the time, on a summer internship 
program in our group. Experiments were performed using a TruScanTM portable 
spectrometer (Ahura Scientific Inc., Wilmington, MA, USA).  This instrument is 
equipped with a cooled external cavity-stabilized 785 nm laser for excitation, which has a 
maximum output power of 300 mW, a 2048-element silicon CCD detector, and a 
resolution of 7.5-10 cm-1 over the Raman shift range of 2875-250 cm-1. 
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A.3.3. FT-Raman Spectroscopy 
FT-Raman spectroscopy experiments were performed by Dr. Camilla Ricci, a 
postdoctoral associate with Dr. Sergei Kazarian in the Department of Chemical 
Engineering in Imperial College, London. Laboratory Raman spectra were acquired for 
each sample in air at room temperature using a Fourier transform Equinox 55 
spectrometer (Bruker Optics Inc., Ettlingen, Germany) with an FRA 106 Raman module 
equipped with a 1064 nm Nd:YAG laser. For these experiments, the laser power was set 
to 400 mW. A liquid nitrogen cooled Ge detector was used with a resolution of 4 cm-1 
and 32 scans in the spectral range 3500-100 cm-1. 
 
A.3.4. Direct Ionization (DESI and DART) MS 
DESI MS experiments were performed on each sample in both the reagentless and 
reactive DESI MS modes using the same ion source and settings described in section 
2.3.3. Experiments were performed using the MS conditions described in section 3.3.2. 
Reagentless DESI MS was performed on each sample in both the positive and negative 
ion mode to determine the mode that gave unambiguous detection and identification of 
analytes desorbed from the sample surface. Reactive DESI MS was performed 
exclusively in the positive ion mode. Several points on the tablet surface and interior 
were sampled during DESI analysis to obtain an accurate picture of the components 
present. 
DART accurate mass measurements were performed using a JMS-100TLC 
(AccuTOF™) TOF mass spectrometer (JEOL, Peabody, MA, USA) equipped with a 
DART ion source (IonSense, Saugus, MA). Experiments were performed in the positive 
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ion mode, at a temperature of 250 °C. Other settings were as follows: the He flow rate 
was 4.2 L min-1, the discharge voltage was 2500 V and the exit grid electrode voltage was 
200 V. Samples were manually held with a pair of clean metal tweezers in front of the 
DART ion source for approximately 20 s. The mass spectrometer ion optics settings198 
were as follows: inlet orifice voltage 30 V, ring electrode voltage 5 V, orifice-2 5 V, ion 
guide bias voltage 29 V, ion guide peaks voltage 300 V. The detector voltage was set to 
2,650 V. Mass spectra were acquired in the 100 to 1000 Da range. Unknowns were 
identified by accurate mass measurements. The spectrometer’s mass drift was corrected 
using neat polyethylene glycol (PEG, average molecular weight 600, Sigma Aldrich, St. 
Louis, MO, USA). DART mass spectra were exported into MS Excel and searched via a 
system of macros, against an in-house library of exact masses for protonated molecules 
derived from the Model List of Essential Drugs published by the WHO.291 A match was 
considered positive if the difference between the experimental accurate monoisotopic 
mass and the theoretical mass values was less than 5 mmu, and the relative intensity 
equal or larger than 5 %. 
 
A.4. Results and Discussion 
This study was carried out in three stages. First, samples were rapidly analyzed 
using the portable Raman instrument for the analysis of molecular composition of the 
tablets. Second, the results were validated through the vibrational characterization of the 
samples using FT-Raman spectroscopy. Portable Raman and FT-Raman spectroscopy 
was performed through both the blister packs and after sample removal from the blister 
packs. The spectra were found to be practically identical due to the transparent nature of 
   184 
the blister packs, which present little or no spectral features. Also, both sides of the 
tablets were analyzed and no difference was detected. The principal advantage of using 
FT-Raman spectroscopy with a near infrared laser is that less fluorescent interference is 
induced from samples compared to visible excitation. Third, mass spectrometry was used 
to evaluate the results obtained with spectroscopic techniques and confirm the presence 
of the active ingredient in the potentially counterfeit tablets. 
 
A.4.1. Analysis of Genuine Artesunate and Artemisinin-containing Tablets 
The genuine artesunate tablet and all other samples containing artemisinins 
resulted in poor efficiency of Raman scattering due to competition with fluorescence 
phenomenon. This precluded the application of conventional portable Raman 
spectroscopy for their analysis. The observation of strong fluorescence from such 
samples by portable Raman spectroscopy however, suggested the presence of an 
artemisinin, which was identified following FT-Raman and direct ionization MS analysis.  
Figure A.1.a shows traces obtained from the FT-Raman spectroscopy analysis of 
an artesunic acid standard together with those for a genuine artesunate tablet 
manufactured by Guilin Pharmaceutical Co. Ltd (trace (i)) and Mekophar Chemical 
Pharmaceutical Joint Stock Co. (trace (ii)). Apparently, these measurements do not suffer 
from fluorescence and the FT-Raman traces show very similar features for both types of 
genuine sample clearly indicating the presence of artesunic acid in these samples. 
Figure A.1.b shows results from the complementary analysis of the genuine Guilin 
artesunate tablet by DESI MS, which was very similar to that for the Mekophar tablet 
(data not shown). Reagentless DESI MS analysis of this sample generated peaks 
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predominantly at m/z 407.2 and 791.3 corresponding to the species [artesunic acid + Na]+ 
and [2 artesunic acid + Na]+ respectively (Figure A.1.b.i). Analysis by reactive DESI MS  
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Figure A.1. (a) FT-Raman spectra of genuine (i) Guilin and (ii) Mekophar artesunate 
tablets, compared with the reference spectrum of artesunic acid. (b) DESI spectra of the 
genuine Guilin tablet obtained by the (i) reagentless DESI MS and (ii) reactive DESI MS 
modes. 
 
resulted in the peak at m/z 570.4 corresponding to [artesunic acid + DDA + H]+ as the 
predominant species in the spectrum (Figure A.1.b.ii). The presence of artesunic acid in 
these samples was also verified by DART MS analysis (data not shown). The detection of 
artesunic acid as the only active ingredient in both types of genuine artesunate samples by 
direct ionization MS was consistent with Raman results. 
 As with the genuine samples, analysis of the sample S 40-1 by conventional 
Raman spectroscopy resulted in significant fluorescence, which made it difficult to obtain 
an unambiguous Raman spectrum for this sample using the portable instrument. This 
however, suggested the presence of an artemisinin or one of its derivatives in the sample. 
The sample was determined to contain artemisinin (the artesunic acid precursor) 
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following FT-Raman spectroscopy analysis (Figure A.2.a). FT-Raman analysis also 
revealed the presence of starch in this sample. The composition of the sample was  
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Figure A.2. (a) FT Raman spectra of fake tablet S 40-1 compared with the reference 
spectra of starch and artemisinin. (b) Corresponding DESI spectra of fake tablet S 40-1: 
(i) reagentless DESI MS and (ii) reactive DESI MS. 
 
verified by direct ionization MS as follows. Reagentless DESI MS analysis showed peaks 
at m/z 305.1 and 587.3 corresponding to the species [artemisinin + Na]+ and 
[2 artemisinin + Na]+ respectively (Figure A.2.b.i). These assignments were verified by 
reactive DESI, which revealed the characteristic protonated artemisinin adduct with 
dodecylamine at m/z 468.4 (Figure A.2.b.ii). A peak at m/z 750.5 corresponding to the 
species [2 artemisinin + DDA + H]+ can also be seen in the reactive DESI spectrum of 
this sample. Again, the detection of artemisinin in this sample by DESI MS was 
consistent with the results obtained by Raman spectroscopy. 
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A.4.2. Analysis of Counterfeit Tablets 
Analysis of counterfeit artesunate tablets, most of which do not contain 
artemisinins, generally resulted in very negligible fluorescence allowing the collection of 
Raman spectra data using both portable and FT-Raman spectrometers. Results form the 
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Figure A.3. (a) (i) Portable Raman and (ii) FT-Raman spectra of fake tablet LAO BW8 
compared with the reference spectra of starch and dypirone. (b) Corresponding 
reagentless DESI spectra of fake tablet LAO BW8.  
 
spectroscopic techniques consistently verified the absence of artesunic acid in this 
sample. However, the Raman spectra show bands predominantly at 1000, 1355, 1598, 
1632 and 1666 cm-1 which indicate the presence of dipyrone (C13H17N3O4S, an analgesic) 
as wrong active ingredient in this sample. A band at 478 cm-1 attributed to the presence of 
starch was also observed.  Further analysis of this sample by reagentless DESI MS in 
negative mode (Figure A.3.b) shows peaks at m/z 310.1 and 643.2 corresponding to the 
species [dipyrone - H]- and [Na-dipyrone + dipyrone - H]- respectively . These peak 
assignments were verified by DESI MS/MS analysis (data not shown). A peak at m/z 
   188 
191.1 corresponding to a dipyrone fragment due to the neutral loss of Ph-N=NCH3 from 
its precursor was also observed in this reagentless DESI spectrum (Figure A.3.b). The 
detection of dipyrone in this sample was again consistent with results obtained by Raman 
spectroscopy using both portable and FT-Raman instruments. 
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Table A.1. Description of the samples studied. 
artesunic acidb, c, ecalcite, starch, artesunic acidstarchGenuine (Guilin)Lao 0703-1
aThe number for types correspond to the type of fake based on the hologram. bActive Pharmaceutical ingredient (API) detected by reagentless DESI MS. cAPI detected by 
reactive DESI MS. dAPI detected only on the sample surface. 
no API detectedb, c, ecalcite, starchcalcite, starchFake (16)Lao 0701-1
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Guilin)S 62
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Traphaco Co.)Lao 0709-5
artesunic acidb, c, ecalcite, starch, artesunic acidstarch, calciteGenuine (Guilin)Lao 0704
artesunic acidb, c, ecalcite, starch, artesunic acidstarch, calciteGenuine (Mekophar Co.)S 57
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Pharbaco)Lao 0708
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Pharbaco Co.)S 65
no API detectedb, c, ecalcite, starch, talccalcite, starch, talcFake (1)Lao 0702-1
artemisininb, cartemisinin, starch, talcstarch, talcFake (10)China 0604
artesunic acidb, cstarch, calcite, artesunic acidfluorescenceGenuineGhana 0601
artesunic acidb, cstarch, calcite, artesunic acidfluorescenceGenuineS 55
artesunic acidb, cstarch, calcite, artesunic acidfluorescenceGenuineS 51
artesunic acidb, cstarch, calcite, artesunic acidfluorescenceGenuineS 50
artesunic acidc, dstarch, calcite, talcstarch, talcFake (14)S 47-3
artemisinin,c, d artesunic acidc, dstarch, calcite, talcstarch, talcFake (14)S 47-1
artemisinincstarch, calcite, talcstarch, talcFake (14)S 47-2
artemisinincstarch, calcitestarch, calcite, talcFake (13)S 40-2
acetaminophen,b, c artemisinincstarch, acetaminophen, talcstarch, acetaminophen, talcFake (1)S 45
artemisininb,cstarch, artemisinin, talcstarch, talcFake (13)S 40-1
acetaminophen,b, c artemisinincstarch, acetaminophen, calcite, talcstarch, acetaminophen, talcFake (9)S 29
artesunic acidb, c, eartesunic acid, calcitefluorescenceGenuineArtesunate China
artesunic acidb, c, eartesunic acid, calcite, talcstarch, calcite, talcGenuineArtesunate Vietnam
dipyrone,b, e erucamideestarch, dipyronestarch, dipyroneFake (10)Lao BW 8
no API detectedb, c, estarch, acetaminophen, calcite, talcstarch, acetaminophen, calcite, talcFake (11)Lao 0503
artemisininb, cstarch, calcite, talcstarch, calcite, talcFake (6)Lao 0604
artemisininb, c, estarch, calcite, talcstarch, talcFake (10)China 0605
artemisininb, cstarch, calcite, artemisininstarch, calciteFake (6)Lao 12012
erythromycin A,f acetaminophenb, c, fcalcite, acetaminophencalcite, acetaminophenFake (8)Lao 12060
dipyroneb, estarch, dipyrone, calcitestarch, dipyroneFake (10)Lao BW 9
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Guilin)S 60
artesunic acidb, c, ecalcite, starch, artesunic acidfluorescenceGenuine (Guilin)Lao 0705
Results from FT-Raman 
spectrometer
Results from portable 
spectrometer
Genuine/fake as determined by 
packaging inspection and MS 
(Type)a
Sample code MS results
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Table A.1 summarizes the results obtained by both vibrational techniques 
compared with those obtained by direct ionization MS. A total of 30 potentially 
counterfeit artesunate samples were investigated in this study. Although artesunic acid 
shows strong fluorescence, making the collection of Raman spectra data using TruScanTM 
difficult, this shortcoming however serves an indication of the presence of artesunic acid 
in the sample. In all of such cases the presence of artesunic acid was verified by both 
FT-Raman and MS. Also for all the samples for which Raman spectra was obtained using 
TruScanTM, results were consistent with those obtained by FT-Raman spectroscopy. It is 
worth noting that some samples exhibited a band around 676 cm-1, which can be assigned 
to the symmetric Si-O-Si stretching mode of talc (Mg3Si4O10(OH)2).
292 In most cases 
characteristic features at 363 and 293 cm-1 were observed, and these can be related to the 
deformation modes of the silicate network and the stretching Mg–O vibrations, 
respectively. This finding is in agreement with the results presented by de Veij et al.293  
In summary, except for the samples S 47-1 and S-47-3, which contained very 
small amounts of artesunic acid on their surface detected only by reactive DESI MS, 18 
of 32 of the samples were determined to contain artesunic acid by both Raman and MS 
methods. Various wrong active ingredients including acetaminophen, artemisinin, 
dipyrone, erythromycin, erucamide were also detected in various samples by both Raman 
spectroscopy and MS. No active ingredient was detected in the samples LAO 05017, Lao 
0503, Lao 0702-1 and Lao 0701-1 using MS methods. 
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A.5. Conclusions 
This appendix demonstrates the capabilities of a portable Raman spectrometer 
(TruScanTM) as a potentially inexpensive field device for characterizing the composition 
of counterfeit artesunate antimalarial samples without sample preparation. The strong 
fluorescence of artesunic acid makes it difficult to obtain Raman spectra using the 
portable Raman unit. This can however be advantageously exploited as a hint for the 
absence of artesunic acid in the sample during the determination of counterfeits, which in 
general do not show any appreciable fluorescence. The use of the more sensitive FT-
Raman instrumentation allowed the verification of the absence/presence of artesunic acid 
in such samples. For samples, which show negligible fluorescence, typically counterfeits 
with various wrong active ingredients or no active ingredient, the results obtained using 
the portable Raman unit show consistency with those obtained by FT-Raman. Using the 
more sensitive direct ionization MS methods including DESI MS and DART MS, the 
identity of the API present in the various counterfeit artesunate samples was verified. 
These results suggest the applicability of this portable Raman instrument (TruScanTM) as 
a reliable analytical tool for the routine on-site field analysis of pharmaceutical tablets for 
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APPENDIX B. COMBINING TWO-DIMENSIONAL 
DIFFUSION-ORDERED NUCLEAR MAGNETIC RESONANCE 
SPECTROSCOPY, DESI MS AND DART MS FOR THE INTEGRAL 
INVESTIGATION OF COUNTERFEIT PHARMACEUTICALS 
 
B.1. Abstract 
This appendix presents an investigation of the complementarity between 
two-dimensional diffusion-ordered 1H nuclear magnetic resonance spectroscopy (2D 
DOSY 1H NMR) and ambient (DART and DESI) MS methods for assessing the quality 
pharmaceutical tablets for forensic purposes. Fourteen different artesunate tablets, 
representative of what can be purchased from informal sources in SE Asia, were 
investigated using these techniques. The correct API was detected in five formulations by 
both NMR and MS methods. Common organic excipients such as sucrose, lactose, 
stearate, dextrin and starch were also detected. The graphical representation of DOSY 1H 
NMR results proved very useful for establishing similarities among groups of samples, 
enabling counterfeit drug “chemotyping”. Overall, this study suggests that 2D DOSY 1H 
NMR combined with ambient MS composes a powerful suite of instrumental analysis 
methodologies for the integral characterization of counterfeit antimalarials. 
 
B.2. Introduction 
The ever-growing sophistication of counterfeit drugs has placed a requirement for 
the constant development and deployment of increasingly more in-depth pharmaceutical 
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analysis approaches for investigating their composition and origin. In this appendix, 
2D DOSY 1H NMR,294 accurate mass DART and DESI MS are compared and combined 
for the forensic investigation of artesunate antimalarial tablet formulations.  
2D DOSY 1H NMR294 relies on the decrease in diffusion coefficients (D) with 
increasing molecular mass as a means to virtually separate components in a solution 
mixture. The separation is based on the differences in the translational diffusion 
coefficients of individual components in the mixture, which are largely dependent on 
various physical parameters including temperature, solvent viscosity, size and shape of 
the molecule. 2D DOSY 1H NMR spectra therefore show correlations between chemical 
shifts presented on the horizontal axis and the diffusion coefficients expressed in µm2 s-1 
on the vertical axis. All 2D DOSY 1H NMR peaks generated from the same component 
line up at the same diffusion coefficient. As such this technique in a sense provides a 
localized separation of the components in a mixture solution without the need to for any 
physical separation such as observed in chromatographic techniques.  
Two-dimensional DOSY 1H NMR has already been shown to provide a highly 
comprehensive chemical fingerprint of genuine pharmaceutical formulations.295, 296 In 
combination with ambient MS methods, the multipronged approach investigated in this 
study is likely to produce comprehensive chemical information for determining the 
similitude between different classes of fake artesunate pharmaceuticals, a critical step in 
guiding law enforcement and public health agencies towards their most probable origin. 
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B.3. Experimental Details 
B.3.1. Samples 
Fourteen tablet formulations (1-14) were analyzed in this study by both DOSY 
and ambient MS methods. Formulations 4, 6, 7, 9, 13 were classified as genuine products 
based on packaging inspection and were manufactured by Pharbaco (Hanoi, Viet-Nam), 
Mekophar (Ho Chi Minh City, Viet-Nam), Yangon Pharma (Rangoon, Burma), Mepha 
(Basel, Switzerland) and Guilin Pharmaceutical (Guangxi, China), respectively. The 
remaining samples (classified as counterfeit by packaging analysis) were collected on the 
Thai/Burma border, Burma, Cambodia and the Lao PDR (Laos) and mimicked genuine 
antimalarial tablets as manufactured by Guilin Pharmaceuticals. A blister pack containing 
12 tablets was collected for each suspect sample and one tablet from each blister pack 
was available for this study. One half of each tablet was processed for NMR experiments 
whilst the second half was analyzed by DART and DESI MS. The formulations, 
indicated on their blister packs to all contain 50 mg artesunate per tablet were labeled 
with the following collection codes with corresponding packaging types200 respectively: 1 
(S1/2005, Type 9); 2 (S2/2005, Type 4); 3 (S3/2005, Type 4); 4 (S4/2005, Pharbaco, 
Hanoi, Viet-Nam); 5 (S5/2005, Type 10); 6 (S8/2005, Mekophar, Ho Chi Minh City, Viet 
Nam); 7 (S9/2005, Yangon Pharma Industry); 8 (S10/2005, Type 9); 9 (S23/2005, 
Plasmotrim, Mepha, Switzerland); 10 (Laos 05/03, Type 11); 11 (Burma 2/14029, fake, 
Type unknown as hologram cut off); 12 (Laos 2/12070, Type 4); 13 (Cambodia 2/13008, 
genuine, Guilin Pharmaceutical Co. Ltd.); 14 (Laos 05/15, Type 8). 
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B.3.2. 
1
H and 2D DOSY 
1
H NMR Analysis 
1H and 2D DOSY 1H NMR experiments were performed by Stéphane Balayssac, 
a postdoctoral associate with Dr. Robert Martino in the Groupe de RMN Biomédicale,  
Université Paul Sabatier, Toulouse, France. For 1H NMR analyses, a quarter of each 
tablet was powdered and dissolved in 2 mL of dimethylsulfoxide (DMSO)-d6 (Eurisotop, 
Gif-sur-Yvette, France), with magnetic stirring for 15 min and sonication for 5 min. The 
suspension was centrifuged (10 min, 6000 rpm) and the supernatant poured into a 5 mm 
NMR tube for analysis. NMR experiments were performed at 298 K on a Bruker Avance 
500 spectrometer (Bruker BioSpin, Wissembourg, France) equipped with a triple 
resonance 5 mm 1H cryoprobe (TCI) with z-axis gradient. Typical acquisition parameters 
for 1H NMR experiments were as follows: 1.02 s acquisition time, 8000 Hz spectral 
width, 16 K data points, 1 s relaxation delay and 32 scans.  The chemical shifts (δ) were 
referred to an internal trimethylsilylpropane sulfonic acid (TMPS) standard, which gives 
a singlet for the trimethylsilyl moiety at 0 ppm and three multiplets for the propyl chain at 
0.51, 1.58 and 2.40 ppm.  In each spectrum, the peaks at 3.17 and 2.53 ppm correspond to 
the residual signals of HOD and DMSO, respectively. 
For 2D DOSY 1H NMR analyses, stimulated echo bipolar gradient pulse 
experiments including an eddy-current delay of 10 ms and spoiler gradients of -7.92 and 
 -6.09 G cm-1 with a pulse length of 0.6 s were used. The gradient recovery delay was 
3 ms and the relaxation delay was 2 s. Pulse field gradient lengths varied between 
2-2.4 ms and the diffusion delay between 100-170 ms. Sequence parameters were 
adapted in order to decrease the intensity of aromatic NMR signals from the API by at 
least a factor of 50 at 95% of the full gradient strength. When no API was detected, 
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signals from excipients were used for sequence optimization. Forty gradient increments 
(32 scans for each experiment) were recorded with the gradient intensity linearly sampled 
from 5 to 95%. The gradient system was calibrated to 46.25 G cm-1 at maximum intensity 
prior to all experiments. All data were processed using Gifa 5.2 via the inverse Laplace 
Transform method together with the Maximum Entropy algorithm (MaxEnt). The 
processing parameters were 2048 points along the Laplace spectrum diffusion axis and 
20,000 MaxEnt iterations. The inverse Laplace Transform was computed only on the 
columns presenting a signal 32 times greater than the noise level of the experiment. The 
identification of all APIs and excipients was done by comparing δ values to an in-house 
2D DOSY 1H NMR library, or by spiking the samples with standards. Two-dimensional 
gCOSY, gHSQC, and gHMBC 1H NMR experiments were performed to assign the NMR 
signals of artemisinin and artesunic acid (Table B.1), which matched previous literature 
data.297 Spectra analysis was done using the NMR notebook software.298 
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a Spectra were recorded at 298K in DMSO-d6.  
b s: singlet; d: doublet; t: triplet; m: multiplet.  
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B.3.3. Ambient Ionization (DART and DESI) MS 
DART MS experiments were performed by Glenn Harris, a graduate student in 
our group. Experiments were performed using a custom-built DART-type ion source187 
interfaced to a JMS-100TLC (AccuTOF™) TOF mass spectrometer (JEOL, Peabody, 
MA, USA). All experiments were performed in positive ion mode, using similar MS 
setting described in section A.3.4. The DART-type ion source settings were as follows: 
high-purity He (99.999% ultrahigh purity helium, Airgas, Atlanta, GA) flow rate 
7.2 L min-1, heater temperature 200 ºC, corona discharge needle voltage 1000 V, counter 
electrode voltage 200 V, fixed distance between ion source and MS orifice 3 cm.  MS 
data were acquired and processed using the same procedure described in section A.3.4. 
DESI MS experiments were performed using the set-up described in section 6.3.2. 
Experiments were performed by spraying samples with a solution of 99.9% MeOH, 0.1% 
HCOOH at a flow rate of 5 µL min-1. The MS experimental parameters were the same as 
described in section 4.3.4. 
 
B.4. Results and Discussion 
All the samples investigated in this study were first analyzed by 2D DOSY 1H 
NMR followed by complementary analyses by ambient MS methods including DART 
and DESI for validation purposes. These analyses resulted in the samples placed into 
various classes based on the observed chemical signatures, as discussed in the following 
sections.  
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B.4.1. Analysis of Genuine Artesunate Tablets 
The samples 4, 6, 7, 9 and 13 were all categorized as genuine products based on 
packaging inspection, and originated from different manufacturers. They were grouped as 
Class A samples (Table B.2). 2D DOSY 1H NMR and ambient MS analyses revealed two 
different sub-classes within Class A samples, with samples 4, 6, 7 and 9 in one sub-class, 
and sample 13, manufactured by Guilin Pharmaceutical Co. Ltd, being of a different sub-
class. The expected API, artesunic acid, was observed in all the formulations with 
stearate and starch as excipients, as exemplified by the analysis of formulation 4 














Figure B.1. Analyses of formulation 4 by: (a) 2D DOSY 1H NMR in DMSO-d6 with 
TMPS as internal reference standard, positive ion mode (b) DART MS (C) DESI MS. 
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identity of the disaccharides present (lactose vs. sucrose). Lactose was identified in the 
first sub-class (4, 6, 7, 9) and sucrose in the second. Results for formulation 4 are a good 
example of the virtual separation of components, based on their diffusion coefficients, 
observed in a 2D DOSY 1H NMR experiment (Figure B.1.a). Differences between self-
diffusion coefficients of low MW components, H2O (D ≈ 1100 µm
2 s-1) and DMSO (D ≈ 
910 µm2 s-1), intermediate MW components, artesunate (D ≈ 300 µm
2 s-1) and lactose (D 
≈ 250 µm2 s-1), and starch with a very low diffusion coefficient typical of polysaccharides 
(D < 10 µm2 s-1) are readily observed.  DART MS analysis of formulation 4 showed 
peaks at m/z 267.2 and 533.4, assigned as [artesunic acid-C4H6O4+H]
+ and 
[2(artesunic acid-C4H6O4)+H]
+ respectively (Figure B.1.b). Figure B.1.c shows the 
complementary DESI spectrum of this sample. The predominant peaks in the spectrum 
(m/z 407.2, 673.2 and 791.2) were assigned to [artesunic acid+Na]+, 
[2 artesunic acid-C4H6O4+Na]
+, and [2 artesunic acid+Na]+ respectively. Also in this 
spectrum, the peaks at m/z 365.3 and 707.2 were identified as [lactose+Na]+ and 
[2 lactose+Na]+ after comparison against DESI MS2 analyses of standards (vide infra). 
 
B.4.2. Analysis of Counterfeit Artesunate Tablets 
Figure B.2.a shows the 2D DOSY 1H NMR spectrum of formulation 2, which had 
a unique chemical signature, and was thus placed in a unique sample class (Class B, 
Table B.2). Three compounds were identified in this formulation. The API was 
artemisinin (D ≈ 620 µm2s-1), the naturally-occurring precursor for a number of semi-
synthetic antimalarial drugs including artesunate, artemether, dihydroartemisinin and 
artelinic acid. In addition to artemisinin, two other excipients were found in this tablet,  

















































































































Figure B.2. Analyses of formulation 2 by: (a) 2D DOSY 1H NMR in DMSO-d6 with 
TMPS as internal reference standard (SDMSO represents DMSO satellite signals), positive 
ion mode (b) DART MS (c) DESI MS. 
 
viz: dextrin, which shows two characteristic doublets at 6.71 and 6.39 ppm, a triplet at 
4.93 ppm and two series of broad signals between 5.2-5.8 and 3.8-3.0 ppm in 1H NMR. 
The second excipient was a stearate-based lubricant that leads to four signals located at 
0.88 (triplet), 1.26 (broad singlet), 1.50 (quintuplet) and 2.14 (triplet) ppm. Results from 
the complementary analysis of this sample by both DART and DESI MS are illustrated in 
Figures B.2.b-c. The peaks at m/z 283.2 and 565.3 in the DART spectrum (Figure B.2.b) 
correspond to the protonated artemisinin monomer and dimer, respectively. Peaks at m/z 
300.2 and 582.7 were also observed, corresponding to the respective ammonium adducts. 
Analysis of this sample by DESI MS in positive ion mode showed peaks at m/z 305.1, 
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587.3 and 869.4 (Figure B.2.c), which corresponded to sodiated adducts of monomeric, 
dimeric, and trimeric artemisinin. The excipients detected by 2D DOSY 1H NMR were 
not detected by either DART or DESI MS. Although stearate is not expected to ionize 
well in positive ion mode, dextrin, which could be ionized, was also not observed. This 
phenomenon could stem from the higher ionization efficiency of artemisinin, which 
suppresses ionization of other compounds in the sample. Surprisingly, these species were 
not observed in the negative ion mode probably due to similar effects. The correct API, 
artesunic acid, was not observed in this sample by any of the assayed methods. 
2D DOSY 1H NMR analysis of formulation 11 (Figure B.3.a) revealed a unique 
chemical signature, and was assigned as Class C (Table 1). The tablet contained no 
identifiable API, but a stearate-based lubricant along with the tablet diluents starch (five 
broad signals at 5.53, 5.43, 5.13, 4.61 and 3.61 ppm) and sucrose (two doublets at 5.08 
and 4.52 ppm, a triplet at 3.91 ppm and multiplets at 5.21, 4.82, 4.42 and between 3.8 and 
3.1 ppm) were found to be present. Minor unknown signals (a singlet at 6.50 ppm and 
four doublets at 6.08, 7.62, 8.19 and 8.36 ppm) were also detected. DART MS analysis of 
sample 11 did not yield any identifiable peaks. However, analysis of this sample by DESI 
MS in positive ion mode showed two prominent peaks at m/z 365.3 and 707.2, identified 
as sodiated sucrose monomer and dimer respectively (Figure B.3.b). The peak identities 
were determined by comparing the DESI MS and MS2 spectra of this sample against 
sucrose (Figure B.3.c) and lactose (Figure B.3.d) standards. Because these disaccharides 
are structural isomers, only DESI MS2, but not DESI MS, can distinguish between them. 
Figure B.4 summarizes the various cleavages and fragment ions observed by DESI MS2 
of the precursor ions, m/z 365.3. For both sodiated sugars, cleavages at the glycosidic  
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Figure B.3. Analyses of formulation 11 by: (a) 2D DOSY 1H NMR in DMSO-d6 with 
TMPS as internal reference standard (SDMSO represents DMSO satellite signals); and 
(b) DESI MS in positive ion mode. (C) DESI spectrum of a sucrose standard (10 µL, 1 
mg mL-1), (D) DESI spectrum of a lactose standard (10 µL, 1 mg mL-1). Standards were 
deposited onto PTFE and analyzed after air drying. The inserts in (b), (c) and (d) 
represent the corresponding DESI MS2 spectra generated from the ion at m/z 365.3. 
 
bonds occur with the competitive retention of a sodium ion on each monosaccharide unit, 
with or without an additional loss of a water molecule to generate [monosaccharide+Na]+ 
and [monosaccharide-H2O+Na]
+ ions at m/z 203.2 and 185.1, respectively.  For sodiated 
lactose (Figure B.4.a), additional fragment ions corresponding to the loss of a water 
molecule or two formaldehyde molecules from the precursor ion are observed, generating 
diagnostic signals at m/z 347.2 and m/z 305.2 for distinguishing between sucrose 
(Figure B.4.b) and lactose. The detection of sucrose and no APIs in this sample by DESI 
MS was thus consistent with DOSY NMR results. 
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(a) (b)
 
Figure B.4. Fragment ions observed for the isomeric species: (a) [lactose + Na]+ and 
(b) [sucrose + Na]+. 
 
 Table B.2 presents a summary of the results obtained following 2D DOSY 1H 
NMR and ambient MS analyses of all the samples investigated in this study. The analyses 
of artesunate tablets formulation using these complementary analytical techniques 
enabled the comprehensive determination of the chemical signatures presented by each 
sample readily placing them into distinct classes (chemotypes). For a total of 14 
formulations evaluated, the correct API was detected in only five formulations. The 
remaining formulations were observed to contain various “wrong” APIs. DESI and 
DART did not readily offer information about the presence of stearate and polymeric 
excipients such as dextrin, which were detected by 2D DOSY 1H NMR. Interestingly, no 
disaccharides (lactose, sucrose) were detected by DART. This is possibly due to the 
different desorption mechanism of this technique, which is believed to be predominantly 
thermal, compared to DESI, which relies on the solubility of the analyte in the spray 
solution.  
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Table B.2. APIs and excipients detected by 2D DOSY 1H NMR, DESI and DART MS in 14 different antimalarial 
formulations. 
Formulations 
Class A Class B Class C Class D Class E Class F Class G Compound Technique 
4, 6, 7, 9 13 2 11 10, 14 12 1, 8 3, 5 
Packaging Type200   Genuine Genuine 4 N/Ac 8, 11 4 9 4, 10 
DOSY NMR          
Artesunic acid 
DESI/DART MS / /─       
DOSY NMR          
Artemisinin 
DESI/DART MS   /      
DOSY NMR          
Acetaminophen 
DESI/DART MS       /  
DOSY NMR          
Dipyrone 
DESI/DART MS        / 
DOSY NMR          
Stearate 
DESI/DART MS         
DOSY NMR           
Sucrose DESI/DART MS  /─  /─     
DOSY NMR           
Lactose 
DESI/DART MS /─    /─    
DOSY NMR          
Dextrin 
DESI/DART MS         
DOSY NMR          
Starch 
DESI/DART MS         
cThe packaging type of Class C formulations could not be assigned, because the hologram had been cut off. 
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B.5. Conclusions 
This appendix highlights the use of complementary analytical methods, 2D 
DOSY 1H NMR and ambient (DART and DESI) MS to characterize the chemical 
composition of counterfeit antimalarial drugs. Both methods allowed the detection of 
various APIs and tablet excipients enabling samples to be readily categorized into seven 
distinct classes based on their chemical signatures. 2D DOSY 1H NMR allows a much 
increased peak capacity compared to classical 1D 1H NMR, arising from the use of both 
chemical shifts and diffusion coefficients as analytical dimensions in the former, making 
it a very appealing analytical technique. The facile chemotyping of samples following 2D 
DOSY 1H NMR and ambient MS analyses provides compelling evidence that suggests 
that samples within each chemotype are most likely manufactured by the same 
establishment thus alluding to the number of distinct genuine and/or counterfeit 
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APPENDIX C. A COLLABORATIVE EPIDEMIOLOGICAL 
INVESTIGATION INTO THE CRIMINAL FAKE ARTESUNATE 
TRADE IN SOUTH EAST ASIA 
 
C.1. Abstract 
This appendix presents efforts by an international collaboration for the 
conglomeration of detailed forensic evidence on genuine and counterfeit artesunate 
tablets, using a plethora of analytical techniques with the goal of determining the source 
of counterfeits. This collaboration involved our laboratory, a group of police, criminal 
analysts, palynologists, and health workers, working together under the auspices of the 
International Criminal Police Organization (INTERPOL) and the Western Pacific World 
Health Organization Regional Office. The evidence collected following chemical, 
mineralogical, biological, and packaging analysis suggested that at least some of the 
counterfeits were manufactured in southeast People’s Republic of China. This evidence 




Since the first description of fake artesunate in 2000, very little effort has been 
invested towards a careful collection of forensic evidence, which could enable a 
determination of their source to allow possible law enforcement in shutting down 
operations and prosecution of counterfeiters. Notwithstanding the huge public health 
consequences of counterfeit artesunate antimalarial, the only actions that were taken 
   208 
included surveys,217, 218, 220, 222, 299, 300 warnings and educational films220, 301 resulting in 
some strengthening of drug regulatory authority (DRA) and malaria program capacity. 
This appendix presents efforts by a joint multidisciplinary team comprising our lab. 
(performing ambient MS), the center for disease control (CDC), criminal analysts, 
palynologists, and health workers under the auspices of the INTERPOL and the Western 
Pacific World Health Organization Regional Office to collect forensic evidence for the 
different types of fake and genuine artesunate samples to enable a criminal investigation 
into the counterfeiting ring. 
Following the worsening contamination of the supply of antimalarials in the 
Greater Mekong Sub-Region by counterfeits, a confidential meeting was held in Manila 
in May 2005 at the WHO Regional Office for the Western Pacific (WPRO). This meeting 
brought together WHO officials, physicians, pharmacists and scientists working in the 
region with the INTERPOL to discuss what could be done. It was decided to join forces 
to investigate where the counterfeits were being manufactured and develop an 
intelligence document that could be presented to concerned governments with a request 
that measures be taken to stop the lethal manufacture and trade in counterfeit artesunate. 
In the hope that forensic analysis of genuine and counterfeit tablets would provide clues 
as to the origin of the counterfeits, samples were subjected to high performance liquid 
chromatography (HPLC), ambient mass spectrometry, X-ray diffraction (XRD), isotope 
ratio mass spectrometry (IRMS), gas-chromatographic (GC) ‘head space’ analysis of the 
gases surrounding tablets in blisterpacks, pollen analysis (palynology) and detailed 
packaging inspection. This appendix presents a summary of the forensic evidence 
acquired and the findings relevant to public health. 
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C.3. Experimental Details 
C.3.1. Samples 
Data were pulled together from the analyses of a total of 391 samples collected in 
a wide area of SE Asia encompassing Vietnam (75), Cambodia (48), Lao PDR (115), 
Myanmar (137) and the Thai/Myanmar border (16), during 2000-2006 period and were 
kept refrigerated (4° C) until analysis. The samples were collected using convenience 
sampling,217, 218, 299 random sampling (in Laos only)287 and ad hoc at the request of 
individuals and NGOs in the region. All samples underwent Fast Red Trypaflavine (TR) 
Dye testing227, 302 and/or HPLC, packaging analysis (see section 2.3.2.) and ambient MS. 
A subset of 27 fakes from this collection and 5 genuines, along with 4 fake (collected in 
Cambodia) and 2 genuine samples from the United States Pharmacopeia (USP) Drug 
Quality and Information program, also underwent detailed forensic chemical and 
palynological examination. 5 samples seized by the Ministry of Public Security (MPS) 
investigation in China were also evaluated. All laboratories performed the analyses 
blinded to the results from other laboratories. 
 
C.3.2. Palynology  
Palynology is the science that deals with the study of contemporary and fossil 
palynomorphs, including pollen, spores, dinoflagellate cysts, acritarchs, chitinozoans and 
scolecodonts, together with particulate organic matter and kerogen found in sedimentary 
rocks and sediments. Some of these substances have been found trapped in counterfeit 
drug tablets, and their geographical origin, especially of pollen, have been used to link 
counterfeit drugs to their source of manufacture. However, results obtained from 
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palynological analysis must be interpreted with caution as the spore and pollen content 
could be indicative of either the place of manufacture, the source of the individual 
ingredients, or both, and could also be influenced by their wind dispersal and seasonality. 
Palynological analysis200 was performed by Dallas C. Mildenhall of GNS Science, 
Lower Hutt, New Zealand. Briefly, tablets were dissolved in hot distilled water or 10% 
hydrochloric acid yielding two fractions of material in which the top fraction, which 
contains spores and pollen, was dissolved in 9:1 (v:v) acetic anyhydride:sulfuric acid. 
Mineral material remaining was removed by 50% hydrofluoric acid and was filtered 
through a 6 µm mesh. All residues were mounted on glass microscope slides and 
examined at a magnification of x125-250. The taxa of suspected pollen grains were 
identified by comparison with an internal GNS Science reference library of modern 
spores and pollen collection.303-306  
 
C.3.3. XRD and IRMS 
XRD307 analyses were performed by S. W. Ray Soong from GNS Science, Lower 
Hutt, New Zealand while stable isotope ratio MS308 was performed by Kevin Faure, also 
from GNS Science. The basic protocol was as follows: each sample was crushed and 
mounted as a slurry on a silicon plate and was analyzed by XRD (X'Pert Pro X-ray 
Diffractometer, Philips, Almelo) and IRMS analysis to determine the mineral 








































































































notation.309 Samples were analyzed in duplicate and values averaged. 
   211 
C.3.4. LC Diode Array Analysis 
HPLC analysis198 was performed by Dr. Michael D. Green of the Division of 
Parasitic Diseases of the CDC, Atlanta, GA. Briefly, a 150 x 4.6 mm octadecylsilica 
column with a mobile phase consisting of 45% acetonitrile and 55% 0.05 M perchlorate 
buffer (pH 2.5) was used to effectively separated artemisinin, acetaminophen, and 
artesunate. For quantitative acetaminophen analysis, the mobile phase was changed to 
10% acetonitrile and 90% perchlorate buffer. Components were detected using a diode 
array detector with wavelengths set at 220 and 254 nm. UV spectra of samples were 
compared with artesunate, artemisinin and acetaminophen reference standards for 
validation. 
 
C.3.5. Ambient Ionization (DESI and DART) MS 
Ambient MS analyses by DESI and DART MS was performed using the 
procedure described in section A.3.4. DESI was performed in both the reagentless and 
reactive mode for validation purposes.  
 
C.4. Results and Discussion 
A total of 14 different hologram types were identified in the wide area of SE Asia, 
up to and including 2006. A further two hologram types were identified in 2006-2007 
making a total of 16 hologram types identified in this region (see Figure 2.2, Chapter 2). 
The aggregated results obtained from the various analyses of the samples constituting all 
16 hologram types are summarized in Table S1 of Newton et al.200 
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C.4.1. Determination of API(s) in the Samples 
HPLC and/or DART- and DESI-MS confirmed that all specimens speculated to 
be counterfeit (195/ 391, 49.9%) on the basis of packaging contained no or small 
quantities of artesunic acid (up to 12 mg per tablet as opposed to the expected 50 mg per 
genuine tablet). One sample from Cambodia had apparently genuine packaging but 
contained only 21 mg artesunic acid and was therefore either substandard or had 
deteriorated in transit and/or storage.222 Of 321 samples labeled as made by Guilin 
Pharmaceutical, 195 (61%) were counterfeit. A wide variety of unexpected ‘wrong’ 
pharmaceuticals were identified in the counterfeit samples, including acetaminophen (n = 
24), sulphadoxine (n = 18), pyrimethamine (n = 11), dimethylfumarate (n = 17), 
erythromycin (n = 8), erucamide (n = 5), safrole (n = 6), artemisinin (n = 10) dipyrone (n 
= 10), 2- mercaptobenzothiazole (n = 5), chloramphenicol (n = 4), metronidazole (n = 2) 
and chloroquine (n = 2). 
 
C.4.2. Palynological and Mineralogical Investigation 
Most of the spores and pollen identified in the samples had a distinct northern 
Asian temperate signature with evidence for plants such as firs, pines, cypresses, 
sycamores, alders, wormwood, willows, elms, wattles, and fern spores. Figure C.1 shows 
photos of some of the debris found in the counterfeit tablets. 
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Figure C.1. Photomicrographs of material found in fake artesunate tablets. (a) Debris, 
including charcoal fragments. (b) Pinus pollen grain. (c) Juglans pollen grain. (d) Acacia 
pollen grain with charcoal deposit. (e) Dermatophagoides mite nymph. 
 
The estimated origin of the samples includes northernmost Vietnam, southern 
China, and near the mountains, bordering Myanmar and Vietnam (see Figure 2.2). Some 
of the plant remains, such as Juglandaceae pollen (walnut), Carya (wing nut), and 
Pterocarya (hickory), suggest manufacture in southern China. In terms of palynological 
analysis for samples having different types of fake hologram/sticker, Type 2 differs from 
the others as it lacks fern spores, Type 1 contained little material but appeared similar to 
Type 3, and Types 10, 11 and 12 had similar pollen signatures. Types 5 and 8 did not 
contain anything to enable comparisons to be made and Types 4, 6, 7, 9, 13 & 14 were 
not examined. 
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In addition to plant remains, five samples contained invertebrates, including a 
Dermatophagoides mite nymph (from Type 11, Vietnam, Figure C.1.e), which is 
commonly found in house dust and has a global distribution. All fake artesunate tablets 
contained charcoal fragments and black chips, broken up by the processing for pollen. In 
some samples, charcoal was so abundant that it suggested the source was an area 
suffering severe air pollution. 
XRD demonstrated great variability in tablet mineralogy. Although, maize starch 
is the main excipient in the genuine Guilin product, talc (hydrated magnesium silicate), 
calcite (calcium carbonate) and starch were the main excipients detected in the 
counterfeit tablets. Trace amounts of aragonite were present in two calcite-dominated 
fake tablets and traces of chlorite (iron-magnesium hydrosilicate) and quartz (silicon 
dioxide) were found in another two. Stable isotope analysis of the calcite fraction gave 
δ
18O and δ13C values between -11 to +2% and +2 to + 25 %, respectively, as shown in 
Figure C.2. 
Given the similar isotope signatures, the calcite in all (Types 2, 4, 5, 8, and 11) 
but one sample appears to come from the same source and is either hydrothermal or 
medical in origin. The one exception is sample 05/17 (Type 12) from southern Laos 
which, if the calcite is assumed to have been formed by natural geological processes, is 
typical of marine limestone. 
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Figure C.2. Plot of δ13C and δ18O values, in % of carbonate in tablets. Approximate 
values expected from calcite in different geological environments (pink = igneous; 
yellow = metamorphosed; green = unaltered) is also plotted. The top right data point 
represents sample 05/17. 
 
C.4.3. Interpretation of the Evidence 
Although at first glance, the pooling of chemical, palynological and packaging 
evidence suggests a wide diversity of fake artesunate in SE Asia with strikingly different 
fake holograms and chemical signatures, some generalization can be made. For example, 
palynological evidence suggests that all counterfeits were produced in temperate areas 
along the borders between China and neighboring countries in SE Asia. Inspection of 
maps of the geographical distribution of fake artesunate (see Figure 2.2) suggests that 
there may be two different origins of counterfeit artesunate, with similarities between the 
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samples in Myanmar, the Thai-Myanmar border and northern Laos in a westerly group, 
and similarities between those recovered in southern Laos, Vietnam and Cambodia in a 
easterly group. Of the 319 samples labeled as made by Guilin Pharmaceutical Co, with a 
detailed location recorded, there were a significantly higher proportion of counterfeit 
drugs in the east than in the west (41% (62/151) vs. 79% (133/168), p < 0001). In 
addition, in the west 73% (37/51) of batch numbers used were invalid whereas in the east 
only 1.5% (2/128) were invalid (χ2 = 107.8, p<0.0001). 
Fakes with stickers were only found in Vietnam and Cambodia while those with 
holograms were only found in Myanmar and along the Thai-Myanmar border. Both 
stickers and holograms were found in northern and southern Laos. All of the different 
fake holograms have mis-registration of the outer ring of the Guilin logo and although the 
errors differ between all Types, they have been made in the same way, suggesting the use 
of similar technology and machines. Types 2, 3, 5, 7, 11, and 12 were only found in the 
east while 6, 9, and 10 were only found in the west. Types 1, 4, and 8 were found in the 
east and the west but in varying proportions as 82% of Type 1, 17% of Type 4 and 25% 
of Type 8 were found in the west. With the exception of Type 4, all counterfeits 
containing calcite bore stickers and not fake holograms. However, the pollen signatures 
of Types 3, 11 & 12 (easterly) and 9 & 10 (westerly) were similar, suggesting that the 
manufacturing sites of these two groups may be in the same area of southern China, but 
that are parts of separate operations having different distribution networks. Types 8, 11, 
and 12 all contain an error in the upper case font for ‘Mfg’ and ‘Exp’ suggesting a link 
between the producers of these three types. The occurrence of a Type 10 blisterpack in a 
Type 4 box and a Type 13 blisterpack in a Type 9 box suggests links between the 
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producers and/or distributors of these fakes. All of this evidence supports the ‘easterly’ 
and ‘westerly’ distribution hypothesis. 
The existence of two main sources is also suggested by DART- and DESI-MS 
analysis. Metronidazole and artesunate were only found in westerly group samples while 
sulphadoxine, pyrimethamine, erythromycin and erucamide were found only in the 
easterly group samples. Dimethylfumarate (88%), 2-mercaptobenzothiazole (80%), 
metamizole (70%), safrole (67%), acetaminophen (67%) and artemisinin (60%), were 
found predominantly in the east. Samples containing chloramphenicol, and chloroquine 
were in equal numbers in each geographical group. Counterfeit artesunate (Type 14) was 
shown to contain some artesunate on the exterior surface suggesting that the counterfeit 
tablets may have been contaminated with the genuine ingredient in the tablet press left 
over from the manufacture of genuine product at an unknown location.102 The presence of 
sulphadoxine and pyrimethamine further suggests that the factory had been making, or 
had access to, sulphadoxine+pyrimethamine, an anti-malarial combination therapy that is 
no longer effective in SE Asia. The discovery of safrole is of considerable concern and 
interest as it is a precursor in the synthesis of methylenedioxymethamphetamine (MDMA 
or Ectasy) and is a banned chemical in the United Nations Convention Against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances.310 However, MDMA was not 
detected in or on the counterfeits. 
All of the counterfeits purchased from Vietnam, except for Type 12, contained 
calcite having C and O stable isotope ratios that are consistent with what would be found 
in an area being volcanic in origin rather than that originating from marine or terrestrial 
limestone or tap water precipitation. One such area having high temperature 
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hydrothermal calcite is mined in an area west of Nanning, close to the Vietnam border 
(see Figure 2.2) and the calcite used in Types 2, 4, 5, 8 and 11 may have originated from 
these mines. 
This combination of excipient composition and palynology results therefore 
suggested that at least some of the counterfeit artesunate were coming from southern 
China or close to its border with Vietnam, Thailand and Myanmar. Furthermore, the 
evidence suggests that there are at least two distribution routes followed for these 
counterfeit products with westerly origins via Myanmar and easterly origins via Vietnam 
with Laos in the middle, an area of overlap afflicted by Types of both groups. 
The evidence described here was presented by the Secretary General of 
INTERPOL (Mr. Ronald K Noble) to the Assistant MPS (Mr. Zheng Shaodong) in 
March 2006 in Beijing, China. In response, a criminal investigation was carried out 
leading to the arrest of a native of Yunnan Province who, it was alleged, had bought 
240,000 blisterpacks of counterfeit artesunate (Figure C.3) from a native of Guangdong 
Province, China, which is thought to be the origin of these counterfeits. As Guilin 
Pharmaceutical Co. Ltd. exported 272,000 blisterpacks to Myanmar and Thailand during 
this time, an estimated 47% of artesunate available in the market was fake which is 
consistent with previous estimates of the proportion of fake artesunate in mainland SE 
Asian shops. 
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Figure C.3. Counterfeit artesunate samples seized during arrests made after reporting of 
findings of Operation Jupiter to Chinese government officials. 
 
The seized samples appeared to be related to the more sophisticated westerly 
counterfeits found in Myanmar, Thai-Myanmar border and Laos bearing sophisticated 
holograms and without the plethora of wrong APIs (other than artemisinin). This 
assertion was also supported by the absence of calcite in these counterfeits. However, 
based upon the findings presented here, there is a strong possibility that there is a second 
trade route involving a different group of criminals distributing and/or manufacturing 
fake artesunate, with poor quality stickers and a variety of wrong ingredients with calcite, 
into Vietnam, Cambodia and southern Laos. If this hypothesis is correct, future 
examination of the prevalence of different types would be expected to demonstrate a 
reduction in the westerly distribution, but not that being fed by the easterly trade route. 
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C.5. Conclusions 
This appendix showcases the strengths of combining a plethora of analytical 
techniques including HPLC, ambient MS, XRD, IRMS, GC ‘head space’ analysis, 
palynology and packaging analysis to allow the collection of detailed forensic evidence to 
enable a determination of the source of counterfeit artesunate antimalarial tablets. Of 391 
tablets investigated using these techniques, 196 (50.1%) were shown to be genuine 
artesunate samples while the remaining 195 samples were determined to be counterfeit. 
The counterfeit samples contained various wrong active pharmaceutical ingredients 
including erythromycin (22.5%), acetaminophen (6.1%), artemisinin (2.6%), safrole 
(1.6%), as well as several other compounds. This evidence suggested two different 
origins of counterfeit artesunate, with similarities between the samples in Myanmar, the 
Thai-Myanmar border and northern Laos in a westerly group, and similarities between 
those recovered in southern Laos, Vietnam and Cambodia in a easterly group. The 
abundant forensic evidence provided by these tools was advantageously exploited to 
initiate a criminal investigation into the critical fake artesunate trade. This first led to the 
arrest of a native of Yunnan Province who, it was alleged, had bought 240,000 blister 
packs of counterfeit artesunate from a native of Guangdong Province, China who was 
also arrested. All those arrested are currently being prosecuted. The international cross-
disciplinary approach presented in this study may be appropriate in the investigation of 
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